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ABSTRACT 
In this thesis, the synthesis and applications of biomimetic amphiphilic ABA triblock copolymers are 
discussed. Polydimethylsiloxane hydrophobic middle block was synthesized and end-functionalized. Hydrophilic 
poly-2-methyl-2-oxazoline blocks were polymerized onto the PDMS macroinitiator, in symmetric cationic ring 
opening polymerization reaction. The end-groups of the synthesized block copolymers were further 
functionalized with biotin and methacrylate groups. Block copolymers were designed to self-assemble into 
vesicular structures in dilute aqueous solutions and the properties of the resulting membranes were tuned by the 
molecular weight of the hydrophobic blocks and the hydrophilic to hydrophobic ratio. Membranes built from the 
synthesized triblock copolymers were used to mimic the properties of natural lipid bilayers providing higher 
stability.  
Block copolymer membranes were reconstituted with a number of natural membrane proteins, thus 
introducing biological activity and functionality to synthetic materials. Insertion of a bacterial Aquaporin-Z 
channel protein into water (and solutes) impermeable polymeric membrane resulted in novel hybrid materials 
promising great improvement in the area of water purification. High impermeability and stability of the triblock 
copolymer membranes provided an excellent tool to investigate the influence of environmental conditions on 
transport properties of Aquaporin-Z. Combining the outer membrane protein F - reconstituted polymer vesicles, 
encapsulating water-soluble enzymes, with receptor-ligand mediated immobilization resulted in an development 
of immobilized polymeric nanoreactors system.  Its potential relevance is in the field of microfluidics, sensors 
and single molecule spectroscopy, as well as basic research on sensitive molecules and chemically/biologically 
active surfaces. Block copolymer membranes, in combination with a complex membrane protein, NADH: 
Ubiquinone Oxidoreductase, were used in the design of the electron -transfer nanodevice that allows site-specific 
reactions driven by redox-potential differences. Vesicular morphology of aggregates formed by triblock 
copolymers in dilute aqueous solutions was also utilized in the studies towards potential applications as a drug 
delivery platform. Interactions of block copolymers with lipids of different properties are also discussed.  
The structure of the thesis guides the reader through a general introduction to amphiphilic materials, their self-
assembly properties and applications (Chapter 1). Polymer-protein hybrid materials are introduced together with 
membrane proteins used in this work (Chapter 1). The experimental part is divided into two sections: the first 
describing synthetic routes and characterization of the block copolymers, and the second in the form of original 
publications, presenting applications of the block copolymers (Chapter 2). Conclusions drawn from our 
experiments are presented in Chapter 3 and the outlook of our work is outlined in Chapter 4. Information about 
the materials and methods used and not presented in original publications is shown in Chapter 5 and literature 
references listed in Chapter 6.  
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Abreviations list: 
AFM   atomic force microscopy 
AQP-Z   aquaporin-Z 
CLSM   confocal laser scanning microscopy 
Complex-I NADH:Ubiquinone Oxidoreductase 
Cryo-TEM  cryogenic transmission electron microscopy 
Da   Dalton (g/mol) 
DCC   dicyclohexyl carbodiimide 
DLS   dynamic light scattering 
DMAP   4-dimethylaminopyridine 
FCS   fluorescence correlation spectroscopyh hour(s) 
FTIR                         fourier transform spectroscopy 
GPC gel permeation chromatography  
H hour(s)  
IEM   2-isocyanatoethylmethacrylate 
IR   infrared spectroscopy 
LamB   Maltoporin 
MALDI-TOF-MS matrix assisted laser desorption absorption-time of flight-mass spectrometry 
M   mol/L 
Mn   number average molecular weight 
sec   second  
NMR   nuclear magnetic resonance spectroscopy 
OmpF   E. coli outer membrane porin F 
PDI   polydispersity index 
PDMS   poly(dimethyl siloxane) 
PEG   poly(ethylene glycol) 
PMOXA  poly(methyl oxazoline) 
ppm   parts per million 
Rg   radius of gyration 
Rh   hydrodynamic radius 
SLS   static light scattering 
TEA   triethylamine 
TfSA    triflic anhydride 
Tg   glass transition temperature 
TEM   transmission electron microscopy 
THF   tetrahydrofurane 
UF   ultra filtration 
UV   ultra violet 
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Objectives and scope 
The main objective of this work was to explore the possibility of application of synthetic ABA 
block copolymers, in new polymer - membrane protein hybrid materials. Combining the advantages of 
using stable polymer membranes of tunable properties with functions of the specific membrane 
proteins, incorporated in the membranes of vesicular aggregates, allows the design of bioinspired 
nanoscale devices with potential application in: 
- Water treatment: by incorporation of highly selective membrane protein channel, 
Aquaporin-Z, into otherwise highly impermeable polymer membranes (Chapter 2.4.1).  
- Sensors: by development of the immobilized protein-polymer nanoreactor system (Chapter 
2.4.2). 
- Biomimetics: by providing a stable and impermeable platform for studying the functions of 
membranes reconstituted with membrane proteins: water transport and its gating in 
Aquaporin-Z in different external environmental conditions (Chapter 2.4.3), and proton 
transfer in NADH: ubiquinone reductase (Chapter2.4.4) 
- Drug delivery: Receptor-targeted polymer vesicle-based Drug Delivery Formulation of 
Pravastatin (chapter 2.4.5) and Functionalized Nanocompartments (Synthosomes) with a 
Reduction-Triggered Release System (Chapter 2.4.6). 
 
In the scope of this thesis, synthesis, modifications, characterization and applications of bio-
inspired, symmetric, amphiphilic ABA tri-block copolymers, mimicking and/or substituting natural 
membranes functions, will be discussed. The self-assembly of the synthesized ABA block copolymers 
into vesicular structures, mimicking and/or substituting the function of natural membranes, in dilute 
aqueous solutions was targeted and characterized. Due to the unavoidable presence of lipid molecules 
in purified membrane protein extracts, interactions of ABA block copolymers with lipids of different 
chemical and physical properties are also discussed in Chapter 2.4.7. 
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1. Introduction: 
1.1 The science of macromolecules 
The science of macromolecules can be divided into two important sections: 
biomacromolecules (proteins, polysaccharides, etc.) and synthetic polymers. While the former has 
been mostly studying biomacromolecules in living organisms, the latter focused on the industrial 
production and improvements of everyday use plastics since the emergence of the interest in high 
molecular weight materials in 1930`s.1 The issues addressed in molecular biology, that are so central 
to protein structure - secondary and tertiary structural motifs, ligand-receptor interactions, had no real 
analogue in synthetic polymer science. Meanwhile, subjects of polymer science, such as: 
crystallization, melt dynamics, and rheology had little relevance to biology. With the development of 
modern techniques and methods, both research routes met each other resulting in multidisciplinary 
research combining mutual approaches.2 Thus, in polymer science, we have seen that the focus shifts 
away from the properties of bulk materials to the search for new functionality by design at the 
molecular level and control over molecular architecture. In cell biology, new methods of single 
molecule biophysics  allow us to study the behavior of biological macromolecules in their natural 
environment, rather than in e.g. a protein crystal.3 This is not yet a full control and understanding of 
molecular “machines” and their mechanisms, but a step forward towards the understanding of natural 
processes. The mutual goal of this multidisciplinary research is to create synthetic analogues of the 
natural systems of molecular sensing and communication of the cell. 4  
One of the examples of successful cooperation between synthetic polymer science and 
biology, is the development of new macromolecular systems mimicking the structure and behavior of 
biological objects.5 Employing of such biomimetics allows not only elucidation and study of the 
mechanisms of complex biological reactions, energy-efficient separation, and sorting of molecules, but 
also creation of new candidates for medical applications. The macromolecular self-assemblies are the 
most promising cell membrane mimetic system so far.6 Creating complex nanostructures by 
programmed and controlled interactions of macromolecules, offers the variety of morphologies that 
can be obtained from block copolymer systems in aqueous solutions5. Potential devices inspired by 
reverse engineering of biology would be of huge practical benefit. Equally significant benefit would be 
related to deeper understanding of the mechanisms of biology, which would arise from trying to copy 
it.2 The following chapter provides an overview on architectures and self assembly of amphiphilic 
block copolymers, which prove to be excellent candidates for biological – synthetic hybrid materials. 
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1.2 Amphiphilic block polymers and their self assembly 
1.2.1 Amphiphilic block copolymers 
Amphiphilic block copolymer, as a term derives from amphiphile (Greek αμφις, amphis: both and 
φιλíα, philia: love, friendship) and describes a chemical compound of polymeric nature, composed of 
repeating units of hydrophilic and hydrophobic segments linked together by a covalent bond.7 The 
architectures of amphiphilic block copolymers, follows the same variety as seen for homopolymers: 
linear, cycle, multi-arm star, comb, hyperbranched or dendrimeric8.9 Figure 1 shows the possible 
amphiphilic block copolymers architectures. The number of different blocks involved, is limited only 
by the synthetic route and desired further applications10.  
 
Figure 1. Possible amphiphilic block copolymers architectures: A – AB – diblock, B – ABA triblock, C – ABC – 
triblock, D – dendrimeric, E – star-shape, F – grafted.11   
 
1.2.2 Self assembly of amphiphilic polymers 
Similarly to their low molecular mass analogues (surfactants12 and lipids13), amphiphilic block 
copolymers aggregate in solution. The driving force for self assembly is of a non-covalent nature. The 
unfavorable contact between one of the blocks, with solvent molecules of different polarity, triggers 
organization of macromolecules11, while the covalent bond between the “incompatible” blocks 
prevents the macrophase separation. Thus, the process is driven by an unfavorable mixing enthalpy 
and low mixing entropy.10 The kinetic behavior of chain rearrangements, due to high molecular 
weights of the block copolymers, can influence the phase behavior of amphiphilic systems. Figure 2 
shows a schematic representation of possible aggregate morphologies from amphiphilic block 
copolymers.  
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Figure2. A schematic representation of possible aggregate morphologies from amphiphilic block copolymers: A 
– spherical micelle, B - worm-like micelle, C - vesicle, D - tube.11 
 The morphology of resulting aggregates is governed by the nature of the building blocks, architecture 
of the block copolymer, weight fraction of the hydrophilic block and solvent type10. Additional factors 
influencing morphologies of the aggregates are: concentration of the block copolymer14, temperature15, 
16, pH15, presence of salts15,16 and polymer purity (molecular weight distribution and presence of the 
homopolymer)17. 
In Figure 3, the phase diagram of amphiphilic poly(ethylenoxide)-co-poly(butylene oxide) (PEO-
PBO) is presented, showing the evolution of the aggregates from bulk lamellae, interconnected 
sponge, hexagonally packed vesicles and dilute single vesicles upon increase of water content14.  
 
Figure 3. The phase diagram of PEO115PBO103 in water. Four different phases have been identified. On dilution 
the phase sequence is shown to be lamellae, sponge phase, hexagonal-packed vesicles and singularly dispersed 
vesicles; Wcopolymer is the w/w percentage of copolymer in solution.14 
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1.3 Membrane formation 
1.3.1 Natural membranes and liposomes 
 In nature lipids, proteins and polysaccharides self assemble into bilayers, setting up the cell 
boundary - cell membrane - crucial to cell`s life. Cell membranes maintain the essential differences 
between the cytosol and the extracellular environment, and content of organelles and cytosol. Cell 
membranes are fluid dynamic structures where all of their building molecules are able to diffuse in 
plane of ca. 5 nm thick lipid bilayer. Figure 4 shows a schematic representation of a lipid-based 
membrane, with different classes of membrane associated proteins.18 
 
Figure 4. Association of different types of membrane proteins with a lipid bilayer. (1) Single α helix, (2) multiple 
α helices, (3) a rolled-up β sheet (ß barrel), (4) α helix partitioned into cytosolic lipid monolayer by hydrophobic 
face of the helix, (5) covalent attachment to lipid molecule, (6) attachment via oligosaccharide linker, (7) and (8) 
noncovalent attachment by protein-protein interations.18 
 Membrane models, such as liposomes (vesicles built from lipid molecules), resulted from 
gradual understanding of natural membrane properties like composition, dimensions, selectivity, 
permeation pathways, response to solutes, influence of temperature and pressure.13 Another important 
aspect of studying liposomes - encapsulation of hydrophilic molecules - made great impact on the 
pharmaceutical industry. Liposomes were first proposed as a drug delivery system around 1974 by 
Gregoriadis19. As the most important requirements for effective liposomal drug delivery system, one 
should mention: quantitative retention of drugs, control over the rate of clearance from circulatory 
system (or from compartments of the body where the drug was locally administered), and access or 
preferential uptake by the target. Despite the number of liposome-based injectable formulations that 
have arrived to the market, the stability of lipid vesicles remains a key issue. In order to prolong the 
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circulation time of small liposomes, they are modified by covalent attachment of polyethylene glycol 
chains. This makes the liposome surface more hydrophilic, providing “invisibility” to the immune 
system and protects them from high-density lipoprotein-promoted destabilization.20 This approach is 
the most exploited in pharmaceutical macromolecular drug delivery systems. 
To achieve higher specificity of liposomal drug carriers towards the targeted cells, liposomes 
were modified with covalently attached cell-specific ligands, in order to recognize the target, bind to 
it, and, if possible, penetrate the cell membrane towards the cell interior. The use of polyclonal 
antibodies against a variety of tumor cell lines was shown to be successful in vitro20. In vivo 
experiments used polyclonal antibodies targeting solid tumor and galactose-terminating glycoprotein 
(known for its specific binding to liver`s galactose recepton) 20. Those results and subsequent studies, 
using vesicles of varying structural characteristics, incorporating anti-target monoclonal antibodies 
(immunoliposomes) or other cell-specific ligands20,  lead to established conditions for optimal 
targeting, and showed the limitations of this approach. For example, the presence of immunoglobulin 
on the liposome surface promotes accelerated interception of the aggregates by liver and spleen. A 
promising solution to overcome the clearance of such liposomes, is to combine the immunoliposomal 
approach with described above PEGylation, thus extending the liposome life time in the circulation 
system.20  
1.3.2 Properties of the ABA platform 
Despite all advantages of using natural or synthetic lipids for model membranes or carrier systems, 
there are serious drawbacks resulting from the nature of the lipid molecules themselves. The molecular 
weight of a typical lipid does not exceed 1000 g/mol resulting in formation of thin (ca. 5 nm) and, in 
most cases, fluid membrane structures. Due to lipid sensitivity to lipid oxidation, these membranes are 
characterized by relatively high permeability and fragility21, thus limiting the scope of aplications.4, 5 
As described in chapter 1.1, the so far best solution to the insufficient stability of liposomal systems is 
to transfer the methodology of lipidic membranes to macromolecular amphiphilic systems. We have 
the possibility to design and synthesize amphiphilic block copolymers of different types (AB, ABA, 
ABC), which self-assemble to superstructures resembling lipid bilayers.  
The platform chosen for our studies is based on ABA block copolymers, where hydrophilic – (A) 
blocks are composed of 2-methyl-2-oxazoline repeating units and the hydrophobic – (B) blocks of 
dimethylsiloxane repeating units. Polydimethylsiloxanes possess the unique combination of properties, 
not shown by any other polymeric material, including: extremely low glass transition temperatures (-
120°C), very high chain flexibility, good oxidative, thermal and UV stability, water repellency, 
physiological inertness, high gas permeability and excellent atomic oxygen and oxygen plasma 
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resistance. From the synthetic point of view, an additional attractive feature of these highly 
hydrophobic and surface active polymers is their solubility in many commonly used nonpolar solvents, 
in contrary to comparable, but insoluble highly fluorinated polymers.22 The interest in hydrophilic 
polyoxazolines originates from the research in the field of biocompatible materials for medical 
applications.23 It was reported that both homo- and co-polymers of poly(2-oxazoline)s are non-toxic.24 
Polyoxazolines possess the same protein-repellent properties as PEG. Thus, particles from 
polyoxazoline-containing amphiphilic block copolymers are interesting candidates for drug-delivery 
systems. In addition, in contrary to PEG, it is relatively easy to bring desired end-functionality25, as 
well as partial or full chain functionality in the polyoxazoline blocks.23  
 
1.4 Polymer - membrane protein hybrid materials 
As indicated in Chapter 1.3.1, membrane proteins are active components of cell membranes. They 
regulate cell communication and response to the environment through signaling pathways and 
molecular transport. Many membrane proteins were identified as drug targets and are the subject of 
intense studies because of their biotechnological potential. Hybrid materials consisting of naturally 
occurring proteins embedded in artificial membranes have the application potential in sensor 
technology, diagnostics, gene therapy, rapid drug screening, targeted drug delivery and as protein 
investigation platform (e.g. structural biology via protein crystallization). There were many attempts to 
realize these applications using lipid membranes26, 27, however, load retention, and poor stability often 
pose problems. These problems could be overcome by substitution of lipids by synthetic polymers. In 
addition, block copolymer chemistry broadens the range of achievable material properties. There are 
two main experimental approaches to study proteins embedded in polymer membranes, either using 
planar membranes or vesicles. The former system is useful for conductance measurements or the 
fabrication of functionalized surfaces, but does not resemble the natural membranes28 29. Many details 
of the mechanism of membrane protein incorporation in polymeric bilayers are still poorly understood. 
Natural receptors and channels are designed to span a hydrophobic lipid membrane core of 3–4 nm. 
Since in block copolymer membranes this thickness is exceeded by several fold, they would appear 
unsuitable to host transmembrane proteins in their functional state. Despite this thickness mismatch, 
however, experimental and theoretical evidence confirms the successful incorporation of natural 
proteins in such an artificial matrix. Figure 5 shows a schematic representation of AB diblock 
copolymer chains conformation near a protein inserted in a polymeric bilayer.30  
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Figure 5. A schematic representation of AB diblock copolymer chains near a protein inserted in a polymeric 
bilayer. 30 
 
For instance, the channel proteins Outer membrane protein F (OmpF) and maltoporin (LamB) were 
successfully incorporated into free-standing PMOXA-PDMS-PMOXA block copolymer membranes 
with a hydrophobic thickness of 10 nm.31 Conductance measurements revealed that the protein 
functionality is not influenced by the surrounding membrane and is preserved even after cross-linking 
of the polymer chains32. The experimental data were confirmed by a theoretical model by mean-field 
analysis, which calculated the energetics and thickness profiles of diblock copolymer membranes in 
the presence of a transmembrane protein.30 It was found that membrane perturbations by the protein 
may extend laterally to distances of 25–30 nm (or 3–4 times the bilayer thickness). This length scale 
also determines the range over which embedded proteins interact. The perturbation energy increases as 
a function of thickness mismatch, although only moderately. This means proteins are able to insert 
into polymer membranes even if they are considerably shorter than the unperturbed membrane width.  
This line of research produces materials that are not just passive structural components but promise 
design of stable structures that are biologically active and able to respond to outside stimuli.33  
1.4.1 Aquaporins 
Water transport across biological membranes is not fully explained by simple diffusion through the 
lipid bilayer. Observations of highly water-permeable tissues led to the development of theoretical 
tools for the study of osmotic and diffusion processes across membranes and pores, and prompted the 
long pursuit of the molecular entity responsible for water transport. The first characterized water 
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channel, aquaporin-1 (AQP-1), was serendipitously identified and purified from human red blood 
cells. Expression of AQP1 mRNA in Xenopus oocytes led to its recognition as the erythrocyte water 
channel, a conclusion confirmed by liposome reconstitution with highly purified AQP125. Screening of 
mRNA libraries prepared from different tissues permitted identification of at least ten mammalian 
homologues. Multiple homologues have also been identified in other vertebrates, plants, yeast and 
bacteria. Some of the identified proteins are highly specific for water transport (“orthodox 
aquaporins''), whereas others transport water, glycerol and other small molecules 
(”aquaglyceroporins''). The amino acid sequences of aquaporins are approximately 30% identical; 
however, the conserved residues are distributed in defined clusters, which themselves are fully 
conserved throughout the family32. All homologues are predicted to contain six transmembrane 
segments formed by the tandem duplication of three transmembrane domains joined in obverse 
symmetry. The N and C termini reside in the intracellular space, leaving three extracellular and two 
intracellular connecting loops. Figure 6 shows a schematic representation of predicted primary sequence and 
membrane topology of 10-His-Aqaporin-Z.26, 34 
 
 
Figure 6. Predicted primary sequence and membrane topology of 10-His-AqpZ.26 
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Loops B and E share the most highly conserved residues, suggesting that they may be directly 
responsible for the channel selectivity. Because several residues in these loops are hydrophobic, it was 
proposed26 that loops B and E fold into the membrane-spanning region of each subunit and are 
surrounded by the six transmembrane segments forming a structure referred to as the ”hourglass”. 
Although each subunit apparently contains a single water pore, AQP1 and other aquaporins are 
believed to exist as tetramers in mild detergents and in the native membranes26. Even though certain 
well-defined residues distinguish aquaporins from aquaglyceroporins, the molecular determinants of 
the functional differences between the two groups are far from clear. Their elucidation awaits the 
structural and biophysical characterization of multiple homologues, chimeras and mutants. Single 
channel water permeability is hard to determine in this system due to the lack of an accurate method 
for quantification of plasma membrane protein expression, the possible contribution of endogenous 
proteins, and differences in membrane trafficking. Because AQP1 is commonly purified from human 
red blood cells, structure-function analysis is currently limited to the wild-type molecule. Thus, 
development of expression systems and purification methods for large quantities of wild-type and 
modified aquaporins is essential for understanding the molecular basis of aquaporin`s biophysical 
properties. AQP-Z, the aquaporin from E. coli, was identified as a good candidate for purification 
following overexpression in bacteria, and recognized as a good substrate for structure-function 
studies.26, 34 
Figure 7 shows the shape of the aqueous pore (blue), derived from calculations based on the structure 
of bovine AQP135. The four water molecules shown in bold colors represent transient interactions with 
the pore-lining residues at discrete sites. Bulk water in the extracellular and intracellular vestibules is 
depicted in pastels. Three features of the channel specify selectivity for water: (a) Size restriction: 8 Å 
above the midpoint of the channel, the pore narrows to a diameter of 2.8 Å (approximately the 
diameter of a water molecule). (b) Electrostatic repulsion: the conserved residue (Arg-195), at the 
narrowest constriction of the pore, imposes a barrier to cations, including protonated water (H3O+). (c) 
Water dipole reorientation: two partial helices meet at the midpoint of the channel, providing 
positively charged dipoles that reorient a water molecule as it crosses this point. Disrupting hydrogen 
bonds in the single-file chain of water molecules prevents proton conductance.35 
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Figure 7. A schematic architecture of the channel within an AQP1 subunit.35 
 
1.4.2 Outer membrane protein F (OmpF) 
The outer membrane protects Gram-negative bacteria against harsh environment. At the same time, the 
embedded proteins fulfill a number of tasks that are crucial to the bacterial cell, such as solute and 
protein translocation, as well as signal transduction. Unlike membrane proteins from other organisms, 
integral outer membrane proteins do not consist of transmembrane α-helices, but instead fold into 
antiparallel ß-barrels. 36 Over recent years, the atomic structures of several outer membrane proteins 
from six families have been determined. They include general porins (e.g. OmpF) and substrate-
specific porins (e.g. LamB). Crystallographic studies yielded invaluable insight into and significantly 
advanced the understanding of the functions of these intriguing proteins.36  
Membrane proteins expose their hydrophobic surface to the lipid bilayer core, a property that 
distinguishes them from water-soluble proteins. As mentioned before, all integral membrane proteins, 
known till now, consist of either α-helical bundles, or β-pleated sheets in the form of a closed barrel. 
These architectures not only define two classes of membrane proteins, but also correlate with the 
location: while α-helical bundles are only found in the cytoplasmic membrane, β-barrels are restricted 
to the outer membrane. It is generally assumed that this differentiation originates from the biogenesis 
of outer membrane proteins: their polypeptide chains have to cross the cytoplasmic membrane, which 
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would not be possible if they were too hydrophobic.36 Figure 8 shows a bacterial β-barrel membrane 
protein, OmpF, as seen from the plane of the membrane and from the top of the membrane. 
 
 
 
Figure 8. Bacterial β-barrel membrane protein OmpF , as seen from the plane of the membrane (left) and from 
the top of the membrane (right). The polypeptide backbone is shown in yellow, and  protein segments that 
constrict the barrel interior (loop L3) are shown in red.36 
 
The general diffusion pores formed by porins allow the diffusion of hydrophilic molecules (up to 600 
Da) and show no particular substrate specificity, despite some selectivity for either cations or anions. 
A general porin, OmpF, was the first membrane protein to yield crystals of a size and order suitable 
for high resolution structural analysis by X-ray crystallography. However, it took more than 10 years 
before the atomic structure of the osmotically regulated bacterial porin OmpF was elucidated. 36 
Unlike other loops, the OmpF`s third loop, L3, is not exposed to the cell surface but folds back into the 
barrel, forming a constriction zone at half the height of the channel, giving it an hourglass-like shape. 
Therefore, this loop contributes significantly to the permeability properties of the pore, such as 
exclusion limit and ion selectivity. At the constriction site, strong transverse electrostatic field is 
caused by acidic residues in loop L3 and a cluster of basic residues at the opposite barrel wall (Fig. 9).  
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Figure 9. Constriction site of OmpF, as seen from the top of the outer membrane. The polypeptide backbone is 
shown in yellow. Side chains of positively and negatively charged residues that are involved in the formation of 
transverse electrostatic field are shown in blue (Lys-16, Arg-42, Arg-82, Arg-132) and red (Asp-113, Glu-117), 
respectively36.  
The total charge arrangement contributes to the formation of specific electric field, giving each porin 
its unique properties.36 Porins are extremely stable proteins that can resist denaturation in the presence 
of 5 M guanidium hydrochloride or 2% sodium dodecyl sulfate at 70°C. Recent studies showed that 
the latching loop L2 of OmpF, which bends over the wall of the adjacent monomer, contributes 
strongly to this exceptionally high stability. The hydrophobic trimer interface is also thought to add to 
the robustness of trimeric porins, as removing specific monomer-monomer interactions by site-
directed mutagenesis results in a dramatic stability decrease in the case of OmpF and PhoE36. It seems 
unlikely that stability results from the hydrophobic interface only. Probably, this interface drives the 
molecules to oligomerize in the periplasm before insertion into the outer membrane. In this lipophilic 
environment, hydrophobic interactions play a less significant role, and stability is ensured by other 
types of interactions. Lipid bilayers can be reconstituted with purified porins, where ion-permeable 
pores form. Conductance measurements showed that most porins exist in either open or closed states, 
depending on the transmembrane potential.  
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1.4.3 NADH: ubiquinone reductase (Complex I) 
Respiratory complex I plays a central role in cellular energy production in bacteria and mitochondria. 
Its dysfunction is implicated in many human neurodegenerative diseases, as well as in aging.37 This 
enzyme catalyzes electron transfer from NADH to ubiquinone and couples this transfer to the 
translocation of protons across the inner mitochondrial membrane. Proton-pumping NADH: 
ubiquinone oxidoreductase is the most complicated and least understood enzyme of the respiratory 
chain. Clearly, this is due to the fact that complex I is very large and has numerous subunits and redox 
centers (the subunits of complex I are named according to their apparent molecular weights). It 
contains a core of 14 subunits that are conserved in prokaryotes and eukaryotes and comprises eight to 
nine iron–sulfur clusters and one flavine mononucleotide cluster (FMN). Seven of these subunits are 
encoded by the mitochondrial genome in most eucaryotes and form the common membrane-integral 
part of complex I. Up to 31 additional “accessory” subunits are found in mitochondrial versions of 
complex I. All redox prosthetic groups reside in the peripheral arm of the L-shaped structure. The 
NADH oxidation domain harbouring the FMN cofactor is connected via a chain of iron–sulfur clusters 
to the ubiquinone reduction site that is located in a large pocket formed by the PSST- and 49-kDa 
subunits of complex I (Figure 10).38 
 
 
Figure 10. Two views of the proposed overall architecture of complex I. Complex I consist of three functional 
modules: N (NADH oxidation, yellow), Q (ubiquinone reduction, blue-green) and P (proton pumping, light red). 
The binding region of an antibody against the 49-kDa subunit of the Q module is indicated by an orange Y. The 
mass corresponding to the 51-kDa and 24-kDa subunits is depicted in the darker shade of yellow. Iron–sulfur 
centers are shown as black and grey (if hidden) circles. Ubiquinone molecules in an extended conformation are 
drawn to scale in red. The red bar indicates the approximate position of FMN.38 
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The reaction catalyzed by the protein is well established for the mitochondrial enzyme and plays a 
central role in oxidative phosphorylation by catalyzing the transfer of two electrons from NADH to 
ubiquinone - 10, with concomitant translocation of 3-5 protons from the matrix to the cytosolic side of 
the inner mitochondrial membrane: 
NADH + ubiquinone + 5H+Matrix → NAD+ + ubiquinol + 4H+Intermembrane space 
Complex I contributes significantly to cellular oxidative stress and possibly redox-signaling by the 
generation of superoxide.38  
1.5 Block copolymer lipid interactions 
Literature data show, that drug-loaded self-assemblies (vesicles) are able to enter cells and release 
their cargo, which subsequently leads to effects such as tumor size decrease39. All those phenomena 
involve the vesicle integration with cells: at some stage of that process the vesicular membrane will 
come into close contact with a cellular membrane (either outside or inside the cell) and interactions 
between the two membranes can be expected. This process may be critical for the drug delivery 
process and depending on the synergy / antagonism between the cell membrane components and the 
polymeric amphiphile may lead to stabilization or disruption of the cell membrane. Therefore, it is 
important to study the membrane interactions in such mixed lipid-polymer systems, in order to 
optimize the delivery vehicles and avoid their unwanted effects on the cell membranes. 
 Our goal was to investigate interactions between lipids and amphiphilic block copolymers by a 
monolayer technique. This method allows for simultaneous monitoring of the morphology of spread 
films (by Brewster angle microscopy) and energetic effects associated to the mixing / demixing 
phenomena in two-dimensional binary systems. Additionally due to presence of natural lipids in the 
membrane protein extracts their interactions with synthetic block polymer components may contribute 
to understanding of the reconstitution in synthetic bilayer-like membranes. 
2. Experimental part 
In sections 2.1 – 2.3 the synthesis, characterization and end-group functionalization of the PMOXA-
PDMS-PMOXA block copolymers are discussed. Further on, applications of the synthesized block 
copolymers in novel functional polymer-protein hybrid materials and natural membrane mimics are 
shown in the form of separate original publications or submitted manuscripts. Experiments involving 
characterization of the self-assembly properties of synthesized block copolymers and their applications 
that were not published are presented in the Appendix.  
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2.1 ABA block copolymers synthesis 
The synthesis of symmetric poly(2-methy-2-oxazoline)-b-polydimethylsiloxane-b-poly(2-methyl-
2-oxazoline) (PMOXA-PDMS-PMOXA) block copolymers library used for our studies, followed the 
procedure published by Nardin et al25 with certain modifications. The first step of the synthetic route 
involved acid-catalyzed polycondensation of dimethoxydimethylsilane in the presence of water and 
end-capper, resulting in butylhydroxy-terminated bifunctional PDMS. Liquid PDMS was than purified 
by vacuum stripping at 80°C and a sequence of precipitations in 1:1 w/w water/methanol mixture.40 
Purified PDMS was reacted with triflic acid anhydride in hexane at -10°C for 3 h, resulting in triflate-
PDMS bifunctional macroinitiator. Solvent was then removed under high vacuum. The reaction 
mixture was solubilized in freshly dried hexane and filtered under argon through a G4 filter. Hexane 
was evaporated under vacuum and dry ethyl acetate was added as reaction solvent. Addition of dry 2-
methyl-2-oxazoline resulted in symmetric ring-opening cationic polymerization of PMOXA blocks on 
the macroinitiator. The reaction was terminated by addition of 0.5 M potassium hydroxide in methanol 
solution. Figure 11 shows the schematic representation of synthetic procedure.  
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Figure11. Synthetic route of ABA block copolymers. 
The synthetic route involved multiple purification steps, and required additional care in handling. 
Activation of the PDMS, filtration of macroinitiator and 2-methyl-2-oxazoline polymerization 
required water-free conditions and all these steps were performed under inert argon atmosphere. 
Modifications of existing protocols started with the middle block (PDMS) synthesis, followed by 
careful, multistep purification. Synthesis of the starting hydrophobic block, with full control over its 
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molecular weight, provided the possibility to tune the membrane thickness in resulting block 
copolymer aggregates. 
  Purification of the bi-triflate functionalized polydimethylsiloxane utilized filtration via 
ceramic G4 filter under argon atmosphere. Filtration was carried out in the self-made glass filtration 
unit allowing cooling of the filtration mixture (-11°C), thus enhancing the precipitation of organic 
salts. The resulting colorless, activated PDMS did not require additional purification, steps such as 
addition of activated char-coal for organic salt removal. The goal of the modifications introduced to 
the synthetic procedure was to reduce the molecular weight distribution of the resulting polymers 
(polydispersity index, PDI). The PDI increase for amphiphilic block copolymers may result in 
broadening the range of possibly coexisting morphologies of self-assemblies in solution41. In addition, 
increase of the molecular weight distribution triggers reduction of aggregate sizes. Figure 12 shows 
the series of TEM micrographs of vesicles, prepared from polystyrene-b-poly(acrylic acid) 
copolymers, with increasing polydispersity, where the influence on size and size distribution is clearly 
visible.17,41, 42  
 
Figure 12. TEM micrographs of vesicles prepared from polystyrene-b-poly(acrylic acid) copolymers, with 
increasing polydispersity, influencing their size and size distribution41. 
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2.2 Analysis of ABA block copolymers library 
Characterization of the synthesized block copolymer utilized 1H Nuclear Magnetic Resonance (NMR) 
analysis providing the values of number average molecular weights of polymers and block 
copolymers, and thus their blocks length ratios43. The size distribution of the polymers and block 
copolymers was estimated by Gel Permeation Chromatography (GPC)1, 43 in chloroform and/or 
tetrahydrofurane, with polystyrene standards. 
 
2.2.1 NMR 
NMR analysis was used to estimate the number average molecular weight (Mn) of synthesized 
polymers and block copolymers.43 Mn of the synthesized bi-hydroxybutyl-PDMS was calculated on 
the base of ratio between the integrals of peaks corresponding to the protons in the end-hydroxybutyl 
groups and the integral of the signal of protons assigned to the methyl groups bound to silicon atom in 
polymer repeating units. Figure 13 shows an example 1H NMR spectrum of PDMS in CDCl3 (55 
repeating units). 
 
Figure 13. 1H NMR of the bi-hydroxybutyl-PDMS, with corresponding peaks assignment in CDCl3. 
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The peak at 3.64 ppm corresponds to the protons of CH2 – groups (E) and can be attributed to 4 
protons (bi-functionality of the polymer). The integral of the broad peak around 0 ppm, assigned to 
methyl groups of the polymer repeating unit (A) - 330.19, divided by number of protons in repeat unit 
(6) gives the degree of polymerization of 55.  
In order to estimate the degree of polymerization of the symmetric PMOXA chains grown onto the 
PDMS macroinitiator, two approaches can be used. Either the integral signal of the PDMS with known 
degree of polymerization or the integral of the signals of the PDMS end-linkers are used as a 
reference.  Figure 14 shows an example 1H NMR spectrum of the A12B55A12 block copolymer, 
indicating peak assignments relevant to PMOXA hydrophilic blocks in CDCl3. 
 
 
Figure 14. 1H NMR spectra of A12B55A12 PMOXA-PDMS-PMOXA block copolymer in CDCl3. 
The described methodology of ABA block copolymers 1H NMR characterization, where the end-
linkers of the hydrophobic block are used as a reference is applicable only in the case of low molecular 
weight copolymers. The higher the total Mn of the block copolymer the higher the error resulting from 
27 
 
the end-linker analysis, due to the increasing intensity of the peaks related to the repeating units. 
Therefore the PDMS peak around 0 ppm was used for the characterization of block copolymer library.  
Results of 1H NMR and GPC analysis of the polymer library are shown in table 1 of the following 
section.  
2.2.2 Gel Permeation Chromatography 
 
The lack of suitable solvents for ABA triblock copolymers made the GPC analysis difficult. The 
partial aggregation of the material in the solvent used as eluent was impossible to avoid. Therefore 
sample solutions (20-40 mg in 10 mL HPLC grade THF) were filtered through a 0.2 μm filter before 
loading into the autosampler. Lack of availability of the standards for amphiphilic copolymers limited 
the analysis to examination of the size distribution of the synthesized block copolymers 
(polydispersity index, PDI). The PDI indexes of polymers are the library and blocks lengths are listed 
in Table 1. Figure 15 shows example of the GPC trace for A12B55A12 block copolymer in THF.  
Polymer compositionNMR Mn (g/mol)NMR PolydispersityGPC 
A12B55A12  6222 1.64 
A9B106A9 9486 1.38 
A15B110A15 10700 1.62 
A65B165A65 23372 1.63 
A13B110A13  10462 1.44 
A14B110A14 10632 1.36 
 
Table 1. Block copolymer library, A - PMOXA, B - PDMS. 
 
28 
 
 
Figure 15. GPC chromatogram of A12B55A12 in THF. 
Partial aggregation of the material in THF is represented by small peak (7.5 – 8 ml) Figure 15. 
2.3 End-functionalization of ABA block copolymers 
End groups of synthesized block copolymers were further modified, in order to introduce additional 
functionality. Covalent attachment of functional groups to the end of the hydrophilic blocks of the 
ABA block copolymers allowed introduction of the desired functionality to the surface of resulting 
aggregates.  
2.3.1 Introduction of “bio-linker” 
A14B110A14 and A65B165A65 block copolymers were functionalized with biotin end-groups. The 
reaction utilized attachment of D-biotin to the polymer`s hydroxyl groups in N,N'-
dicyclohexylcarbodiimideate (DCC)/ 4-dimethylaminopyridine (DMAP) catalyzed esterification44 in 
chloroform45. The product was purified from unreacted biotin by subsequent ultra-filtration, in 1:5 
ethanol – water mixture. Figure 16 shows the biotinylation reaction scheme. 
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Figure 16. DCC/DMAP catalyzed esterification of ABA block copolymer. 
Introduction of biotin end groups to the hydrophilic clocks of the polymers allowed utilization of 
biotin-streptavidin interaction as “bio-linker”. Streptavidin is a 53 kDa tetrameric protein known for its 
strong binding affinity to biotin group. The dissociation constant (Kd) of the biotin-streptavidin 
complex is on the order of ~10-15 mol/L, thus the strongest known non-covalent interaction. Four 
binding sites on the tetrameric streptavidin make it an excellent platform for coupling, labeling and 
immobilization experiments involving nano-particles46. Figure 17 shows a schematic representation of 
coupling, labeling and immobilization strategies utilizing biotin-streptavidin interaction.  
 
Figure 17. A schematic representation of immobilization, labeling and coupling strategies, utilizing biotin-
streptavidin interactions. 
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Due to the high molecular weights of the block copolymers functionalized with biotin, the 
quantification of the degree of biotinylation of the copolymers end-groups utilizing 1H NMR was 
inaccurate (weak signals of the biotin groups). Therefore, the presence and availability of biotin 
groups was determined by fluorescence correlation spectroscopy in solutions of vesicles prepared from 
the biotinylated block copolymers. Biotinylated vesicles from A14B110A14  (10 mg/ml, 10% 
biotinylated) were prepared with solvent displacement method  and incubated with fluorescently 
labeled streptavidin (3 x 10-8 M). Upon binding of the fluorescent streptavidin to the biotin groups at 
the surface of the vesicles, significant diffusion time increase of the labeled protein was observed 
proving presence and availability of the biotin end-groups of the block copolymers. Figure 18 shows 
the comparison of the diffusion of the free dye, labeled streptavidin and the labeled streptavidin bound 
to biotinylated vesicles. 
 
 
Figure 18. FCS normalized autocorrelation curves comparison of the diffusion of the free dye Cy5 (blue), free 
Cy5 labeled streptavidin (green) and the Cy5 labeled streptavidin bound to A14B110A14 vesicles (red). 
Figure 19 shows confocal-LSM images of A14B110A14 biotinylated vesicles after addition of Avidin488 
(about 5 min incubation time) (A) and A14B110A14vesicles (no biotin) after addition of Avidin488 
(about 7 min incubation time) (B), showing specific binding of streptavidin to biotinylated vesicles.  
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A       B 
Figure 19. (A) - CLSM image of biotinylated A14B110A14 vesicles, after addition of Avidin488 (about 5 min 
incubation time). (B) - CLSM image of A14B110A14 vesicles (no biotin) after addition of Avidin488 (about 7 min 
incubation time) (B). 
Figure 20 shows CLSM images of A14B110A14 biotinylated vesicles, after addition of Avidin488 (about 
35 min incubation time) (A) and CLSM image from A14B110A14 vesicles (no biotin) after addition of 
Avidin488 (about 20 min incubation time) (B). Increasing amounts of visible fluorescent particles 
indicate non-specific adsorption of Avidin488 to A14B110A14 vesicles at extended incubation times (B). 
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A       B 
Figure 20. (A) - CLSM image of biotinylated A14B110A14 vesicles after addition of Avidin488 (about 35 min 
incubation time). (B) - CLSM image of A14B110A14vesicles (no biotin), after addition of Avidin488 (about 20 
min incubation time).  
The same approach was used to confirm the presence and availability of the biotin end-groups in 
A65B165A65 block copolymer aggregates. Figure 21 shows binding of Alexa Fluor 488 labeled 
streptavidin to biotinylated particles, by increase in diffusion time of the protein bound to the polymer 
particles. 
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Figure 21. Normalized autocorrelation curves showing binging of Alexa Fluor 488 labeled streptavidin to 
A65B165A65 biotinylated particles.  
2.3.2 Introduction of  “cross-linker” groups 
A15B110A15 and A12B55A12 block copolymers were functionalized with methacrylate groups, allowing 
cross-linking upon exposure to UV light for the stabilization of the vesicular structures. Hydroxyl 
groups of ABA block copolymers were reacted with 2-isocyanatoethylmethacrylate, using dibutyltin 
dilaurate as catalyst in dry ethyl acetate.47 Figure 22 shows the methacrylation reaction scheme. 
 
Figure 22. Methacrylation of ABA block copolymer. 
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The product was purified by subsequent ultra-filtration in 1:5 ethanol - water mixture. Methacrylation 
of both copolymers (A14B110A14 and A65B165A65) was confirmed by FTIR experiments and cross-
linking kinetics upon UV-light exposure was studied. 
A series of experiments were conducted to systematically investigate UV induced crosslinking 
behavior of methacrylated ABA triblock copolymers. Knowledge of the kinetics and dose 
requirements of this process is important for application of such triblock copolymers in situations 
where the mechanical and chemical stability of the polymer resulting from crosslinking would be 
important. Two methacrylated copolymers were used: PMOXA15-PDMS110-PMOXA15 and PMOXA12-
PDMS55-PMOXA12. A glass slides were coated with a polymer solutions in chloroform to make a 
thick film, from which chloroform was evaporated by leaving over night in case of PMOXA15-
PDMS110-PMOXA15 and glass slide was put in a vacuum evaporator to dry off the CHCl3 from the 
PMOXA12-PDMS55-PMOXA12 film. Attenuated Total Reflection – Fourier Transform Infra Red 
(ATR-FTIR) spectroscopy was performed on those functionalized copolymer films. The polymer was 
then subjected to UV irradiation from a solar simulator with UV intensity of 17mW/cm2 in the 340 -
390 nm range and an overall intensity of 407 W/cm2 over different periods of time. The polymer 
sample was analyzed after each exposure with FTIR to determine the kinetics of crosslinking between 
the methacrylated groups. Solubility of the crosslinked polymers was evaluated by conducting 
dissolution tests of the crosslinked polymer in ethanol. 
For both copolymers the FTIR spectrum shows distinct peaks for the PDMS and the PMOXA 
parts of the polymer, indicating that this method is excellent to characterize this class of polymers 
(Figure 20).  
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Figure 20: FTIR spectra of methacrylated PMOXA15-PDMS110-PMOXA15 (blue) and PMOXA12-PDMS55-
PMOXA12 (red) copolymers.  Peaks represent the PDMS and PMOXA components of the block copolymer. 
These are identified as 1. (~798 cm-1) Si-C stretching and CH3 rocking (from PDMS). 2. & 3. (~1018 and 1092 
cm-1) Si-O-Si stretching vibrations (from PDMS). 4. (~1260cm-1) CH3 symmetric deformation of Si-CH3 (from 
PDMS). 5. (~1632 cm-1) amide C=O bond (from PMOXA). Two additional peaks found in the spectra of 
PMOXA15-PDMS110-PMOXA15 correspond to residual amount of chloroform (680, 774 cm-1, no vacuum 
treatment). 
The peaks corresponding to pure PDMS are very evident in the spectrum (Figure 20). These peaks 
include the 798 cm-1 representing the Si-C stretching and CH3 rocking vibrations. The twin peaks at 
1018 and 1092 cm-1 represent the Si-O-Si stretching vibrations. The peak at 1260 cm-1 represents the 
CH3 symmetric deformation of Si-CH3 bonds. The peak at 1632 cm-1 represents the amide C=O bond 
from the PMOXA. These peaks are common to PMOXA15-PDMS110-PMOXA15 and PMOXA12-
PDMS55-PMOXA12 copolymers.  
 
The samples were exposed to UV light in a collimated beam apparatus to induce crosslinking 
of the methacrylate end-groups. UV treatment was carried out over different periods of time (0.5 min 
to 3.5 hours) to vary the irradiation dose. After each exposure, samples were analyzed using FTIR to 
monitor changes in functional end-groups. Exposure of methacrylate end-functionalized block 
copolymers to UV irradiation results in an increase of the intensity of the peak at ~790 cm-1. It 
represents the formation of methylene bonds  
δ (-CH2-) bonds which are usually observed at 814 cm-1.1, 46 The methacrylate end-group was bound to 
the large PMOXA block which may result in a shifting of this peak. The change in area under the 790 
cm-1 peak provided values for the crosslinking rate with time.  
The spectra of PMOXA15-PDMS110-PMOXA15 copolymer, after exposure to different UV doses are 
shown in Figure 21-A. The degree of crosslinking was calculated by determining the area under peak 
at 790 cm-1 (Figure 21-B) and its evolution over time represents the kinetic of crosslinking for this 
polymer (Figure 21-C). 
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Figure 21: (A) FTIR Spectra of PMOXA15-PDMS110-PMOXA15 copolymer exposed to increasing UV dose 
(time), (B) magnification of the peak at 790cm-1 used for monitoring of crosslinging (C) Kinetics of crosslinking 
of PMOXA15-PDMS110-PMOXA15 polymer. 
Figure 22 presents the results obtained for PMOXA12-PDMS55-PMOXA12 methacrylated 
copolymer, with analytical approach as described before. A lower level of crosslinking was found for 
this polymer as seen in Figure 22 B.  
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Figure 22: (A) FTIR Spectra of methacrylated PMOXA12-PDMS55-PMOXA12 copolymer exposed to increasing 
UV dose (time) (B) Kinetics of crosslinking of methacrylated PMOXA12-PDMS55-PMOXA12 copolymer 
The crosslinking kinetic curve shown in Figure 22B exhibits unexpected trace and the effective 
methacrylation may lead to better UV curving.  
The methacrylated PMOXA15-PDMS110-PMOXA15 copolymer was soluble in ethanol prior to 
UV exposure and became insoluble after 192.5 minutes of UV treatment. Two days of exposure to 
ethanol led to less than 10% of initial mass loss. 
Both the non-treated mathacrylated and UV-treated PMOXA12-PDMS55-PMOXA12 copolymers 
dissolved easily in 100% ethanol. This is consistent with the low level of crosslinking observed for 
PMOXA12-PDMS55-PMOXA12 copolymer. Methacrylation of this polymer appears to be low, most 
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probably due to contamination with water during the synthetic procedure. Increasing methacrylation 
might lead to better UV curing and solvent resistance properties of this block copolymer.  
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2.4 Applications of synthesized ABA block copolymers 
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2.4.1 Highly permeable polymeric membranes based on the incorporation of the functional 
water channel protein Aquaporin Z 
 
  
Highly permeable polymeric membranes based
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channel protein Aquaporin Z
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The permeability and solute transport characteristics of amphiphilic
triblock-polymer vesicles containing the bacterial water-channel pro-
tein Aquaporin Z (AqpZ) were investigated. The vesicles were made
of a block copolymer with symmetric poly-(2-methyloxazoline)-poly-
(dimethylsiloxane)-poly-(2-methyloxazoline) (PMOXA15-PDMS110-
PMOXA15) repeat units. Light-scattering measurements on pure
polymer vesicles subject to an outwardly directed salt gradient in
a stopped-flow apparatus indicated that the polymer vesicles were
highly impermeable. However, a large enhancement in water
productivity (permeability per unit driving force) of up to 800
times that of pure polymer was observed when AqpZ was incor-
porated. The activation energy (Ea) of water transport for the
protein-polymer vesicles (3.4 kcal/mol) corresponded to that re-
ported for water-channel-mediated water transport in lipid mem-
branes. The solute reflection coefficients of glucose, glycerol, salt,
and urea were also calculated, and indicated that these solutes are
completely rejected. The productivity of AqpZ-incorporated poly-
mer membranes was at least an order of magnitude larger than
values for existing salt-rejecting polymeric membranes. The ap-
proach followed here may lead to more productive and sustainable
water treatment membranes, whereas the variable levels of per-
meability obtained with different concentrations of AqpZ may
provide a key property for drug delivery applications.
permeability  triblock copolymer  water treatment
B iological membranes have excellent water transport charac-teristics, with certain membranes able to regulate perme-
ability over a wide range. The permeability of membranes such
as those present in the proximal tubules of the human kidney (1)
can be increased by insertion of specific water-channel mem-
brane proteins known as Aquaporins (AQPs). Other biological
membranes, such as those in mammalian optic lenses (2),
erythrocytes (3), and many other cell membranes (4) are con-
stitutively AQP-rich. The permeabilities of AQP-rich mem-
branes are orders of magnitude higher than those observed for
unmodified phospholipid membranes (5). Additionally, some
members of the AQP family have excellent solute retention
capabilities for small solutes such as urea, glycerol, and glucose,
even at high water transport rates (5, 6). These properties result
from the unique structure of the water-selective AQPs. These
AQPs have six membrane-spanning domains and a unique
hourglass structure (7) with conserved charged residues that
form a pore that allows both selective water transport and solute
rejection. The AQP used in this study was a bacterial aquaporin
from Escherichia coli, Aquaporin Z (AqpZ). AqpZ was selected
because it can enhance the permeability of lipid vesicles by an
order of magnitude while retaining small uncharged solutes (5).
Additionally, AqpZ can be expressed in relatively large quanti-
ties in E. coli and has been reported to be quite stable under
different reducing conditions and at temperatures of 4°C (5)—
properties that make it attractive for drug delivery and water
treatment applications.
The AQP’s high permeability and high specificity could be
valuable for a variety of applications. High permeabilities and
excellent solute retention of small solutes are important for
water treatment in critical medical applications such as dialysis
(8, 9) because they could lead to reduced equipment size and
more efficient energy use. A significant improvement in the
permeability of solute-rejecting membranes would also be a
large step in improving the economics of desalination for
drinking water applications. Desalination is becoming increas-
ingly important for water production in semiarid coastal regions
(10, 11). Reverse-osmosis membranes are most commonly used
for this application, whereas the use of membranes in a forward-
osmosis scheme is becoming more interesting to water planners
(10, 12). Both of these processes need extensive pretreatment of
the source water to remove particulates and microbial contam-
inants, but they provide excellent treatment for properly pre-
treated water. However, reverse osmosis requires large energy
consumption, and forward osmosis will require large membrane
areas. This is because of the low productivity of currently used
commercial reverse-osmosis and forward-osmosis membranes.
The AQP-rich membrane proposed here, when suitably sup-
ported, could be used in similar processes with lower energy or
membrane area requirements. Finally, the ability to produce
membranes with low initial permeabilities is desirable for drug
delivery applications (13), whereas a high level of control over
permeability could be an additional advantage in designing
alternative delivery methods (14).
The effects of AQPs on the permeability of liposomes (5), frog
oocytes (3), and cellular secretory vesicles have been studied
(15). However, the low stability of biological membranes or
synthesized lipid membranes for water treatment and drug
delivery applications is an important disadvantage (16). Obtain-
ing and processing large volumes of such membranes would also
present technical challenges.
The use of synthetic polymers, in particular, lipid-bilayer-like
amphiphilic block copolymers, is intriguing because they are
chemically and mechanically stable while still providing an
amphiphilic structure that allows incorporation of membrane
proteins such as AQPs (17). Somemembrane proteins have been
functionally inserted into block copolymer membranes (18–21).
These include the -barrel ompF protein, the bacterial receptor
lamB protein, and bacteriorhodopsin. Directed insertion of the
eye lens AQP (Aquaporin 0) into similar block copolymer
membranes has also been demonstrated (22), although this
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initial study did not examine function. Additionally, there are few
studies on the permeability of block copolymer membranes (13,
23), and no previous studies have reported on the magnitude of
permeability improvement obtained by insertion of AQPs in
block copolymer membranes. Data on rejection of dissolved
ionic solutes such as salt (NaCl) have also not been reported for
AQP-rich membranes.
To investigate the potential of protein-polymer membranes
for the applications described above, solute and water transport
properties and physical characteristics were analyzed for a
specific protein-polymer membrane. This membrane was com-
posed of a triblock copolymer with inserted AqpZ and is referred
to throughout the text as an AqpZ-ABA membrane. The com-
position of the symmetric triblock copolymer was poly(2-
methyloxazoline)-block-poly(dimethylsiloxane)-block-poly(2-
methyloxazoline) (PMOXA15-PDMS110-PMOXA15). This ABA
polymer has a larger hydrophobic block (110 dimethylsiloxane
units)-to-hydrophilic block (15 methyloxazoline units) ratio than
those tested in previous studies (18, 19, 24–27). The physical
characteristics of the ABA triblock copolymer were studied by
using microscopy techniques, whereas light scattering was used
to characterize the permeability.
Results
Synthesis of AqpZ-ABA Polymer Membranes.AqpZwas produced by
a recombinant strain of E. coli by using a plasmid that allowed
high levels of expression and incorporated 10 histidine residues
at one end of the expressed protein to facilitate purification. This
recombinant AqpZ was purified by using nickel affinity chro-
matography (5, 28). A large yield of pure protein (between 2.5
and 15 mg/liter of culture) was obtained for three different
purification runs, indicating the potential for large yields by using
the procedures described. PMOXAm-PDMSn-PMOXAm (ABA)
triblock copolymers were synthesized by using a ring-opening
cationic polymerization procedure. Polymer vesicles were pro-
duced by using the film rehydration method described in detail
in Materials and Methods.
Characterization of Polymer Vesicles. To determine the permeabil-
ity and solute rejection properties of polymer vesicles by using
stopped-flow spectroscopy, a knowledge of the physical dimen-
sions (radius in hydrated state) and morphology (hollow vs. solid
sphere structure) is necessary. ABA polymer vesicles were
therefore characterized by using static and dynamic light scat-
tering, transmission electron microscopy, cryogenic transmission
electron microscopy, and atomic force microscopy.
A hydrodynamic radius (Rh) of 160 nm was estimated from
dynamic light scattering. This size is consistent with similar
PMOXA-PDMS-based block copolymers with different hydro-
philic-to-hydrophobic block length ratios (26). Dividing the
radius of gyration (Rg) from static light-scattering experiments
by the hydrodynamic radius from dynamic light scattering yields
a value close to one (Rg/Rh  1.03); this result is consistent with
a hollow-sphere morphology (26). Static light scattering indi-
cated a vesicle molecular weight of 52  106 g/mol.
The transmission electron microscope images indicate that the
different vesicles have relatively uniform sizes. Cryogenic trans-
mission electron microscopy indicated a hydrated vesicle radius
of 117 nm. Fig. 1 shows representative images obtained from
electron microscopy. Radii estimated from cryogenic transmis-
sion electron microscopy were used in further calculations of
permeability as the rapid freeze used in this technique best
preserves the hydrated vesicle’s structural features (29).
The presence of spherical vesicle-like aggregates with a hy-
drophilic corona was further supported by atomic force micros-
copy measurements. When a dilute suspension of vesicles was
spread on a hydrophilic mica surface, a film, punctuated with
emerging vesicles, was observed (Fig. 1).
Permeability Measurements. The permeabilities of ABA and
AqpZ-ABA vesicles were investigated by using stopped-flow
light-scattering experiments as described in Borgnia et al. (5).
Vesicle suspensions were rapidly mixed with osmotic solutions
(1.7 osmol/liter) of salt (NaCl). The shrinkage of these vesicles
was followed by monitoring the increase in light scattering over
time. The initial rise in the experimental data was fitted to an
exponential rise equation, and the exponential coefficient (k)
was used to calculate permeability. These results are shown in
Fig. 2 for the ABA and AqpZ-ABA vesicles with a protein-to-
polymer molar ratio of 1:200. The time scale of initial rise for
AqpZ-ABA vesicles was between 5 and 20 ms, whereas the lower
permeability of the ABA vesicles led to a much longer rise time
on the order of 10 s. The calculated permeabilities of the ABA
and the AqpZ-ABA vesicles were 0.8 m/s and 74 m/s,
respectively. This indicates that protein incorporation leads to a
large permeability increase—almost 90 times greater than the
polymer vesicles. Assuming the polymer vesicles have the mo-
lecular weight estimated from the light-scattering experiments, a
maximum of 25monomers per vesicle is possible. Then, using the
calculated permeability of 74 m/s and the estimated vesicle
surface area based on radius measurements, the water perme-
ability for each AqpZ tetramer is calculated as 13 1014 cm3/s,
Fig. 1. Examination of polymer vesicles by using microscopy. The cryogenic transmission electron microscope images were used for size determination because
regular transmission electron microscopy and atomic force microscopy influence the structure of the observed vesicles. (a) Cryogenic transmission electron
micrograph of an ABA polymer vesicle. (Scale bar: 200 nm.) (b) Electron micrograph of a cluster of vesicles. (Scale bar: 50 nm.) (c) Atomic force micrograph of
vesicles on mica in nontapping mode shows that a film of polymer is formed on the hydrophilic mica surface with vesicles located in the film. (Scale bar: 200 nm.)
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which is similar to values reported for AqpZ reconstituted into
liposomes [10  1014 (5)].
Calculation of Activation Energies. Activation energies for water
transport are calculated by conducting experiments over a wide
range of temperatures, and these energies can be used to
determine whether transport across vesicle membranes is diffu-
sion-driven or channel-mediated. Calculated permeabilities for
the AqpZ-ABA vesicles indicate an increase of 38 to 94 times
over ABA vesicles in these experiments. In Fig. 3, the exponen-
tial constants obtained from these experiments are plotted
against the inverse of temperature to determine the Arrhenius
activation energies. The Arrhenius activation energy calculated
for the ABA vesicles was 8.7 kcal/mol, whereas the AqpZ-ABA
vesicles had a value of 3.4 kcal/mol. The higher value obtained
for the ABAmembrane is consistent with the values of activation
energies reported for polymer membranes in the measured
temperature range (30, 31), indicating transport by diffusion
through the polymer. The low-activation energy for the AqpZ-
ABA vesicles is strong evidence for channel-mediated water
transport through AqpZ molecules. This value is also consistent
with the low-activation energy values found in AqpZ-
incorporated proteoliposomes (5) and AQP1-incorporated
oocytes (3).
Reflection Coefficients. Solute reflection coefficient determines
the extent to which a membrane excludes a particular solute. The
relative reflection coefficients of salt, urea, glucose, and glycerol
were determined by using a procedure described by Meinild et
al. (6). Glucose, with an assumed reflection coefficient of unity,
was taken as the reference solute because of its relatively large
molecular size. The calculated reflection coefficients of salt,
glycerol, and urea were greater than one, indicating higher
relative rejection of these solutes (data not shown). These
reflection coefficients are higher than the values reported by
Meinild et al. (6) for the same solutes, but agree within the
experimental error for our calculations.
Effect of Protein-to-Polymer Ratio on Permeability. Stopped-flow
experiments were conducted at 5.5°C with protein-to-polymer
molar ratios of 1:25, 1:50 1:100, 1:200, 1:500, and 1:1000. Fig. 4
indicates a sharp permeability increase followed by a sharp
decrease as the concentration of protein is increased. Perme-
ability peaks at a protein-to-polymer ratio of 1:50 where the
vesicle permeability is 3,000 times greater than the pure
polymer.
Discussion
Large improvements in the efficiency of water treatment mem-
branes may result from the development of biomimetic mem-
branes with high permeability and selectivity. In this work, we
describe the incorporation of the bacterial water-channel protein
AqpZ into an ABA triblock copolymer and provide data on the
permeability and selectivity of this new membrane. Permeability
varied with the AqpZ:ABA ratio and showed an activation
energy indicative of channel-mediated transport. Furthermore,
the selectivity of the AqpZ-ABAmembrane for water over small
solutes such as salt, glucose, urea, and glycerol was demonstrated.
The orders-of-magnitude increase in permeability observed
on incorporation of AqpZ indicates that the water-channel
protein is functional in the synthetic context, as seen for other
membrane proteins in a similar polymer (19). The magnitude of
increase in permeability and the excellent solute rejection ca-
pabilities demonstrate the potential benefit of such membranes
for water treatment and drug delivery. The ABA triblock
copolymer was found to be relatively impermeable when com-
pared with other membranes; its productivity was 0.22
ms1bar1 at 20°C, which can be compared with the value of
5.7 ms1bar1 at 20°C for a similar diblock copolymer [poly-
ethylethylene–polyethylene oxide; calculated from Discher et al.
(13)]. The large difference in the size and type of the hydro-
phobic blocks used here (110 units of dimethylsiloxane) and the
diblock copolymer studied by Discher et al. (37 units of ethyl-
eneethylene) could account for this difference. The permeabili-
ties of lipid membranes are reported to be an order of magnitude
Fig. 2. Stopped-flow light-scattering experiments. (a) Increase in relative
light scattering with and without reconstituted AqpZ into the ABA polymer at
5.5°C at a molar ratio of 200:1 (polymer:protein). Fits are shown as guides. The
initial rise rates were used to calculate the permeability. As seen from a, a rise
cannot be calculated for the pure ABA polymer vesicles. (b) Shown is the rise
in scattering between 2 and 10 s for the ABA vesicles that was used in
calculating permeability at 5.5°C.
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Fig. 3. Arrhenius plots for calculation of activation energy for osmotic
transport of water across polymer membranes with incorporated AqpZ (AqpZ-
ABA) and pure polymer membranes (ABA).
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higher than the polyethylethylene–polyethylene oxide copoly-
mer (13). The incorporation of AqpZ increases the productivity
of ABA membranes by 800 times (Fig. 5). Additionally, the
productivities of AqpZ-ABA membranes reported here exceed
those for any salt-rejecting membrane (Fig. 5). Although these
values were measured by using different procedures, it can be
seen from this comparison that the AqpZ-ABA protein-polymer
system investigated here represents more than an order-of-
magnitude improvement over existing reverse-osmosis and for-
ward-osmosis membranes. Additional research will be needed to
identify appropriate support materials and pretreatment that
could lead to successful new water treatment schemes.
The AqpZ-ABA system studied here may benefit from further
optimization of the protein incorporation conditions, leading
hopefully to membranes with greater permeability. Increasing
the amount of AqpZ leads first to a permeability increase, then
to a permeability decrease—similar to the performance of lipid
membranes. In experiments with lipid membranes, a limiting
concentration of AqpZ was observed around a protein-to-
polymer weight ratio of 1:200 (5). We see such a limiting
concentration at a protein-to-polymer ratio of 1:19 (1:50 molar
ratio). The difference may result from the fact that the molecular
weight of the polymers used here is greater than lipid molecular
weight. The limiting concentration observed is probably due to
the method of incorporation used. Detergent concentration
increases at the higher AqpZ concentrations because detergent
is present in the AqpZ stock solution. This may have resulted in
a low AqpZ reconstitution efficiency and lower permeabilities
when higher volumes of AqpZ stock solution are used. Unfor-
tunately, the number of AqpZs inserted per vesicle has not been
determined in this or other AqpZ studies (5); hence, we cannot
offer a definitive conclusion. However, other studies have shown
that vesicles with a AqpZ-to-lipid weight ratio of 1:1 can be
synthesized by using slow detergent removal methods (32, 33).
This indicates that higher permeabilities might be possible with
other reconstitution methods. These results also indicate that
membranes with specified levels of water permeability can be
synthesized by controlling the concentration of AqpZ—a prop-
erty that may be useful for drug delivery applications.
The protein-polymer membranes developed here have salt
rejection and permeability ideal for desalination. Excellent
control over the permeability of polymers was also demon-
strated. Incorporation of AQPs (or suitable molecular mimics)
into compatible synthetic polymers (such as the block copolymer
system investigated in this study) is an innovative approach for
making membranes for medical, industrial, and municipal de-
salting applications.
Materials and Methods
The detergent dodecyl maltoside used in protein purification was obtained
from Anatrace Chemicals. Ni-NTA agarose beads were obtained from Qiagen.
Sepharose 4B was used for chromatographic separation and was obtained
from Sigma Aldrich. Other chemicals were obtained as described in the
following sections.
Expression and Purification of AQP-Z. The plasmid allowing overexpression of
histidine-tagged AqpZ (pTrc10HisAqpZ) was obtained from Dr. Peter Agre (Duke
University Medical Center, Durham, NC) (5). It was transformed into the E. coli
strain JM109 by electroporation. The resulting strain was grown and protein
production induced by addition of isopropyl--D-thiogalactoside according to
Borgnia et al. (5) with two modifications. The induction time was optimized at
7–8 h. The ultracentrifugation setup for recovery of membrane fractions was
replaced by the use of a Biomax filter (MWCO of 30 kDa) in a centrifuge for 45–60
min for removal of smaller-molecular-weight material. Protein purification was
performed by using nickel affinity chromatography (5).
Protein purification was followed by solubilization with a standard SDS
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cracking buffer (34) with an additional component, 1% dodecyl maltoside,
and polyacrylamide gel electrophoresis (34) to determine presence of protein.
The purified protein was quantified by using the Lowry method (35).
Synthesis of ABA Polymer. The ABA was a symmetric poly-(2-methyloxazoline)-
block-poly-(dimethylsiloxane)-block-poly-(2-methyloxazoline) (PMOXA15-
PDMS110-PMOXA15) polymer. The first step of the synthesis procedure in-
volved acid-catalyzed polycondensation of dimethoxydimethyl silane in the
presence of water and end-capper, resulting in butylhydroxy-terminated
bifunctional PDMS. Liquid PDMS was purified by vacuum stripping at 80°C and
precipitation in an equal (by weight) water/methanol mixture. Purified PDMS
was reacted with triflic acid anhydride in hexane at10°C for 3 h, resulting in
triflate-PDMS bifunctional macroinitiator. The reaction mixture was then
filtered under argon through a G4 filter. Hexane was evaporated under
vacuum and dry ethyl acetate was added as reaction solvent. Addition of dry
2-methyl-2-oxazoline resulted in symmetric ring-opening cationic polymer-
ization of PMOXA blocks on the macroinitiator. The reaction was terminated
by addition of a methanol solution of 0.5 M potassium hydroxide. The syn-
thesis of a similar, lower-molecular-weight polymer system with a lower
hydrophobic-to-hydrophilic block-length ratio is described in further detail in
Nardin et al. (26).
Preparation of ABA Vesicles and AQP Incorporation. Block copolymer vesicles
(1–2 wt % of polymer in PBS at pH 7.4) were prepared by using the film
rehydration method. Sixty milligrams of polymer was first dissolved in chlo-
roform (5–10 ml), and the chloroform was evaporated slowly in a rotary
vacuum evaporator at 40°C and a vacuum of400 mbar to form an even film
on the inside of round-bottomed flasks. This film was then further dried under
a 0.3-mbar high vacuum for at least 4 h. Ten milliliters of PBS was then added
dropwise to the film with alternating vigorous vortexing and periodic soni-
cation (of durations 30 s) for several minutes. This mixture was then left
stirring for at least 8 h. The resulting suspension was extruded several times
through a 0.4-m track-etched filter (Isopore, Millipore), followed by a 0.2-m
track-etched filter (Nucleopore, Whatman) to obtain monodispersed unila-
mellar vesicles. For reconstitution experiments, 500 l of an AqpZ stock
solution (1.6 mg/ml in 1.5% dodecyl maltoside, 66 mM KH2PO4, 133 mM NaCl,
13% glycerol, 3.33 mM -mercaptoethanol, and 33.33 mM Tris) was added
during the formation of the polymer vesicles, and subsequent steps were
completed on ice. The resulting protein-containing vesicles were purified
chromatographically by using a column packed with Sepharose 4B to remove
nonincorporated protein and trace detergent.
Characterization of Vesicles. Light scattering. The static and dynamic light-
scattering experiments were performed according to Nardin et al. (26) by
using a commercial goniometer (ALV) equipped with a He-Ne laser (wave-
length, 633 nm) at scattering angles between 30° and 150°. An ALV-5000/E
correlator was used to calculate the photon intensity, and an autocorrelation
function was used to calculate vesicle size.
Atomic force microscopy. These measurements were conducted by using a
Picoscan SPM LE scanning-probe microscope equipped with a Picoscan 2100
SPM controller (Agilent Technologies). Measurements were conducted in
tapping mode by using a Si cantilever (NCH) (Nanosensors). The length of this
cantilever was 125 m and the nominal force constant was 42 N/m. Samples
were prepared by placing a dilute vesicle suspension on freshly cleaved mica
for 1 min and then carefully washing with double-distilled water. This sample
was dried and the measurements were performed on dry samples.
Transmission electron microscopy. These measurements were conducted on
vesicle samples by using a Philips 400 microscope (Philips). The samples were
prepared by dilution up to 1,000 times and then stained with 2% uranyl
acetate on plasma-treated copper grids.
Cryogenic transmission electron microscopy. The vesicle suspension was de-
posited on a holey carbon grid and frozen rapidly by plunging into liquid
ethane above its freezing point by using a cryo holder. This holder was then
transferred to the microscope and imaged in transmission mode at 200 kV at
liquid nitrogen temperature. The equipment used for this measurement was
a Zeiss 922 Omega microscope with a Gatan CT3500 cryo holder and a Gatan
Ultrascan 1000 camera system.
Permeabilitymeasurements. The permeability of the two types of vesicles were
determined by using a stopped-flow procedure (5). The stopped-flow appa-
ratus was a SX.17 MV spectrometer (Applied Photophysics). Vesicles were
rapidly mixed with a solution containing the osmotic agent (salt, glucose,
glycerol, or urea) causing water efflux from the vesicles. The changes in light
scattering caused by vesicle shrinkage were recorded at an emission wave-
length of 600 nm in the stopped-flow apparatus [Borgnia et al. (5) and Milon
et al. (36)]. These experiments were conducted with a constant 7-bar pressure
to minimize pressure variations that could complicate kinetics analysis. Results
were corrected for pressure-related mechanical compression by subtracting
the baseline observed in control experiments without osmotic agents. These
data were then fitted to an exponential rise equation to calculate the expo-
nential coefficient, and the osmotic water permeability (Pf) was calculated by
using the following expression (5):
Pf k/S/Vo  VW osm,
where k is the exponential rise rate constant for the initial rise in the light-
scattering curve, S is the initial surface area of the vesicles, Vo is the initial
volume of the vesicles,Vw is the molar volume of water(18 cm3), andosm is the
difference in osmolarity driving the shrinkage of the vesicles.
Several sets of experiments were conducted with similar conditions but
different preparations (prepared in different batches) to ensure repeatability.
Additionally, initial experiments with up to 12 traces per experimental con-
dition showed that five traces were adequate for providing sufficient data for
analysis. Therefore, in subsequent analyses, a minimum of five traces were fit
to the initial exponential rise by using the curve-fitting toolbox available
through the MATLAB software (Mathworks).
Stopped-flow experiments were repeated at different temperatures (5.5,
7.5, 10, 12.5, and 15°C) for the ABA and AqpZ-ABA vesicles. The exponential
rise rates calculated from these experiments were plotted against the inverse
of temperature to determine the Arrhenius activation energies.
The reflection coefficients for salt, urea and glycerol were calculated based
on the method presented by Meinild et al. (6). Glucose was used as the
reference solute and the comparative experiments were all conducted at 15°C.
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Block copolymers can be used to construct robust nanoscale reactors permeabilized by protein channels.  
We demonstrate the use of these nanoreactors as a novel immobilization platform for generating 
precisely patterned chemically and/or biologically active surfaces. These were used to study enzymatic 
conversion of the phosphatase substrate, ELF97® by encapsulated acid phosphatase. The model 
methodology utilized can be easily adapted to study complex multi-component reactions with potential 
applications in sensors, analytics and microfluidics. 
 
Nanoreactors, active surfaces, immobilization, block copolymer vesicles, enzymatic conversion, 
kinetics. 
In living organisms enzymatic reactions occur in precisely defined time and space. An important goal 
of interdisciplinary research is to not only study the behavior of biological macromolecules in their 
natural cellular environment1, but also create synthetic analogues of complex natural functions such as 
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molecular sensing and communication.2 It also strives to apply the resulting knowledge to develop 
devices inspired by reverse engineering of biology.3 Bioinspired polymeric vesicles4, with integrated 
transport proteins5 and encapsulated enzymes6 are such a system. 
An immobilization system for liposomes has been previously reported by Vermette at el.7 In this 
study intact liposomes were immobilized on different solid substrates by the NeutrAvidinTM approach. 
There are several drawbacks of lipidic systems related to the nature of the lipid molecules themselves. 
The molecular weight of a typical lipid is less than 1000 g/mol resulting in formation of thin (ca. 5 nm) 
membrane structures. Due to potential for lipid oxidation, these membranes are characterized by 
relatively high permeability and fragility6 thus limiting the scope of aplications.2, 8 A solution to these 
limitations is to transfer this methodology to the macromolecular scale utilizing block copolymers. We 
have designed amphiphilic ABA block copolymers to form highly impermeable bilayer like membranes 
in aqueous solutions.6, 9 Additionally, we have developed a method to functionalize resulting vesicles 
with several functional groups including biotin.  Immobilization of block copolymer vesicles enabled 
the design of new stable reactive surfaces.  This provides us with an ability to carry out conversions 
(chemical and biological) at a precise location and enables control over the reaction micro-environment 
in situ. This is potentially relevant for application in the field of analytics, specifically sensors.  It also 
extends our ability to conduct basic research on enzymatic reactions in confined environments which 
use unstable or sensitive materials, by shielding of the reactive species in the cavity of the nanoreactor6. 
Furthermore this approach provides a tool for single molecule spectroscopy in tethered nanoreactors10. 
 
We present here the first successful application of polymer vesicles as an immobilization platform, for 
studying a model enzymatic conversion inside nanoreactors. The successful immobilization of 
nanoreactors on a glass substrate was realized by employing the receptor-ligand pair, biotin-
streptavidin11. The surface of the glass substrate was structured by micro-contact printing12 of bovine 
serum albumin, labeled with biotin. Exposure of biotinylated protein patterns to streptavidin followed 
by incubation with biotinylated particles lead to their immobilization. 
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Figure 1. Laser scanning microscopy images of structured immobilization of streptavidin-alexa 488 
(3A) and vesicles loaded with sulforhodamine B (3B). Alexa 488 labeled streptavidin was incubated 
with the glass surface structured with biotinylated BSA resulting in its immobilization resembling the 
exact structure of the micro-contact printing mask. Incubation of the streptavidin functionalized surface 
with biotinylated dye loaded vesicles led to their successful immobilization on the surface. Vesicles 
remained intact upon immobilization. Control samples structured with BSA-biotin and incubated with 
sulforhodamin loaded biotinylated vesicles in green (1C) and red (1D) channel. No immobilization can 
be observed. 
 
The model reaction chosen for studying enzymatic conversion inside nanoreactors was the 
dephosphorylation of the fluorogenic substrate - ELF 97® by acid phosphatase. The enzyme is known 
to dephosphorylate phosphate groups13, 14 from ELF 97® substrate, optimally at pH=5.5. The product 
ELF 97 alcohol, becomes insoluble and fluorescent, enabling direct time resolved laser scanning 
microscopy (LSM) observation of product formation. Acid phosphatase was encapsulated15 in 
biotinylated A12B55A12 (poly-2-methyl-2-oxazoline-b-polydimethylsiloxane-b- poly-2-methyl-2-
oxazoline) block copolymer vesicles16. The accessibility of the substrate to the enzyme was provided by 
reconstitution of the bacterial derived outer membrane protein F channels (OmpF) in otherwise highly 
impermeable9 vesicular walls. The OmpF channels are known to be fully functional upon reconstitution 
in synthetic bilayer-like membranes, providing a molecular cut-off of 600 g/mol17, 18, thus providing an 
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avenue for selective permeability of ELF 97® substrate (M.W.= 431 g/mol) to the interior of the 
nanoreactor.  
In order to verify whether the encapsulation process affects enzyme activity, initial kinetic 
experiments were performed in solution. Time resolved fluorimetric studies, presented in Figure 2 
(excitation wavelength of 350 nm and emission of 550 nm) performed for substrate, control native 
polymer vesicles (encapsulating acid phosphatase but without OmpF channels) and nanoreactors 
(encapsulating acid phosphatase and bearing OmpF channels) in solution, show that enzymatic turnover 
of the substrate takes place only in case of samples with reconstituted channel proteins, where the 
permeation of the ELF97® phosphate into the cavity of the vesicle is enabled.  
 
 
  
Figure 2. Enzymatic conversion of ELF®97  phosphate (5µM) inside nanoreactors with incorporated 
OmpF channel proteins (green) compared with vesicles encapsulating acid phosphatase without channel 
protein (red) and the free substrate (blue) in solution.  
The nanoreactors with OmpF channels and with biotin functionalized polymer were then immobilized 
on the patterned functionalized glass surface. Figure 3 shows a schematic of the immobilization 
procedure and the nanoreactor system.  
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Figure 3. Schematic representation of the immobilization of nanoreactor system on glass surface. 
Acid phosphatase was encapsulated in the OmpF bearing biotinylated vesicles and immobilized on the 
surface of the glass structured with streptavidin.   
 
Incubation of structurally immobilized nanoreactors with the substrate (ELF97®) resulted in 
enzymatic turnover of the substrate, leading to product formation (ELF 97 alcohol). The product 
formation results in increase of fluorescence intensity in the area structured with nanoreactors. Figure 4 
shows LSM images of structured nanoreactors on the surface of the glass slide before (4A) and after 
incubation (20 minutes) with 75 µM substrate (4B). The structure of the intense fluorescence signal 
from the surface resembles the morphology of the micro-contact printing mask, thus proves successful 
selective immobilization of the nanoreactors on the surface (Figure 4B).   
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A       B 
 
Figure 4. LSM images of structurally immobilized nanoreactors before (4A) and after incubation (20 
minutes) with ELF® 97 substrate (4B). Nanoreactors were immobilized on the glass slide imaged and 
the fluorescent product formation was followed by time resolved LSM.    
Comparison of time resolved intensity profiles of nanoreactors bearing OmpF channels reconstituted 
in the vesicular wall, with the control vesicles immobilized on the glass slide surface confirmed results 
obtained from measurements in bulk solutions. Figure 5 represents the time resolved fluorescence 
intensity profile (excitation 405 nm) of the immobilized nanoreactors and control vesicles incubated 
with 75 µM ELF 97®and indicates that the reaction occurred only in the case of nanoreactors with 
reconstituted OmpF. 
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Figure 5. Time resolved fluorescence intensity profile of reaction in nanoreactors encapsulating acid 
phosphatase and bearing OmpF channel (green) and control vesicles encapsulating acid phosphatase 
(red) immobilized on the surface incubated with 75 µM Elf 97® substrate. Enzymatic turnover of the 
substrate inside of the immobilized nanoreactors results in increase of the fluorescence intensity.  
The fluorescence intensity profile of the reaction at the surface resembles the kinetic behaviour of the 
free enzyme and nanoreactors in solution. The lag time of the enzymatic turnover was different for the 
set of the measurments of free enzyme (~14 sec, 10 µM ELF®), nanoreactors in bulk (~600 sec, 10 µM 
ELF®)  and immobilized nanoreactors (~1600 sec, 10 µM ELF®). This increasing lag time can be 
explained by limited access of the substrate to the enzyme due to reduced mixing. The saturation of the 
profile in case of immobilized nanoreactors can be atributed to the inhibition of the enzyme, by steric 
hindrance due to precipitation of the fluorescent product in the cavity of the nanoreactor.   
 
 In order to verify the possibility of studying reaction kinetics inside the nanoreactors, substrate 
concentration was varied and time resolved measurements conducted. Figure 6 shows the influence of 
substrate concentration on the kinetics of fluorescent product formation. Differences in the slopes of the 
normalized curves can be observed and attributed to increasing substrate concentrations. Data in Figure 
6 has been fitted with a guided exponential rise equation using MATLAB®.  
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Figure 6. Relative fluorescence intensity increase for immobilized nanoreactors incubated with 20, 50 
and 75 µM ELF 97®. Fits are shown as guides and not used for kinetic analyses. 
The Michealis-Menten19 approach was used to determine the kinetic parameters of the acid 
phosphatase encapsulated in nanoreactors in solution and immobilized at the surfaces.20 The Michaelis 
constant Km resulting from Lineweaver–Burke20 plot was found to be 4 µM for the free enzyme, 7 µM 
for the nanoreactors in bulk and 46 µM for the immobilized nanoreactors.  Obtained values lies in the 
range observed for most enzymes (10-1 – 10-7M)20. The observed 6.5 times lower activity of the 
immobilized nanoreactors, in comparison to the nanoreactors in solution, could be due to the presence 
of  unstirred aqueous layers at the polymer membrane/solution interface posing a diffusional barrier for 
otherwise rapidly permeating substrate.21 The thickness of such unstirred layers in biological 
membranes can range from 5 µm to 0,5 mm depending on the mixing conditions. Influence of such 
diffusional barrier is more expressed in case of membranes characterized by fast solute transport21, 22. 
Additionally, reduced accessibility of the membrane proteins due to their positioning towards the 
surface, resulting from immobilization on solid support, may contribute to the observed decrease of the 
enzyme activity.  
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The described system may serve as an investigation tool for studies over a wide range of different 
reactions or bioconversions and can be applied as a novel method for construction of 
chemically/biologically active surfaces for analytics, sensors and even controlled reactions. This enables 
several possibilities, including for instance control of a precisely localized reaction and delivering the 
product at desired time and space. The studied immobilization methodology can be easily extended by 
the use of covalent attachment onto different types of substrates, by modifications of the functional end-
groups of the block copolymer with control over the density of reactive species. In addition, post 
modification of the block-copolymer may lead to introduction of further functionality at the surface of 
the nanoreactors and accompanied by inclusion of active compounds in the hydrophobic part of the 
membrane - enabling studies of cascade reactions23. The morphology of the reactive surface is 
dependent on the structure of the PDMS mask used and may be chosen for specific application (total 
coverage vs. various shapes).  
Model reaction kinetics were studied in nanoreactors and immobilized nanoreactors. The influence of 
the substrate concentration on the kinetics of enzymatic turnover (presented in Figure 6) shows an 
increase in reaction rate with increasing substrate concentration. The kinetic parameters obtained for 
nanoreactors in bulk and at the surfaces were compared to free enzyme and the analysis indicated 
reduced activity of the enzyme inside the nanoreactor system, with preservation of its key characteristics 
in the studied concentration range. The Km values estimated for the nanoreactors at the surfaces were 
obtained from the LSM measurements with the use of 405 nm laser-line, therefore the detection of the 
product formation was not optimal resulting in decrease of the signal-to-noise ratio. Thus the reported 
Km values for immobilized nanoreactors shall be treated as an estimate.   
 In this work we have shown successful application of immobilized polymer vesicles incorporating 
membrane protein channels as nanoreactors for studying model enzymatic reaction of water soluble 
enzymes. This work is an initial step of more detailed and systematic studies on immobilization of 
nanoreactor systems employing different enzyme-substrate pairs and complex reaction cascades.  
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SUPPORTING INFORMATION 
OmpF expression and purification: 
OmpF gene was transformed into the expression host E coli BE strain BL21 (DE) opm8 (Prilipov et al. 
1998). 10 ml of overnight culture were used to inoculate 1 l LB medium (2 l shaking flasks; Infors HT 
Multitron; 250 rpm, 37˚C). The OmpF expression was induced at an OD600 of 0.6 by addition of 
isopropyl-β-D-thiogalactopyranoside (IPTG) to a final concentration of 1 mM. Cells were further grown 
until an OD600 2.0 when they were harvested by centrifugation (Sigma 3-18k Fischer Biostock  
Scientific; 20 min, 6000rpm, 4˚C). 
Cells were resuspended in 10 ml 20 mM Tris-Cl pH 8.0, 2% SDS buffer/ 1g cell pellet and the 
mixture was sonicated 30 sec x 6 times, amplitude 40 ( Ultrasonic Processor GE130). The membrane 
fractions were removed by centrifugation (60 min @ 4°C, 22000 rpm). 
A pre-extraction step has followed in 0.125% octyl-POE in 20mM phosphate buffer pH 7.4 with an 
incubation time of 1 h. (Memmert GMBH. Germany, 37°C, 250 rpm). The membrane fractions were 
removed by centrifugation (60 min @ 4°C, 22000 rpm) and further treated with 3% octyl-POE in 20mM 
phosphate buffer pH 7.4 for OmpF extraction. The solubilised OmpF was separated from the 
memebranes by centrifugation (10 min, 4000rpm, 4˚C). 
The purity of the extracted protein was verified by SDS-acrylamide gel electrophoresis (12%). 
 
 
Polymer synthesis: 
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Figure S1. ABA block copolymer structure. 
The A12B55A12 block-copolymer was synthesized by cationic ring-opening polymerization of 2-
methyloxazoline using a bi-triflate activated polydimethylsiloxane macroinitiator. The synthetic route 
followed the one described in Nardin et al.24. The molecular weight of the polymer obtained from 1H 
NMR was 6325g/mol. Figure S1 shows the polymer structure. 
Formation of Nanoreactors: 
Biotinylated block copolymer vesicles were prepared by using the film rehydration method. Twelve 
milligrams of polymer (10% biotinylated) were first dissolved in ethanol (2–5 ml) together with 200 µL 
of OmpF solution (8 µM), and the ethanol was evaporated slowly in a rotary vacuum evaporator at 40°C 
to form an even film on the inside of round-bottomed flasks. This film was then further dried under a 
0.3-mbar high vacuum for at least 4 h. Two milliliters of sodium acetate (100 mM) solution of acid 
phosphatase (Sigma-Aldrich Mw= 110 kDa, 10 µM) were then added to the film and rotated on the 
rotary evaporator at room temperature for 24 h in order to hydrate the polymer film. A small stir bar was 
then added and the solution was stirred for another 24h at room temperature. The resulting suspension 
was extruded several times through a 0.4 µm track-etched filter (Isopore, Millipore), followed by a 0.2 
µm track-etched filter (Isopore, Millipore) to obtain monodispersed unilamellar vesicles. The resulting 
protein-containing and enzyme encapsulating vesicles were purified chromatographically with 
Sepharose 2B packed column to remove non encapsulated enzyme and non incorporated protein. Figure 
S2 shows a typical separation chromatogram. 
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Figure S2. Size exclusion chromatogram of nanoreactors. 
Samples for control experiments followed the same protocol, without the addition of OmpF channel 
protein. 
Self assembly characterization: 
ABA polymer vesicles were characterized using static and dynamic light scattering (DLS/SLS), 
transmission electron microscopy (TEM) and atomic force microscopy (AFM).  
DLS/SLS 
The static and dynamic lightscattering experiments were performed according to Nardin et al.24  by 
using a commercial goniometer (ALV) equipped with a He-Ne laser (wavelength, 633 nm) at scattering 
angles between 30° and 150°. An ALV-5000/E correlator was used to calculate the photon intensity, and 
an autocorrelation function was used to calculate vesicle size. 
A hydrodynamic radius (Rh) of 121 nm was estimated from dynamic light scattering, with size 
polydispercity index PDI < 0.18. This size is consistent with similar PMOXA-PDMS-based block 
copolymers 24. The radius of gyration (Rg) of 121 obtained from static light scattering measurements of 
the same sample indicates hollow sphere morphology of the aggregates (Rg/Rh=1)24. 
 
 
‐1
19
39
59
79
99
119
139
159
179
0 20 40 60 80 100 120
mAu
Time [min]
ABA Ompf vesicles/ Acid Phosphatase separation
 AFM 
Measurem
Picoscan 2
using a Si 
force const
cleaved mi
dried and th
 
Analysis 
the conclus
hydrophilic
spheres of a
A  
Figure S3
 
ents were 
100 SPM c
cantilever (
ant was 42
ca for 1 mi
e measurem
of topograp
ions drawn
 substrate 
verage size
 
. Topograp
conducted 
ontroller (A
NCH) (Nan
 N/m. Sam
n and then
ents were
hy and pha
 from light
(mica) and
 of 108 +/-
  
hy (A) and
using a Pic
gilent Tech
osensors). 
ples were 
 carefully w
 performed 
se images 
 scattering m
 the analy
 12 nm; see
 
 phase (B) i
oscan SPM
nologies). 
The length
prepared by
ashing wi
on the dry 
obtained fr
easureme
zed single 
 Figure S3
 B 
mages of v
 LE scannin
Measureme
 of this can
 placing a
th double-d
sample. 
om dry stat
nts. Dilute 
particles e
. 
esicles adso
g-probe m
nts were c
tilever was
 dilute vesi
istilled wa
e atomic fo
vesicle solu
xhibited ty
rbed on mi
icroscope e
onducted in
 125 µm an
cle suspen
ter. This sa
rce microsc
tion was d
pical profil
ca substrat
quipped wi
 tapping m
d the nom
sion on fre
mple was t
opy suppo
eposited on
e of collap
e. 
15
th a 
ode 
inal 
shly 
han 
rted 
 the 
sed 
 
 16
 
TEM 
Measurements were conducted on vesicle samples using a Philips 100 microscope (Philips). The 
samples were prepared by dilution of 100 times and stained with 2% uranyl acetate on plasma-treated 
copper grids. 
Transmission electron micrographs of vesicles stained showed spherical particles of uniform sizes, see 
figure S4.  
 
 
 
Figure S4. Transmission electron micrograph of polymer vesicles stained with 2%uranyl acetate. 
 
Micro contact printing and immobilization procedure: 
The structured polydimethylsiloxane PDMS mask (source) was cleaned with ethanol and dried with 
nitrogen flow. BSA-biotin solution was cast onto the mask (0.1 mg/ml BSA-biotin, sodium acetate 
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buffer, pH 5.5), incubated for 10 minutes and dried with nitrogen flow forming protein film. The BSA-
biotin covered mask was than pressed to the surface of dried clean microscopy glass slides, cleaned by 
multiple sonication in 2% Hellmanex detergent, water and methanol) and incubated for 10 minutes 
resulting in patterning of the surface with BSA-biotin. The glass slide was than mounted into the 
chamber of the flow cell and sealed. The surface was passivated by incubation with BSA solution 
(1mg/ml, sodium acetate pH 5.5), washed with buffer and incubated with streptavidin solution (0.1 
mg/ml, sodium acetate pH 5,5) resulting in its immobilization in structured manner followed by washing 
steps. Biotinylated nanoreactors were than immobilized on the streptavidin stripes resulting in formation 
of BSA-biotin-streptavidin-biotin-nanoreactor link. 
Time resolved Fluorescent measurements: 
The free enzyme and nanoreactors in solution kinetic experiments were performed using Perkin Elmer 
LS55 fluorimeter, with the excitation wavelength of 350 nm and emission wavelength of 550 nm, at the 
slit width of 5nm. The free enzyme and nanoreactors kinetic measurements were performed in 500 µL 
total volume. To the 1 µM acid phosphatase solution in sodium acetate (pH=5.5), varied amounts of 
substrate were added (0.5, 5, and 10 µM final ELR 97® concentration). The kinetic trace was recorded 
and the kinetic parameters were evaluated using Lineweaver-Burk plot.20 Same methodology was 
applied to the nanoreactors in solution kinetic studies, where the nanoreactors (2 mg/ml polymer) were 
incubated with the substrate of increasing concentration (1, 5, 10, 50, 100 and 150 µM final ELR 97® 
concentration).  
 
 
Time resolved Laser Scanning Microscopy measurements: 
 18
The flow cell containing immobilized nanoreactors was mounted onto the Zeiss Confocor 2 LSM/FCS 
stage. The increase of fluorescence intensity upon exchanging the content of the flow cell with the ELF 
97® substrate solution (Invitrogen, Mw=431.08 Da) was followed in the time series (excitation: 405 nm 
19%, long pass 475 filter, 40x/1.2 objective).  
 
LSM data collection and evaluation: 
Data collection involved choosing and averaging of the results obtained for patterned areas of the 
same starting intensity. Background was collected in the same manner for areas neighboring the 
patterns, averaged and subtracted from initial averaged signals. Intensities were normalized and the 
curves obtained for different concentrations were offset in time for clarity. Resulting curves were fitted 
with guided exponential rise with MATLAB software. The choice of the concentration was mostly 
driven by the sensitivity of the LSM setup. Concentrations below 20 µM Elf 97® are characterized by a 
very low signal-to-noise ratio. In the high concentration regime (above 50 µM Elf 97®) there is no 
significant influence of the increasing concentration of the substrate on the reaction kinetics. Most of the 
commercially available LSM instruments are equipped with laser lines going down to a wavelength of 
405 nm. The excitation spectra of Elf 97 alcohol is characterized by a broad peak, with the maximum at 
350 nm. Performing our measurements at 405 nm decreases the sensitivity and limits us to the 
concentration range of the substrate used for the study of reaction kinetics of this particular enzyme-
substrate pair 
Enzymatic turnover lag time comparison for the systems:   
Figure S5 shows the normalized intensity profile of the reaction for free enzyme, nanoreactors in bulk 
and at the surface.  
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Figure S5. Comparison of the reaction lag-time for free enzyme (black), nanoreactors in bulk (blue)  
and immobilized nanoreactors (red) incubated with  10 µM ELF® 97 substrate.  The data were 
normilized to the saturation of the fluorimeter detector in case of measurements in solution and to the 
reaction saturation in case of immobilized nanoreactors. 
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2.4.3 pH Gating of Aquaporin-Z 
 
 
 
 
 
  
pH gating of Aquaporin-Z reconstituted triblock copolymer membranes and in whole cells 
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Abstract 
Water channel proteins, Aquaporins, are ubiquitous in living organisms.  They mediate rapid water 
transport across cell membranes for specific functions including osmoregulation and turgor 
maintenance. Gating of aquaporins in cells is a common phenomena based on environmental 
conditions, including pH, to rapidly regulate water permeability.  The bacterial aquaporin – 
Aquaporin Z (AqpZ) was reported not to be gated in a narrow pH range in previous studies, and 
the physiological relevance of this protein is unknown.  The use of a synthetic biomimetic 
membrane forming polymer of low permeability allowed insightful examination of AqpZ 
permeability over a wide pH range.  AqpZ incorporated in this polymer membrane was gated 
between pH values of 4 and 6 and gating was reversible.  Whole experiments with E. Coli AqpZ 
mutants confirmed this observation.  Furthermore, AqpZ mutants exhibit reduced survival under 
acid stress. pH gating of AqpZ may be important for cell survival at low pH values in concert with 
the decrease in activity observed in mechanosensitive channels.  
 
 
Text 
 
Aquaporins are a family of transmembrane proteins responsible for rapid water transport across 
cell membranes1.  Certain aquaporins also transport small solutes across membranes2. They are 
present in organisms from all domains of life and contribute to several important functions.3 They 
are critical to rapid response to change in osmotic pressure for large cells such as red blood cells 
and plant cells.4  The large surface area to volume ratios of small microorganisms have made 
investigators question the physiological relevance of Aquaporins in microorganisms5, 6.   They 
have however been linked to osmoregulation and increase in cell volume during growth7.   
 
Lipid bilayers are usually reconstituted with membrane proteins such as aquaporins to study their 
biophysical properties8.  However, several properties of these lipid membranes, including high 
permeability for water and gases,  make the study of isolated membrane proteins difficult6.  The 
use of synthetic membranes with tailorable properties could provide an alternative to lipid 
membranes  for evaluation of several unique properties of these proteins.   Block copolymers are a 
class of polymers that can mimic lipid bilayers in many significant ways and can be modified to 
provide unique properties and functions by choice of appropriate blocks as well as modifications9.  
We have shown successful insertion of several membrane proteins in these polymer membranes 
and found proteins to be functional10, 11.  Additionally, these polymer membranes are highly stable 
and can serve as a platform for long lasting devices enabling studies on incorporated membrane 
proteins.  
 Aquaporin mediated water transport can be regulated in the cell in several ways.   These 
include mechanisms for control of aquaporin production and degradation, its delivery and insertion 
into the membrane and modulation of the activity of the inserted aquaporin by gating. 12, 13  Gating 
of aquaporins occurs by phosphorylation, pH, divalent cations, effect of other proteins and 
osmolarity.14 Oxidative stress and mechanical stress have also been shown to induce gating13, 15.   
It also provides a rapid way for modulating cell response and has been shown to be responsible for 
helping plants survive drought and flooding.16 The role of gating in mammalian aquaporins such as 
AQP1 and AQP0 in still unclear.  Aquaporin Z was reported not to be  gated in a pH range of 5-7 
in literature17.  In this study, we show that AqpZ is gated between pH values of 4 and 6.   
 
Mechanosensitive channels, like aquaporins, have also been shown to be important for 
osmoregulation and cell survival under changing osmotic environments.  In particular,  MsCL and 
MsCM have been shown to open and rapidly release small solutes to prevent cell plasmolysis 
when a sudden decrease is osmotic pressure occurs18.  This is important for survival of bacteria 
such as E. Coli, which experience changes in osmotic pressure when passing through the digestive 
system.  Additionally, it has been shown that MsCL opening rate might be modulated by a 
decrease in pH19.  It is possible that mechanosensitive channels remain closed even under extreme 
turgor at low pH values to prevent acidosis of the cytoplasm in such environments.   The  effect of 
Aquaporins and Mechanosensitive channels of cell water homeostasis seems to be coordinated 
under neutral pH conditions20.  Such coordination may also exist between the gating of these 
channels at low pH values.  
 
In order to study gating of AqpZ channels, they were incorporated into PDMS-PMOXA based 
triblock copolymers at a constant protein to polymer molar ratio of 1:100. Experiments were 
conducted on these vesicles in the pH range of 2 to 12 using stopped flow light scattering 
experiments.  The general experimental procedure is described in a previous work 11 and exact 
experimental approach in Supplementary Online Materials (SOM).  Figure 1  shows the variation 
in permeability of  vesicles reconstituted with AqpZ channels over above indicated pH range.   The 
activation energy of water transport at pH values of 4, 7.2 and 12 are in the range of 1.8 to 4 
kcal/mole indicating that transport is channel mediated.   
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Figure 1: Polymeric vesicles reconstituted with AqpZ show different permeabilities at different pH values.  a) The 
above figure shows normalized light scattering response on subjecting vesicles prepared in a buffer solution of 
pH 4, 7.2 and 12 respectively to an outwardly directed osmotic gradient in a stopped flow apparatus.  The initial 
exponential rise in the light scattering signal can be correlated to membrane permeability as described in the 
materials and methods section.  b) A sharp increase in permeability is seen between pH 4 and 6 indicating 
gating behavior of the AqpZ.  Permeability was calculated using stopped flow light scattering experiments 
where AqpZ reconstituted in polymer vesicles were subjected to an outwardly directed osmotic gradient.  
Change in the size of vesicles was monitored with change in intensity of scattered light and this was related to 
permeability. 
 
Reversibility of AqpZ channel gating in polymer vesicles reconstituted with AqpZ was 
investigated by recovering vesicles subjected to stopped flow experiments at a pH of 7.2 or 4.0. 
Buffer was then replaced with the one of a different pH.  The possibility of reusing of vesicles 
subjected to osmotic shock was enabled by the stable nature of ABA block copolymer membranes.  
The permeability of recovered vesicles was then remeasured to determine reversibility of the 
gating phenomenon, when going from a low pH to high pH and from a low pH to high pH.  It was 
found that changing the pH from 7.2 to pH 4 reduces permeability of protein reconstituted vesicles 
to levels expected for pH 4 and when pH is changed from pH 4 to pH 7.2 there is a large increase 
in permeability indicating “re-opening” of the AqpZ channels. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: The pH gating effect in AqpZ-ABA vesicles is reversible.   Vesicles were first subjected to an outwardly 
directed osmotic gradient at  pH 7.2.  These vesicles were then spun down in a centrifugal filter and washed 
repeatedly with pH 2 or pH 4 buffer to change the ambient pH to pH 2 or pH 4.  It was seen that the 
permeability is reduced to that observed under pH 2 or pH 4 conditions by conducting stopped flow 
experiments.  Similarly the proteovesicles solutions  from experiments at pH 2 or 4  was recovered in pH 7.2 
buffer.  Stopped flow experiments revealed that the original permeability at pH 7.4 could be recovered from 
both pH 2 and pH 4 indicating reversibilityx 
 
0
200
400
600
800
1000
1200
1400
7.2 pH 2
to 7.2
2* pH 7
to pH
2
pe
rm
ea
bi
lit
y 
(
μm
/s
)
 
0
200
400
600
800
1000
1200
7.2 pH 4
to 7.2
4 pH
7.2 to
pH 4
pe
rm
ea
bi
lit
y 
(
μm
/s
)
  A series of experiments were conducted with E.Coli cells to investigate the occurrence and 
physiological relevance of the AqpZ gating phenomena observed in polymer vesicles.   Three 
strains of bacteria. including a parent strain (ME 9062), a AqpZ knockout strain (AqpZ-) from 
ME9062, and an overexpression strain (AqpZ+) based on the strain JM10917, were tested.  These 
strains were grown to the log phase and subjected to permeability measurements using stopped 
flow light scattering21 under different pH conditions.  The AqpZ+ strain was tested under both 
induced and uninduced conditions.  The low pH value chosen for these tests was 4 as the outer 
membrane proteins, particularly OmpF, have been shown to be closed at a pH below 3.85 
(reference).  We found that for the ME9062 and AqpZ+ strains the permeability measured is lower 
at pH 4 when compared to pH 7.  As expected, the permeability measured for the AqpZ+ strains 
are higher than for the ME9062 strain. For both, the uninduced AqpZ+ strain as well as the 
ME9062 strain there is a decrease of 15-16% in permeability when pH is reduced from 7.4 to 4.   
For AqpZ+ induced strain this difference is higher at 50%.    
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: pH gating is observed in both wild type and mutant strains overexpressing AqpZ.  Strains were grown in 
LB and diluted 1:100 after 15 hours of growth.   These cells were harvested after 8 hours of growth and 
resuspended in 100mM PBS solution (with kanamycin) at pH 4 or 7.4.  ME9062 is the parent strain and shows a 
significant decline in permeability at pH 4.  AqpZ+(I) is an over expression strain which was induced for 4 
hours before harvesting.  AqpZ (UI) is the same overexpression strain with no induction.   Both these strains 
show a higher permeability that the parent strain and the reduced permeability at pH 4 is significant.  AqpZ- 
represents the AqpZ knockout strain from the parent strain (ME 9062).  It shows negligible difference between 
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pH 4 and pH7.   OmpF-  is the AqpZ knockout strain from the same parent strain (ME 9062) and shows 
negligible difference between pH 4 and pH 7. 
 
The permeability difference between pH 7.4 and 4 for the AqpZ- strain is not significant.   
However, this difference increases when the level of expression of AqpZ increases (from ME9062 
strain to uninduced AqpZ+ strain to induced AqpZ+ strain)  indicating that the difference in 
permeability for the other strains is due to the presence of AqpZ gating phenomena between these 
pH values.  The actual permeability of the AqpZ knockout strain (AqpZ-) is significantly higher 
than the ME 9062 strain.  This may indicate that the expression of another water channel with 
higher permeability than the AqpZ channel might be upregulated by this change.  
 
The reversibility of permeability change between pH values of 7.4  and 4 (and between pH 4 and 
7.4) was tested by re-suspending one portion of a culture of AqpZ+ (induced) strain in pH 7.4 (or 
4) buffer21, removal of the buffer and resuspending it in pH 4 ( or pH 7.4) buffer.  Thus the same 
batch was tested at both the pH values to make sure the permeability change occurs in both 
directions.  Figure 4 shows that when pH is decreased from pH 7.4 to pH 4 the resulting cells 
permeability is 101% of that at pH 4 while when pH is increased from pH 4 to pH 7.4 the resulting 
permeability is 73% of that at pH 7.4 indicating most of the decrease in permeability at low pH is 
reversible. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: The pH gating effect in E. Coli strains overexpressing AqpZ is reversible.   Harvested (pelleted) cells 
were resuspended in pH 4 buffer and the permeability measured on a part of the resuspended cells.  The 
remainder of the cells were pelleted again, washed with and resuspended in pH 7.4 buffer.  The permeability of 
 
0
200
400
600
800
1000
1200
1400
pH
pe
rm
ea
bi
lit
y 
( μ
m
/s
)
pH 7.4      pH 4 to 7.4 pH 4     pH 7.4 to 4
of pH 4 vesicles was seen to be the same as the pH 4 E. Coli cells.  However when washed and resuspended in 
pH 7. 4 buffer the permeability increased back to levels similar to those observed in E.Coli cells originally 
resuspended in pH 7.4 cells indicating pH based reversibility of the water transport activity of AqpZ.    
 
The activation energy of water transport measured by conducting the above measurements in the 
temperature range of 5 to 25 deg C was 1.2 kcal/mol for ph 7.4 and 2.1 kcal/mol for pH 4 
indicating transport at both pH values are channel mediated similar to that found for AqpZ 
incorporated in polymer vesicles.  
 
The occurrence of pH mediated AqpZ gating in both polymer vesicles and whole cells indicate that 
pH has a direct effect on the conformation of AqpZ monomer leading to a decrease in its 
permeability.   Molecular dynamics simulations have indicated the presence of two conformational 
states in Aquaporin monomers – an open and a closed state.22  This may indicate that pH induced 
conformation changes within the water selective part of the channel could lead to a higher 
probability of the closed states leading to the reduction in permeability observed in our 
experiments. 
 
Osmoregulation has been indicated as a possible function of water channels in microorganisms.  
Other channels such as the mechanosensitive channels (particularly MsCL and MsCS) are 
important for survival of bacteria acting as a pressure valve releasing solutes when there is a 
sudden downshift in medium osmolarity.  In the absence of MsCL and MsCS there is a large 
mortality in bacterial cells with a small negative change in osmolarity.  Down-regulation of AqpZ 
has also been indicated as a survival mechanism in bacteria as it slows down the rate of water 
entering the cells.  Osmotic response is coordinated between the AqpZ and MsCL with AqpZ 
helping to maintain turgor. At the same time MsCl helps in preventing a fatal rapid increase in cell 
volume.   pH regulation of MsCL has also been reported and indicates that a lower pH might lead 
to a lower rate of activation of MsCL to prevent H+ entry into the cells.    Thus the protective 
action of the MsCL might be reduced at a lower pH indicating that the cell will be more vulnerable 
to a downshift in osmotic pressure.  Thus, in addition to downregulation of AqpZ synthesis - a 
slow process, the rapid reduction in permeability by gating of AqpZ might be an important 
protective step.  
 
In order to study the effect of high water permeability on the viability of E.Coli under lowered pH 
conditions the uninduced AqpZ+(UI) , AqpZ- and ME9062 strains were subjected to acid shock 
(pH 2.5) as well a small osmotic downshift (200 mM).  It was found that both the ME9062 and 
AqpZ- strains had similar survival rates while the AqpZ+ (UI) strain had a significantly lower 
survivability rate (Figure 5) when subjected to simultaneous osmotic downshift and pH shock.  
The AqpZ+ (UI) strain modulates permeability with pH but it still has higher residual permeability 
than the wild type and knockout strains at lower pH values.  The low survivability of this strain 
under combined osmotic and acid shock conditions indicates that a decrease in permeability of the 
expressed AqpZ in wild type strains may be an advantageous biophysical response to the coupled 
pH and  osmotic variations. E. Coli  is exposed to such conditions while passing through the 
digestive tracts of animals.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Lower permeability of knock out and parent strains have higher survival rate than overexpression strain 
under simultaneous hypoosmotic and acid shock conditions.  
 
The short term survival of bacterial cells under changing pH and osmotic conditions is made 
possible by cooperative activity between water channel proteins and mechanosensitive channels.   
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ABSTRACT: 
 
Nanoscale devices involved in energy conversion require the transfer of electrons 
from one compartment to another in order to properly function. The enzyme 
NADH:ubiquinone oxidoreductase (complex I), which in vivo mediates the transfer of 
electrons from NADH to ubiquinone, is an intriguing candidate for such an electron-
transfer role in nanodevices. However, complex I normally requires the presence of 
lipids to remain active, potentially limiting its application. Here we demonstrate for the 
first time that complex I can be actively reconstituted in the synthetic membrane of 
amphiphilic triblock copolymer vesicles, to form hybrid systems at the nanoscale that 
allow site-specific reactions driven by location and redox-potential differences. These 
electron-transfer nanodevices are suitable for a variety of applications such as 
signaling devices or nanoreactors for follow-up redox reactions inside the synthetic 
membrane. 
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INTRODUCTION: 
 
Nanotechnology offers the possibility to design and manufacture specialized 
nanodevices with a range of applications in the fields of biomedicine, pharmacy, or 
energy conversion. A particularly difficult scientific challenge is to design devices able 
to store or transfer energy, and operating at the nanometer length scale. 
 There are in nature various molecular systems that promote energy conversion 
and serve as inspiration for nanotechology. One approach is to mimic natural 
electron transfer processes such as photosynthesis or nitrogen fixation (1). Another 
strategy consists of extracting biological molecules from living systems (bacteria or 
eucaryotic cells) and combining them to work in hybrid environments, as for example 
the reconstitution of membrane proteins in artificial liposomes (2, 3). For example, 
ATP-synthase was incorporated in liposomes together with bacteriorodopsin, a light-
driven proton pump, to construct a device that allows sunlight to be converted into 
chemical energy and stored in ATP (4). However, the use of liposomes for 
technological applications has various drawbacks, such as significant leakage due to 
structural defects and mechanical instability (5),Barenholtz2001 which have not been 
eliminated by using combinations of lipids and synthetic polymers (5, 6). 
 Advanced materials based on polymers have been introduced to design new 
hybrid systems in combination with proteins. In this respect, amphiphilic copolymers 
are of particular interest because they self-assemble in aqueous solution into 
structures, such as micelles, tubes and vesicles, similar to those observed in nature 
(7, 8). The structure and the membrane characteristics of amphiphilic copolymer 
vesicles are analogous to those of liposomes. Recently, it was reported that synthetic 
membranes serve as mimics for biological membranes, and were successfully used 
to incorporate membrane proteins (9-11). In particular, vesicles resulting from the 
auto-assembling of poly(2-methyloxazoline)-block-(polydimethylsiloxane)-block-
(poly(2-methyloxazoline) copolymer (PMOXA-PDMS-PMOXA), have been shown to 
enable functional reconstitution of channel-forming proteins, such as OmpF, LamB, 
or Aquaporin Z (10, 12-14). 
 In addition, amphiphilic copolymer vesicles have been used to design and build 
nanoreactors, which protect enzymes encapsulated in their inner cavity and enable 
them to act in situ (15), or enable the tandem action of soluble and membrane-bound 
proteins (13, 16). Compared to natural lipids, polymers have the benefit of long-term 
stability arising from a combination of high mechanical stability and chemical 
inertness, making them more reliable for technological applications (17). Further, the 
use of synthetic copolymers opens the possibility to modulate and control the 
4 
 
chemical composition and properties of the synthetic membrane by changing the 
chemical nature of polymer blocks, varying their block lengths, or adjusting the ratio 
between hydrophobic and hydrophilic domains (7, 18, 19). 
 Here we have designed and tested a new hybrid system which allows electron 
transfer from the environment into the membrane of polymer vesicles. We chose the 
bacterial respiratory enzyme complex NADH:ubiquinone oxidoreductase (complex I) 
as electron transfer effector. Complex I couples the transfer of electrons from NADH 
to ubiquinone performed by a series of redox centers with a translocation of protons 
across the membrane. It thus contributes to the proton motive force, essential for 
energy consuming processes (3, 20-24). The activity of complex I is very sensitive to 
environmental changes and strongly dependent on the presence of phospholipids 
(25-27) This could compromise its reconstitution in a synthetic membrane.  
 Various studies have shown that the phospholipid environment plays a crucial 
role in maintaining membrane protein activity (28-31). For example, cardiolipin tightly 
bound to Ubiquinol:Cytochrome c Oxidoreductase (complex III) confers stability or is 
needed for proper assembly of the enzyme complex (32). Therefore, we attempted to 
determine the behavior of complex I in polymer media and devoid of most 
endogeneous lipids prior to its incorporation in the polymer membrane. We 
synthesized a library of various PMOXA-PDMS-PMOXA copolymers, modifying the 
length of the hydrophilic and hydrophobic blocks or the ratio between them in order to 
provide membranes with different thicknesses. With this library we established 
whether the synthetic media affect the protein functionality, and in which respect. 
 Electron microscopy revealed the L-shape structure of complex I with a 
peripheral arm containing the nucleotide binding site and a membrane arm 
containing the quinone-binding site (23). To enable electron transfer from outside the 
vesicle to the vesicle membrane or interior, complex I must be properly oriented in 
the membrane to expose the peripheral arm to the external solution. This is a more 
complex task than the incorporation of a rather symmetric channel protein in polymer 
membranes (12), and we needed to adjust the reconstitution processes used with 
membrane proteins in pre-formed liposomes to account for the different properties of 
polymers (33). Fortunately, the self-assembly process of vesicle formation offers a 
facile way to incorporate complex I together with various electron acceptors located 
in different regions of the vesicles, in order to test the function of complex I once 
incorporated into the polymer membrane.  
 
RESULTS: 
Complex I activity restored by copolymers. Complex I was isolated from 
Escherichia coli in the presence of the detergent dodecyl-maltoside, following an 
established protocol(34). During the preparation most of its endogeneous lipids were 
lost and 20 mol of phospholipids, predominantly phosphatidylethanolamine, per mol 
complex I were retained. Complex I, as isolated, showed a low NADH:decyl-
ubiquinone oxidoreductase activity of 0.2 µmol NADH / min mg.  
  The preparation was titrated with increasing amounts of a mixture of 
phosphatidylethanolamine (75%), phosphatidylglycerol (20%), and Cardiolipin (5%), 
mimicking the composition of the E. coli plasma membrane (Figure 1). The addition 
of phospholipids did not significantly change the activity of complex I up to a lipid to 
enzyme ratio of 0.05 (w/w). Beyond this point the enzymatic activity of complex I 
increased dramatically. At a ratio of 0.25 (w/w), the activity was enhanced nearly six 
times. Further increase of the lipid content did not lead to a higher activation of the 
enzyme, as indicated by the plateau region in Figure 1 (dark circles). The ratio 
between complex I activity at the plateau region and that at 0.005 (w/w) ratio, 
activation ratio, will be used as a parameter to compare various environments for 
complex I: either polymers to each other or polymers to lipids. 
 
Figure 1. Dependence of the NADH:decyl-ubiquinone oxidoreductase activity of complex I (E. 
coli) on the  ratio of phospholipids/complex I (dark circles) or polymer/complex I (open 
squares). The block copolymer is PMOXA13-PDMS110-PMOXA13. 
  
 A similar titration curve was obtained with PMOXA13-PDMS110-PMOXA13, 
indicating that the self-assembling block copolymer substitutes for the natural lipids 
and activates complex I to a similar extent as phospholipids (Figure 1 – open 
5 
 
6 
 
n incubation time of 20 minutes at 0°C used in the case of 
hospholipids. 
activation ratio of complex I we 
btained must be considered as an average value. 
x and y are the average number of monomeric units of each block, NA and NB, 
spectively. 
 
positiona ispersity 
squares). It has been shown that polymer self-assembly is usually defined by slower 
dynamics of the constituent blocks compared to the lipids (35). We therefore 
optimized the incubation time and the temperature in order to take into account the 
different chemical composition and kinetics of polymers (Supplementary information, 
Figure S1). The optimum conditions for complex I NADH:decyl-ubiquinone 
oxidoreductase activity were obtained by an incubation time of 30 minutes at 0°C, 
compared to a
p
 
Complex I activity depends on copolymer composition. In order to investigate 
the influence of the copolymer molecular properties on the physiological activity of 
complex I, we synthesized a small library of PMOXAx-PDMSy-PMOXAx copolymers 
with hydrophilic block PMOXA (A) ranging from 9 to 65 monomer units, and 
hydrophobic block PDMS (B) ranging from 23 to 165 monomer units (Table 1). The 
polydispersity of block copolymers imposed a slight variation of complex I activation 
ratio due to the simultaneous presence of polymer chains with slightly different block 
lengths. Thus, in every individual experiment the 
o
 
Table 1. Library of PMOXAxPDMSyPMOXAx copolymers used for the assay of NADH: decyl-
ubiquinone oxidoreductase activity of complex I. A represents the PMOXA block, and B the 
PDMS block; 
re
Polymer com MW a Polyd
A9B106A9 - 1 9486 1.38 
A13B62A13 - 2 6938 1.47 
A15B62A15 - 3 7276 1.50 
A21B69A21 - 4 8816 2.00 
A13B23A13 - 5 4052 Insoluble in TFH 
A65B165A65 - 6 23372 1.63 
A13B110A13 - 7 10462 1.44 
A14B110A14 - 8 10632 1.36 
 
a. Polymer composition and Mw obtained with 1H NMR spectroscopy. b. Polydispersity 
btained by GPC (THF linear PS calibration). o
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uced a significantly smaller activation of 
the enzyme (as for example A21B69A21, 4).  
 
 The activation ratio of complex I strongly depends on the copolymer type 
(Figure 2). The data for each copolymer represent the average results obtained from 
6 independent experiments. Some copolymers, such as A9B106A9, A13B110A13, and 
A14B110A14 (1, 7, and 8) induced a roughly similar or greater activation of complex I 
than the phospholipids (9), while others ind
 
Figure 2. Activation ratio of complex I NADH: decyl-ubiquinone oxidoreductase activity for 
various copolymers PMOXAx-PDMSy-PMOXAx (1 – 8, see Table 1), and phospholipids. The 
ratio of additive/complex I is of 0.1 (w/w). 
ent influence of the hydrophobic and hydrophilic blocks, respectively 
(Figure 3 a, b). 
  
 The distinct effects of the different copolymer types on the activation ratio of 
NADH:decyl-ubiquinone oxidoreductase activity supports the hypothesis that the 
molecular composition of the polymer (hydrophobic and hydrophilic block lengths) 
directly influences the active conformation of the complex. In order to decouple the 
possibly different effects of the hydrophilic and hydrophobic domains, we used two 
sets of copolymers: one set had an almost constant A block (13 to 15 monomer 
units) and a variable B block (23 to 110 monomer units), and the other set an almost 
constant B block (106 to 110 monomer units), and a variable A block (9 to 15 
monomer units). The effect on the activation ratio of NADH:decyl-ubiquinone 
oxidoreductase activity of complex I as a function of these two sets of copolymers 
indicates a differ
 
Figure 3. Activation ratio of complex I NADH:decyl-ubiquinone oxidoreductase activity as 
function of: a) number of monomer units in the hydrophobic B block, NB (A block almost 
constant); b) number of monomer units in the hydrophilic A block, NA (B block almost 
constant). c) Model for the activation ratio of complex I NADH:decyl-ubiquinone 
oxidoreductase activity as function of the number of monomers in both hydrophobic and 
hydrophilic blocks. The curves in a) and b) represent slices through the activation ratio 
surface with NA constant, and NB constant, respectively. Activation ratio of complex I NADH: 
decyl-ubiquinone oxidoreductase activity was calculated for a polymer/complex I ratio of 0.1 
(w/w) and of 0.005 (w/w).   
 
 Within the limits of our experiments, increasing the length of the hydrophobic 
block while keeping the length of the hydrophilic block virtually constant leads to a 
stronger activation of complex I (Figure 3 a). On the other hand, we observed an 
inverse effect of the length of the hydrophilic block A on the activity of complex I, 
while keeping an almost constant length of the hydrophobic block (Figure 3 b). This 
effect is not as significant as the one of the hydrophobic domain, but it modulates the 
latter.  
 We modeled the combined effect of the hydrophobic and hydrophilic domains 
using a least squares approach based on a double parameter polynomial regression. 
The surface which describes the activation ratio of complex I NADH:decyl-ubiquinone 
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oxidoreductase activity as a function of the A and B block lengths indicates a domain 
of polymer properties that activates complex I and another domain (the minimum of 
this surface) which inactivates it (Figure 3 c). A slice through this surface, with either 
NA or NB constant (Figure 3 a and 3 b), shows in more detail how each polymer 
affects complex I activity. It can be seen that the maximum activation of complex I is 
obtained when the copolymers have the biggest hydrophobic (B) block, while 
keeping the hydrophilic (A) block sufficiently small. We emphasize that this effect 
should be considered in the range of hydrophobic blocks we used, and under the 
conditions leading to complex I activation by reconstitution in copolymers. An upper 
limit for the dimension of the hydrophobic domain surely exists, above which the 
membrane imposes such a high distortion on the complex I that it may denature. 
 In order to exclude the possibility that the activity measured in the presence of 
polymers was not the physiological activity of complex I, we determined the inhibition 
of the NADH:decyl-ubiquinone oxidoreductase activity by piericidin A, a specific 
inhibitor of the ubiquinone binding-site (36). The amount of inhibitor needed to block 
50% of the enzymatic activity, IC50 was determined for complex I reconstituted in 
phospholipids and polymer 7, respectively. An IC50 value of 3 µM was obtained for 
complex I reconstituted either in phospholipids or in polymer 7. More than 90 % of 
the activity was inhibited in the presence of 10 µM piericidin A.  
 
Construction of an electron-transfer nanodevice using complex I. The 
robustness of the electron transfer chain of complex I is a critical prerequisite for the 
design of an electron-transfer nanodevice when the enzyme is reconstituted in the 
membrane of vesicles formed by self-assembly of the PMOXA-PDMS-PMOXA 
copolymer.  
 The typical "L-shape" structure of the protein and its orientation – with the 
nucleotide binding site in contact with the aqueous phase and the other arm 
embedded in the hydrophobic membrane (37) – must be maintained in order to 
enable the transfer of electrons in a specific direction. This introduced an added 
complexity to vesicle formation during the preparation of our nanodevice. Usually, 
due to the statistical character of insertion during the self-assembly process of 
vesicle formation, proteins are inserted in both orientations relative to the membrane 
(14) In order to obtain the desired orientation of complex I within the polymer 
membrane we modified the method of membrane protein reconstitution in liposomes, 
introduced by Rigaud et al (33, 38), which has already been used to reconstitute 
complex I in liposomes (3). 
 We specially adopted and modified the concept of reconstitution of membrane 
proteins in pre-formed liposomes, known to induce a high percent of asymmetric 
orientation upon insertion, to the use of amphiphilic copolymers. In our modification, 
a mixture of complex I and surfactant was added to preformed surfactant-doped 
amphiphilic block copolymer vesicles. This generated a hybrid system of protein-
polymer vesicles; named proteovesicles (see Supplementary information). After 
surfactant removal the solution of proteovesicles was analyzed by TEM in order to 
determine whether the vesicles were affected by complex I incorporation (Figure 4). 
The TEM image indicates that the surfactant procedure used to incorporate complex 
I in polymer membrane did not affect the morphology of the vesicles (for comparison, 
a TEM image of empty vesicles is included in the Supplementary Information, Figure 
S2). 
 
 
Figure 4. Transmission Electron Micrograph of complex I incorporated in 
PMOXA13PDMS110PMOXA13 vesicles (room temperature; scale bar = 200 nm).  
 
 The presence of all complex I subunits in the preparation of the vesicles was 
confirmed by gel electrophoresis (Supplementary Information S), and the presence 
of the Fe/S cofactors by EPR spectroscopy (Figure 5a). SDS-PAGE revealed that 
complex I had been inserted in the polymer vesicle membrane. All subunits of 
complex I were present in both lanes, indicating that the protein was not cleaved 
during its insertion in the membrane of polymer vesicles (Supplementary 
Information Figure S3 : lane II)  
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Figure 5. Completeness and functionality of of complex I after reconstitution in 
polymer membrane of the vesicles. a) EPR spectrum of NADH reduced complex I 
incorporated in the vesicles membrane, at 40K. * indicate the values of the 
gyromagnetic tensor for the binuclear Fe-S cluster N1a. + indicate the values of the 
gyromagnetic tensor for the binuclear Fe-S cluster N1b. b).NADH/ ferricyanide 
oxidoreductase activity measured at 410 nm and 25 °C. The reaction was started by 
an addition of NADH (represented by the arrow) to: complex I in solution (curve A), 
complex I incorporated in polymer vesicles (curve B), protein-free vesicles solution 
(curve C). 
 
 In addition, we investigated whether the proteovesicles contained the binuclear 
Fe/S clusters by using EPR spectroscopy. The EPR spectrum of NADH reduced 
complex I in the vesicle membrane (Figure 5a) at 40K is similar to that of free 
complex I (34) g-factor values of 1.94 and 2.03 were attributed to cluster N1b, and 
the values 1.92, 1.95 and 2.00 to the cluster N1a (39). 
 The amount of protein incorporated in the membrane of proteovesicles was 
estimated by a BCA protein assay. Approximately 40 - 60% of complex I in the 
mixture was incorporated into proteovesicles, (data not shown). These values are in 
good agreement with those obtained when complex I was reconstituted in liposomes 
(40).  
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 To demonstrate the preferential orientation of the protein in proteovesicles 
membrane we measured the NADH/ferricyanide oxidoreductase activity. Ferricyanide 
binds to the NADH binding site, and neither involves quinone reduction nor proton 
translocation, representing a direct way to test the orientation of complex I once 
inserted into the polymer membrane (41). The NADH/ferricyanide oxidoreductase 
activity was determined for purified complex I, proteovesicles, and protein-free 
polymer vesicles (Figure 5b). The activity of complex I (curve A) is preserved after its 
incorporation in the polymer membrane (curve B); the lower activity of proteovesicles 
is due to the reduced fraction of the incorporated protein and to a partially “wrong” 
complex I orientation once inserted into the polymer membrane.  
 
Electron transfer mediated by complex I incorporated in polymer membranes. 
We wanted to determine whether and how far complex I mediates electron transfer 
from the vesicles’ environment to their interior (Scheme 1).  
 
 
 
Scheme 1. Electron transfer nanodevice based on complex I reconstituted in the membrane 
of proteovesicles.  
 
 We used ubiquinone 2, CoQ2 , known to be involved in the natural mechanism 
of energy conversion as electron acceptor (36, 42). Due to its hydrophobic character, 
CoQ2 was incorporated simultaneously with complex I into the polymer membrane, 
using the method described above. After addition of NADH, the reduction of CoQ2 
mediated by the protein was followed with EPR spectroscopy. This was compared 
with the EPR spectrum of protein-free vesicles containing CoQ2. 
 Prior tests on electrochemical reduction of free CoQ2 were used to identify the 
semiquinone radical anion of CoQ2, formed by direct electron transfer (43). The EPR 
spectrum generated by direct reduction of free CoQ2 (Figure 6–A a) was simulated 
with hyperfine coupling constants compatible with those reported  for the CoQ2 
radical anion, CoQ2
-
 (Figure 6-A b) (44). Addition of 1 % TRITON™ X-100 (Triton) 
led to line broadening in the EPR spectrum according to increased viscosity, but had 
no influence on the hyperfine splitting representing CoQ2
-
 (44, 45). 
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Figure 6. A. EPR spectrum of electrochemically reduced CoQ2 at 283 K (a) together with its 
simulation (b). B. EPR spectrum of NADH-reduced species of CoQ2 at 283 K, when CoQ2 is 
incorporated in polymer vesicles (a), when CoQ2 is incorporated in proteovesicles (b), 
together with its simulation (c). The solutions were prepared in 50 mM Tris/HCl, 50 mM NaCl, 
pH=7.0 
 
 When CoQ2 is incorporated in the membrane of the polymer vesicles, a very 
weak EPR spectrum, similar to that of the anionic CoQ2
-
 species, appears (Figure 6-
B a compared with Figure 6 – A a). Its integrated area corresponds to approx. 6% of 
the radical anions which can be generated by electrolysis of an amount of CoQ2 
equivalent to that used for the incorporation in polymer vesicles. 
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Figure 7. Double integral of the EPR spectrum of CoQ2
- generated by:  parent CoQ2 (1), 
CoQ2 incorporated in polymer vesicles (2), CoQ2 and AQ incorporated in polymer vesicles (3), 
CoQ2 incorporated in proteovesicles (4). The solutions in 50 mM Tris/HCl, 50 mM NaCl, were 
measured at 283 K. Dotted line indicates the double integral of the EPR spectrum of CoQ2
- 
generated by CoQ2 incorporated in polymer vesicles, after addition of 1% Triton. 
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 This points to only a very low amount of CoQ2 being present on or at the 
surface of the vesicles and therefore being accessible for direct electron transfer 
(Figure 7 -2 compared with -1). After the addition of 1% Triton, the intensity of CoQ2
- 
EPR signal increased significantly (dotted line in Figure 7). Due to their amphiphilic 
character, surfactants are known to partially solubilize the membrane at low 
concentration, while at higher concentration they disorganize it completely. Dynamic 
light scattering data confirmed that a considerable fraction of vesicles remained intact 
after the addition of detergent, explaining the residual fraction of CoQ2 still not 
reduced. Addition of 1% Triton led to the partial destabilization of the polymer 
membrane, thus enhancing the reduction of CoQ2, but does not lead to a complete 
release of the residual CoQ2 (45). 
  The addition of NADH to the proteovesicle solution generated an EPR 
spectrum of CoQ2
- with a significantly higher intensity (Figure 6-B b). Its double 
integral indicates that considerably more of the CoQ2 incorporated in the 
proteovesicles is reduced (Figure 7-4), which proves that complex I mediates the 
electron transfer when reconstituted in the polymer membrane. The presence of 
CoQ2 that is not reduced can be explained by its location in the polymer membrane 
relative to the specific quinone-binding sites of complex I.   
 To determine whether the electron-transfer mediated by complex I 
reconstituted in polymer membranes is regio-selective, we used a second electron 
acceptor, anthraquinone-2,6-disulfonic acid (AQ). This is preferentially soluble in the 
aqueous phase, and therefore located in the inner cavity of proteovesicles. The 
addition of NADH to a free AQ solution in the presence of complex I (Supplementary 
Information, Figure S4) generated an EPR spectrum similar to that of the 
electrochemically reduced AQ (46), and did not change after addition of 1 % Triton. 
Thus, complex I mediates electron transfer to AQ, most likely involving the non-
physiological quinone-site (36). As the EPR spectrum of reduced ubiquinone 2 is only 
partially overlapping to the one of reduced AQ (Supplementary Information, Figure 
S5 and S6), this enables to distinguish to which of them is the electron transfer taking 
place, when they are both present in the nanodevice. However, no EPR signal was 
obtained when AQ was encapsulated in polymer vesicles, and only a very weak EPR 
spectrum of CoQ2
-
 species appeared when both electron acceptors were 
incorporated (Figure 7 -3). The addition of NADH to proteovesicles containing both 
electron acceptors generated the EPR spectrum of CoQ2
-
 similar in intensity to the 
one generated when only CoQ2 was incorporated in proteovesicles (Figure 1- 4). 
Discussion 
The reactivation of complex I by phospholipids is most likely due to the need of 
specific lipids that provide an appropriate environment for the active conformation of 
the complex (3, 25, 26, 47). Although we did not establish the detailed molecular 
aspects of electron transfer and proton-translocation of complex I in copolymer 
membranes, our work shows that amphiphilic triblock copolymers are able to mimic 
biological membranes and that they support enzymatic activity of membrane proteins 
by providing an adequate medium for their physiological activity. By using a library of 
amphiphilic triblock copolymer PMOXAn-PDMSm-PMOXAn we found that for specific 
hydrophilic-hydrophobic domains, the polymer membrane promotes complex I 
activity in a similar way as natural phospholipids. The increase of the length of the 
hydrophobic block while keeping the length of the hydrophilic domains constant leads 
to a stronger activation of complex I. At the same time, the longer the hydrophilic 
block, the thicker is the membrane. These data can be explained by a higher 
mechanical stress imposed on the protein by the thickness of the membrane, and the 
conformational flexibility of the copolymer. Together the effects might favor an active 
conformation of complex I (Figure 8).  
 
Figure 8. Graphical representation of complex I incorporated in copolymer membrane. 
 
An upper limit for the hydrophobic domain surely exists, above which the 
membrane imposes such a high distortion on complex I that the protein complex 
disassembles. However, we did not reach this barrier within our experiments. 
The inverse effect was obtained by increasing the length of the hydrophilic 
block while keeping the length of the hydrophobic block. However, this effect is not 
as significant as the one of the hydrophobic block. Changes in the length of the 
hydrophilic block only modulate the effects obtained by changes in the length of the 
hydrophobic block. The role of these two molecular parameters of the copolymer 
system gives some insight on the intermolecular forces acting between the 
copolymer membrane and the protein (Figure 8). The membrane domain of complex 
I is essential for the proton-translocation activity, tightly coupled to the electron 
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transfer (48). It was shown that conformational changes are exerted on this domain 
during turnover, in agreement with our model, indicating that the hydrophobic block 
has the major effect on the modulation of complex I activation. Contrarily, the 
hydrophilic block might interfere with proton access if its length goes beyond a 
certain threshold. In addition, the specific inhibition of the NADH:decyl-ubiquinone 
oxidoreductase activity by piericidin A demonstrates that the amphiphilic block 
copolymer PMOXA-PDMS-PMOXA does not affect the physiological quinone-binding 
site of complex I.  
 The activation of complex I by amphiphilic triblock copolymers can be 
controlled by varying the molecular properties of these block copolymer systems, that 
is, by varying the lengths of the specific hydrophilic-hydrophobic domains. This is 
remarkable in the context of using complex I for technological applications as the 
lipidic membrane environment previously considered as required for activation can 
now be replaced by amphiphilic block copolymers.  
 The ability of the copolymer to activate complex I as well as to provide a 
suitable hydrophobic environment for incorporation of electron acceptors represents 
the basis for the design of an electron transfer device at the nanometer scale, based 
on the incorporation of complex I in copolymer vesicles, as shown in Scheme 1. By 
adapting the method of membrane protein reconstitution in liposomes to our polymer 
vesicles, we incorporated the asymmetric protein without cleavage and in a suitable 
orientation to mediate electron transfer from the outside to the polymer membrane of 
proteovesicles. During incorporation the enzyme complex did not disassemble nor 
was the electron transfer chain affected. In addition, NADH/ferricyanide 
oxidoreductase activity proved that complex I was inserted with a high probability in 
the desired orientation, with the peripheral arm pointing outwards from the vesicles, 
thus favoring electron transfer from the environment of the vesicles, into their 
membranes.  
The efficiency of the incorporation of complex I into the copolymer membrane of 
proteovesicles of 40 – 60% is in the same order as values obtained for reconstitution 
in liposomes (40). This is remarkable in the context of the higher stability of polymer 
membranes which requires a higher activation energy for the insertion of a 
membrane protein. Thus the driving force for the incorporation of membrane proteins 
in hydrophobic membranes must be very high. The distribution of incorporation 
efficiencies is due to the statistical character of the self-assembly process of 
proteovesicles formation. In biological membranes complex I guides a sub-
millisecond electron transfer from NADH via the long chain of its redox cofactors to 
the substrate quinine (49). It contains at least two quinone binding sites, but only one 
17 
 
is considered as the physiological site due to its coupling with proton translocation 
(36). We studied the electron transfer mediated by complex I reconstituted in polymer 
membrane to various electron acceptors, without characterizing the molecular details 
of the reaction. By using two electron acceptors with different locations with respect 
to the copolymer membrane we established that electron transfer from the outside to 
the membrane of the proteovesicles takes place. 
 
Conclusion 
 The synthetic membrane can be considered as a mimic of biological 
membranes, while offering specific advantages, such as high mechanical stability 
and inert chemical behavior, giving rise to an enhanced stability to the nanodevice. 
This hybrid system allows site-specific reactions, and is suitable for a variety of 
applications such as a trigger system in signalling, or a nanoreactor for specific 
follow-up reactions inside the membrane. 
 The hybrid protein-polymer nanodevice illustrates how complex I could be used 
to reduce suitable molecules in the membrane. In order to transfer electrons to the 
aqueous cavity of the vesicles and reduce molecules there, a second enzyme with a 
substrate reduction site on the opposite site of the membrane is needed, similar to 
what is seen in nature, where complex I acts in tandem with complex III. Using only 
complex I, the hybrid system provides two compartments: the membrane, where 
electrons can be transferred from the environment, and an aqueous compartment 
where other reactions can be followed simultaneously, without interference. 
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Material and Methods 
 Solutions of lipids (E.coli lipid polar extract) were obtained from Aventi Polar 
Lipids, Inc.  The detergent dodecyl-maltoside was obtained from Anatrace, Inc. and 
added to lipids solutions (0.1%), and to polymer solutions (3.5%). Decyl-ubiquinone 
(ubiquinone 2), NADH, TRITON™ X-100 (Triton), potassium ferricyanide and 
anthraquinone-2,6-disulfonic acid (AQ) were purchased from Sigma-Aldrich. Other 
chemicals were obtained as described in the following sections. 
 
Expression and purification of complex I 
 NADH: ubiquinone reductase (complex I) was isolated from Escherichia Coli, 
following an established protocol (3). The protein was stored in 50 mM MES/NaOH 
pH 6.0, 50 mM NaCl, 0.15% dodecyl-maltoside. 
 
Synthesis of ABA triblock copolymer  
 A library of poly-(2-methyloxazoline)-block-polydimethylsiloxane-block-poly(2-
methyloxazoline) copolymers was synthesized following the approach described by 
Nardin et al (13). The polydimethylsiloxane middle block was synthesized by acid 
catalyzed polycondensation of dimethoxydimethylsilane in the presence of water and 
end-capper, resulting in butylhydroxy terminated bi-functional PDMS. Upon 
purification and drying the hydroxyl groups were reacted with 
trifluoromethanesulfonic anhydride in cold hexane for three hours. The solvent was 
then removed under high vacuum and a portion of fresh hexane was added. The 
reaction mixture was filtered through a G4 filter at -10°C under argon. Upon removal 
of solvent the colorless triflate bi-functional macroinitiator was obtained. Addition of 2-
methyl-2-oxazoline to the macroinitiator solution in dry ethyl acetate resulted in 
symmetric ring-opening cationic polymerization of poly-(2-methyloxazoline) blocks. 
The reaction was terminated by addition of potassium hydroxide in methanol. The 
reaction product was purified by ultrafiltration in a 1:5 ethanol/water mixture. In the 
case of A21B69A21, A13B62A13, A15B62A15 and A13B23A13 block copolymers the starting 
siloxane polymers were purchased from Wacker Chemie AG, purified, and reacted in 
a similar manner.  
 
Preparation of ABA vesicles and proteovesicles by incorporation of complex I 
The self-assembly of poly(2-methyloxazoline)-block-poly(dimethylsiloxane)-
block-poly(2-methyloxazoline), PMOXA-PDMS-PMOXA amphiphilic triblock 
copolymers in aqueous solution has been described in a previous publication (13). 
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To prevent the presence of any traces of organic solvents, block copolymer 
vesicles were prepared by directly dissolving 50 mg of the copolymer in 4.950 g of 
buffer (50 mM Tris/HCl, 50 mM NaCl, pH 7.0) rather than using the common solvent 
displacement technique to induce self-assembly. Under over-night vigorous stirring, 
the amphiphilic block copolymers spontaneously self-assemble into vesicular 
structures. Their sizes and size distributions are large yet improved by sonication and 
sequential extrusion cycles through Millipore filters (0.45 μm and 0.22 μm pore size). 
Similar to the incorporation of proteins into surfactant-doped liposomes described by 
Rigaud et al (33) the addition of 0.5 % Triton   to the dispersion of copolymer vesicles 
enables the incorporation of complex I into the synthetic membrane. The polymer 
vesicles were left to incubate with the surfactant for 1 hour prior to sonication (two 
cycles of 5 s). The protein solubilized in dodecylmaltoside (80 µL, 1 mg.mL-1) was 
added to the surfactant-doped amphiphilic block copolymer vesicles and maintained 
under stirring for 3-6 hrs. Afterwards the surfactant was removed using Bio-Beads® 
SM-2(Bio-Rad Laboratories). The total amount of Bio-Beads (1g Bio-Beads for 200 
mg Triton) was sequentially added in three steps spaced by 1 hour. The sample was 
then stirred for 6-8 h at 4 °C. The supernatant containing proteovesicles was then 
centrifuged (Heraeus, 5000 rpm during 20 min.) to remove the Bio-Beads. Non-
incorporated protein was removed by gel permeation chromatography (Sepharose™ 
4B, Amersham Biosciences). 
 
Transmission electron microscopy  
These measurements were conducted on vesicle and proteovesicles samples 
by using a Philips 400 microscope (Philips). The samples were prepared by dilution 
up to 1,000 times and then stained with 2% uranyl acetate on plasma-treated copper 
grids. 
 
Integrity of complex I after its incorporation in polymer membrane 
Gel electrophoresis. A solution of native complex I, a solution of proteovesicles 
containing 1 % (v/v) complex I, and a solution of pure polymer vesicles were 
analyzed with a 12% SDS-PAGE. The proteovesicle solution was concentrated by 
centrifugation and re-dissolved in SDS-PAGE buffer for analysis. Complex I subunits 
were detected by silver staining of the polyacrylamide gel (Silver Staining kit, 
Amersham Biosciences). 
Electron Paramagnetic Resonance, EPR. The Fe-S clusters in NADH-reduced 
proteovesicles were detected with an X-band Bruker ESP300E spectrometer, at 40K. 
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The sample temperature was controlled with an Oxford Instruments helium flow 
cryostat and the magnetic field was calibrated using a strong pitch standard. The 
microwave power was 2mW, the modulation amplitude 6G. Multiple acquisitions were 
done to improve the signal-to-noise ratio. The solutions of vesicles/proteovesicles 
were mixed with NADH (5 mM final concentration) and measured immediately. 
 
Complex I activity assays 
NADH/ferricyanide oxidoreductase activity assay. Activities were determined with 
purified complex I and complex I in proteovesicles, and compared to the activity of 
polymer vesicles without complex I. The enzymatic activity of complex I was 
measured at 25 °C by following the reduction of ferricyanide by NADH at 410 nm. 
The assay was performed with 0.3 mL of vesicles (1mg/ml) (or proteovesicles) 
solution respectively, 0.185 mL of 50 mM Tris/HCl, 50 mM NaCl pH 7.0 buffer and 5 
μL of 0.1 M potassium ferricyanide. After chromatographic removal of non-
incorporated complex I the enzymatic activity was recorded by the addition of 10 μL 
of a 10 mM NADH solution. The NADH stock solution was freshly prepared for each 
set of experiments. Similar measurements were repeated with the surfactant-
solubilized complex I: 5 μL of a 10 mg.mL-1 solution was mixed with 0.485 mL of 50 
mM Tris/HCl, 50 mM NaCl pH 7.0 buffer containing 0.1 % Triton X-100. 
NADH-decylubiquinone oxidoreductase activity assay. Complex I (70 μg) was 
added to a solution of lipids or copolymer with different ratios (w/w) from 0.01 to 1, 
and the solutions were incubated for different times (20 minutes to 3 hours). The 
volume was then adjusted to a total volume of 1mL, and 50μM of decyl-ubiquinone 
was added. After a final incubation of 5 minutes at room temperature, 50μM of NADH 
was added to the solution and the decrease of absorbance was measured at 340nm. 
The buffer used for all titration experiments was 50mM MES/NaOH, 50mM NaCl, 
pH=6.0 Lipid solutions were prepared in similar conditions as previously used by 
Friedrich (3) (incubation time of 20 minutes at 0°C). 
Inhibition assay. The same mixture was prepared as for the NADH-decylubiquinone 
oxidoreductase activity assay. During the 5 minutes incubation at room temperature, 
10µM Piericidin A, a complexI inhibitor, was added to the solution. Finally 50µM of 
NADH was added to the solution and the decrease of absorbance was measured at 
340nm. 
 
Coupled NADH:ubiquinone–2/AQ oxidoreductase activity assay. 10 μM 
ubiquinone 2 (CoQ2) was added and incubated for 1hr with the vesicles or 
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proteovesicles dispersion. The solution was washed by gel filtration prior to the EPR 
measurements. Anthraquinone 2,6-disulfonic acid, disodium salt (AQ) was dissolved 
in 50 mM Tris/HCl, 50 mM NaCl, pH 7.0 buffer, to a 10mM concentration. This 
solution was used to prepare the vesicles and proteovesicles according to the 
previous protocol. Non-encapsulated AQ were removed by ion exchange 
chromatography (Amberlyst A 26, Sigma-Aldrich).  
Reductions of free ubiquinone 2, and AQ were carried out electrochemically, the 
experimental set-up employing a helical gold cathode as a working electrode and a 
platinum wire as a counter electrode. The electrolytic cell was placed inside the 
resonance cavity to allow in situ detection, and EPR measurements were performed 
at 283K, on a Bruker ESP300 spectrometer at X-band and with a microwave power 
of 1mW. The solutions of vesicles/proteovesicles incorporating the electron acceptors 
were mixed with 10 μL of a 10 mM NADH solution and measured immediately after 
preparation, with a Bruker ESP300 spectrometer at X-band and with a microwave 
power of 1mW, and modulation amplitude of 1G. EPR simulations were done with the 
public domain program WinSim. 
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1. Optimisation of the experimental conditions for complex I activation in 
polymer media  
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Figure S1: Dependence of the NADH:decyl-ubiquinone oxidoreductase activity of complex I 
(E. coli) on the protein incubation time and temperature in polymer media: at room 
temperature (black squares) and 0º C (empty circles). The polymer / complex I ratio is 0.1 
(w/w). PMOXA13-PDMS110-PMOXA13. 
 
2. Transmission Electron Micrograph of empty polymer vesicles 
 
Figure S2. Transmission Electron Micrograph of PMOXA13PDMS110PMOXA13 vesicles (room 
temperature; scale bar = 200 nm).  
 
 
3. Integrity of Complex I in polymer membrane 
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Figure S3 : Silver stained SDS-PAGE of: purified E. coli complex I, I, E. coli complex I 
incorporated in the membrane of PMOXA13-PDMS110-PMOXA13 vesicles, II, and pure 
PMOXA13-PDMS110-PMOXA13 vesicle membrane, III. MW: Molecular weight markers 
 
 
 
4. NADH reduction of anthraquinone, AQ  
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Figure S4. NADH reduction of anthraquinone, AQ: in a solution containing 1% triton a), in the 
presence of complex I, in a solution containing 1% triton b). The solutions were prepared in 
50 mM Tris/HCl, 50 mM NaCl, pH=7. 
 
 
5. Reduction of ubiquinone 2, and anthraquinone, AQ  
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Figure S5. Electrolysis of ubiquinone 2 (a), and anthraquinone, AQ (b). The solutions were 
prepared in 50 mM Tris/HCl, 50 mM NaCl, pH=7. 
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Figure S6. EPR spectrum of: reduced ubiquinone 2 (a), together with its simulation (b), and 
reduced anthraquinone (c), together with its simulation (d). The solutions were prepared in 50 
mM Tris/HCl, 50 mM NaCl, pH=7. 
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Inhibition of Macrophage Phagocytotic Activity
by a Receptor-targeted Polymer Vesicle-based
Drug Delivery Formulation of Pravastatin
Pavel Broz, MD,* Nadav Ben-Haim, PhD,* Mariusz Grzelakowski, MSc,†
Stephan Marsch, MD, PhD,* Wolfgang Meier, PhD,† and Patrick Hunziker, MD*
Abstract: Ruptures of macrophage-rich atherosclerotic plaques in
the coronary arteries are the main reason for heart attack. Targeted
therapeutic interventions with an inhibitory effect on the macro-
phages promise to be beneficial, but currently available drugs such as
statins achieve event reductions of only 30%. Dose-limiting adverse
effects in remote organs prohibit achieving higher drug levels known
to have strong inhibitory effects on macrophages. Receptor-specific
targeting using statin-loaded nanometer-sized triblock copolymer
vesicles with targeting moieties might allow high-dose treatment for
improved efficacy, while minimizing toxicity in other cells. Vesicle
uptake by target cells but not other cell types and slow intracellular
content release was observed. A major improvement in biologic
efficacy was observed for polymer vesicles compared to free drug,
whereas no increased cytotoxicity was observed in muscle cells. Such
high-dose, targeted therapy of statins through cell-specific polymer
vesicles allows novel treatment paradigms not only for atheroscle-
rosis, but appears promising for a wide range of drugs and diseases.
Key Words: polymer vesicles, statins, macrophages, scavenger
receptors, oxidized low-density lipoprotein
(J Cardiovasc PharmacolTM 2008;51:246–252)
In recent years, ample evidence has accumulated supportingthe hypothesis that local and systemic inflammatory processes
play a key role in the pathogenesis of atherosclerotic diseases.1–3
Activated macrophages initiate, maintain, and aggravate the
various steps that finally lead to plaque rupture and vessel
occlusion, the most common pathophysiological equivalent of
myocardial infarction and stroke.4,5 The amount of macro-
phages in a plaque correlates directly with the risk of plaque
rupture, making the macrophage and inflammatory plaques
important therapeutic targets in cardiovascular medicine.3,6
Anti-inflammatory drugs such as corticosteroids, calci-
neurin inhibitors, or cyclooxygenase inhibitors are not suitable
for a selective inhibition of active plaque macrophages due to
their low cell line selectivity and serious side effects. An ideal
drug candidate would accumulate in highly active plaque
macrophages, thereby sparing inactive macrophages, mono-
cytes and other nontargeted cell types.
Lipid-lowering drugs of the 3-hydroxy-3-methylglutaryl
coenzyme A (HMG-CoA) reductase inhibitor class have
partial anti-inflammatory and immunomodulatory proper-
ties7,8 and lead to a ~30% reduction of acute cardiac events.9,10
In macrophages, statins exhibit several effects11–13 that in
combination lead to a reduced uptake of oxidized low-density
lipoprotein (LDL), reduced secretion of leucotactic and tissue-
degrading molecules,14 and in consequence a reduced number
of plaque ruptures and acute coronary syndromes.15 These
immunomodulatory effects are concentration dependent, whereby
high concentrations of statins exhibit the most significant
inhibition of macrophage activity and proliferation.16 Further-
more, high-dose statins can directly downregulate the expres-
sion of scavenger receptor class A in macrophages by
increasing the intracellular levels of transforming growth
factor (TGF)-b1.17 Statin concentrations used in this kind of
receptor inhibition experiments (10 mmol/L), however, can
never be achieved in humans without having life-threatening
adverse side effects such as rhabdomyolysis (mean peak
plasma concentration for 40 mg oral pravastatin per day is
7.17 nmol/L).18 By targeting the drugs specifically to mac-
rophages populating the atherosclerotic plaques, the high-dose
toxicity of statins might be circumvented and the immuno-
modulatory effects might be fully exploited.19
Nanometer-sized vesicles self-assembled from biocom-
patible, protein-repellent and immune system evading amphi-
philic block copolymers promise to be useful for selective
delivery,20 triggered activity,21 and controlled release of high
doses of therapeutic agents.22 The copolymers form vesicles in
aqueous solution and enclose a defined part of the dissolved
drug molecules. Recently, it has been shown that the number
of encapsulated molecules can simply be calculated from the
original bulk concentration and the volume of the vesicles.23
By functionalizing the vesicle surface with chemical targeting
moieties, the nanostructures can be directed to specific cellular
targets. In a previous study, the same targeted polymer vesicles
made from (poly(2-methyloxazoline)-b-poly(dimethylsiloxane)-
b-poly(2-methyloxazoline) triblock copolymers were filled
with fluorescent markers to study the targeting properties,
uptake kinetics, and toxicity in cell cultures of scavenger
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receptor A1-expressing transgenic cell lines, human THP-1
macrophages, human smooth muscle cells and human
endothelial cells. The vesicles were target specific to scavenger
receptor expressing cells and macrophages, whereas no uptake
to the other investigated cell lines or THP-1 macrophage pre-
cursor cells was observed. The targeted polymer vesicles did
not exhibit significant toxic effects on both cells taking up and
not taking up the vesicles.20
Here, we present the use of the receptor targeted polymer
vesicles for encapsulation of the hydrophilic drug pravastatin.
Pravastatin has a proven inhibitory effect on macrophage
endocytotic activity and metabolism in cell cultures and
in vivo.15 The vesicles were functionalized with an oligonu-
cleotide sequence (polyG) with a proven affinity to macro-
phage scavenger receptor A1 (SRA-1) and tested in cell
cultures of human macrophages for efficacy, substance release
properties, and toxicity compared to nonencapsulated pravas-
tatin and empty polymer vesicles. Cell-line specificity and
myocyte toxicity were tested in cell cultures of rat skeletal
muscle cells. The myocytes are known to be sensitive to statins
and are a valid model for statin toxicity prediction.24
METHODS
Pravastatin Vesicle Preparation
The polymer used in this work consists of a poly
(dimethylsiloxane) (PDMS) middle block and two poly(2-
methyloxazoline) PMOXA side chains (JW05, Mn 7090
g/mol)25 with biotin-functionalized end groups as described
previously.20 To prepare the vesicles, the polymer (10%
biotinylated, 90% unbiotinylated polymer) was dissolved in
ethanol to give a 15% (wt/vol) solution; 250 mL of this ethanol
solution was added dropwise into 5 mL of phosphate-buffered
saline (PBS) containing 1.12 mmol/L pravastatin (Sigma-
Aldrich, Buchs, Switzerland). After 4 h of continuous stirring,
the solution was repetitively filtrated through filters of defined
pore size (Millex-GV, 0.45 mm and 0.22 mm; Millipore) to
produce a homogenous population of vesicles. Nonencapsu-
lated pravastatin was removed chromatographically (Sephar-
ose 4B, Sigma-Aldrich, in a 37-cm column with 1 cm inner
diameter, Bio-Rad, Reinach, CH). To obtain ligand-bearing
vesicles, 4 mmol/L streptavidin (Sigma-Aldrich) followed by
4 mmol/L biotinylated polyguanylic acid (polyG; Microsynth,
Balgach, CH; 23 G, 3# modified with biotin) were added (2 h
each with continuous stirring). To produce fluorescence-
labeled polymer vesicles, Alexa-610 streptavidin (Invitrogen,
Basel, Switzerland) was used instead of unlabeled streptavidin.
Vesicles were characterized as described earlier with light
scattering and cryogenic transmission electron microscopy.21
Cell Culturing
THP-1 cells (ECACC, Salisbury, UK) were cultured as
recommended by the manufacturer. Differentiation into
functional adherent macrophages was initiated 72 hours prior
to experiment with 100 nmol/L phorbol 12-myristate 13-
acetate (PMA; Sigma-Aldrich) in 24-well multiwell plates
(Becton-Dickinson, Basel, Switzerland) with glass cover slips
(12-mm diameter), resulting in a mean cell density of approx-
imately 1.25e5 cells/cm2. L6 mouse skeletal muscle cells
(ECACC) were grown in enriched Dulbecco’s Modified Eagle
Medium (DMEM) as recommended by the manufacturer and
seeded in a mean cell density of approximately 5e4 cells/cm2
24 hours prior to experiment. Experiments were performed at
37C and 5% CO2.
Cellular Uptake of Vesicles
Alexa-610 labeled polymer vesicles were administered
to cell cultures of macrophages and skeletal muscle cells as
described previously20 for 2 hours in a final concentration of
4 nmol/L vesicles. Cell nuclei were stained with 18 mmol/L
Hoechst 34580 (Invitrogen; stock solution with dimethyl
sulfoxide) for 30 min.
Endocytotic Activity Assay
Polymer vesicles were added to the prepared macrophage
cultures for 24 hours with final pravastatin concentrations in
the medium from 0.02 mmol/L to 1.08 mmol/L. Alexa-488-
labeled acetyled LDL (Invitrogen) or labeled polyG (same as
above coupled to streptavidin-phycoerythrin from Sigma-
Aldrich in a 1:1 proportion) were added for 1 h in final concen-
trations of 20 mmol/L and 1 mg/mL, respectively to test the
endocytotic activity. After washing with PBS, the cells were
fixed in 4% paraformaldehyde for 20 min at room temperature.
Fixed cells were mounted with an antibleaching glycerol-
based mounting medium (Sigma-Aldrich) on glass slides.
Calcein Release Assay
Calcein (Sigma-Aldrich) was encapsulated into func-
tionalized vesicles as described above in a high self-quenching
concentration of 50 mmol/L and checked for absence of
fluorescence signal in fluorescence microscopy. Polymer ves-
icles were given to cultures of macrophages for different time
points in a working concentration of 4 nmol/L. An intact
carrier does not generate a significant signal in fluorescence
microscopy due to the self-quenching properties of encapsu-
lated calcein, whereas the generation of a signal indicates the
disintegration of the carrier. Ratio of cells with significant
green fluorescence (higher than background fluorescence) in
the sample compared to total number of cells seen by phase
contrast microscopy was taken as parameter for the integrity
of the polymer vesicles (no fluorescence indicates intact
vesicles).
Cytotoxicity Assay
Cytotoxicity in macrophages was studied with an
acetoxymethyl (AM) ester derivate of calcein (1 mmol/L in
DMSO; Invitrogen). Macrophages were incubated with
polymer vesicles containing pravastatin or PBS and compared
to controls. After 24 hours of incubation, the cells were
washed with PBS and exposed to 1 mmol/L calcein AM for
60 min. The lipophilic, nonfluorescent calcein AM is hydro-
lyzed inside living cells by nonspecific esterases and stains
selectively living cells. To assess the known toxic effects of
pravastatin on skeletal muscle cells, we additionally performed
a colorimetric LDH release assay (Sigma-Aldrich) in 96-well
multiwell plates to confirm the results from the Calcein AM
release assay.26 Dead cells release intracellular LDH into the
serum-free medium, where it is detected with a standard
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method based on the NADH-mediated conversion of a
tetrazolium dye. The dye was detected with an automated
microplate absorption reader (MPP 4001, Mikrotek, Overath,
Germany) at a wavelength of 490 nm. Ratio of living cells in
the sample compared to the cell number in an untreated control
was taken as cell survival parameter.
Data Acquisition and Statistics
Cells were examined using fluorescence microscopy
(Olympus IX 50, Camera ColorView II FW, Software
analySIS) and confocal laser scanning microscopy (Zeiss
ConfoCor 2, HAL 100, HBO 100, Software LSM 510 Zeiss)
by selecting multiple random fields of view in an unbiased
way. Image acquisition settings were unchanged over the
whole experiment. Digital images were treated according to
Nature’s guide for digital images (Nature Publishing Group,
UK). The resulting series of images were analyzed by standard
data analysis software (ImageJ, National Institutes of Health,
Bethesda, MD) with automated particle counting to determine
the number of cells per field of view whenever necessary.
Standard statistics were used, including calculation of means
and standard deviations (SD), linear regression, least square
fitting to the sigmoid function for determination of ED50,
application of analysis of variance (ANOVA), and Student’s
t test for group comparisons.
RESULTS
Polymer Vesicle Characterization
Polymer vesicles with encapsulated pravastatin (Fig. 1)
show a mean outer diameter of 97 nm (standard deviation 10
nm) in cryogenic transmission electron microscopy, whereof
the inner diameter is 72 nm (SD 14 nm). The resulting mean
width of the polymer membrane itself is 13 nm. Based on the
inner diameter of 72 nm, the calculated inner volume of an
idealized vesicle is approximately 1.8e-19 liter. Based on
a mean vesicle concentration per ml watery solution of 5e12
vesicles per milliliter,25 the total inner volume of all vesicles in
1 mL solution is 8.01 mL. Since the pravastatin encapsulated
into the polymer vesicles has the same concentration as the
initial bulk solution (1.12 mmol/L), it is possible to calculate
the mean pravastatin concentration of the solution after
chromatographic removal of all non-encapsulated pravastatin.
The calculated pravastatin concentration in the resulting
vesicle solution is 8.97 mmol/L.
Targeting of Polymer Vesicles
Polymer vesicles functionalized with polyG ligands
show a strong uptake into active macrophages, but were not
taken up in significant numbers into skeletal muscle cells due
to their target selectivity to class A scavenger receptors (Fig.
2A and B). After 2 hours, the fluorescence-labeled vesicles can
FIGURE 1. Vesicle characterization.
A, Schematic drawing of a ligand-
functionalized amphiphilic triblock
copolymer vesicle with encapsulated
pravastatin. B, Vesicles were visual-
ized with cryogenic transmission
electron microscopy. The images
show a highly homogenous popula-
tion of vesicles with a mean diameter
slightly below 100 nm and an aque-
ous core. C, Detail of (B).
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be found in intracellular compartments of macrophages, most
probably endolysosomes (Fig. 2C).
Inhibition of Endocytotic Activity
Fluorescence-labeled acetylated LDL (ac-LDL) was
used to determine the effect of vesicle-encapsulated pravas-
tatin on the endocytotic activity of macrophages. When treated
with pravastatin-containing polymer vesicles for 24 hours, the
macrophages showed a decreased endocytotic activity com-
pared to cells treated with empty vesicles and untreated cells
(Fig. 3). The effect on the activity was dependent on the
concentration of pravastatin and the ED50 (dosage that
produces a significant reduction of endocytotic uptake in half
of the cell population) was 0.25 mmol/L final pravastatin
concentration in the cell culture medium (Fig. 4A). The same
experiments were performed with the fluorescence-labeled
oligonucleotide polyG as an activity marker. Here, the effect
was comparable to ac-LDL and the ED50 was 0.15 mmol/L
final pravastatin concentration in the cell culture medium
(Fig. 4B). These results confirm the equivalence of polyG as a
marker for macrophage endocytotic activity. The ED50 for
ligand uptake inhibition with nonencapsulated pravastatin was
11 mmol/L (final concentration of pravastatin in the cell culture
medium). Empty targeted polymer vesicles that did not contain
any drugs did not influence the endocytotic competence of
macrophages significantly (Fig. 4C), indicating that the
observed effect of vesicle-encapsulated pravastatin is only
caused by the drug itself and not by the polymeric carrier.
Substance Release Assay
To investigate the substance release properties of the
polymer vesicles inside the macrophages, the calcein release
assay was used (see Methods for details). Experiments with
different time points showed that the polymer vesicles
remained intact for as long as 6 to 12 hours inside the macro-
phages (Fig. 4D). Between 12 hours and 36 hours, there was
a gradual increase of fluorescent signal, indicating a continuous
release and deposition of the dye inside the cell (Fig. 2D). The
results indicate further that the polymer vesicles are bio-
degradable and show sustained release properties, features that
render the results gained in experiments with pravastatin-
containing vesicles even more valuable.
Toxicity Assay
To explore possible toxic effects, we exposed standard-
ized cell cultures of macrophages to high concentrations of
both pravastatin-containing polymer vesicles and empty
vesicles for 24 hours. After 24 hours, 63% (SD 19.6%) of
FIGURE 2. Cellular uptake of vesicles
and substance release. A, Uptake of 4
nmol/L labeled ligand-functionalized
polymer vesicles (red) into THP-1
macrophages (nucleus is stained
blue) was visualized by fluorescence
microscopy. B, L6 skeletal muscle
cells were exposed to 4 nmol/L
labeled polymer vesicles. The muscle
cells do not take up any fluorescence-
labeled polymer vesicles. C, Detailed
analysis of a single macrophage with
confocal microscopy demonstrates
the intracellular localization of a large
amount of polymer vesicles. D,
Green fluorescent calcein is released
from polymer vesicles upon time-
dependent biodegradation of the
polymer membranes in THP-1 mac-
rophages. The image shows the
aspect after 24 h of incubation.
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the untreated macrophages were vital, whereas cells treated
with 10% ethanol showed a survival rate of 2.9% (SD 0.75%;
P , 0.01, always versus untreated control). Treatment with
a high concentration of 10 nmol/L polymer vesicles resulted in
a survival rate of 54% (SD 15.2%; P = 0.40) for pravastatin-
loaded vesicles and 57.9% (SD 16.7%; P = 0.68) for empty
vesicles, respectively.
Cell cultures of rat skeletal muscle cells were incubated
with free pravastatin or pravastatin-containing polymer
vesicles to compare their effect on cell survival. Treatment
with high concentrations of free pravastatin leads to significant
acute toxic effects on the muscle cells in two different assays
(Fig. 5). Viability decreased at concentrations of 2 to 3 times
ED50, and at a concentration of 10-fold ED50 (correspond-
ing to 110 mmol/L pravastatin in medium), only 12.5%
(SD 6.4%; P , 0.01) of the cells remained viable after
24 hours. Ligand-functionalized polymer vesicles on the
other hand lead to no significant increase in cell death up to
15-fold ED50.
DISCUSSION
We showed that receptor-targeted polymer vesicles can
be used for safe encapsulation and highly efficient delivery of
pravastatin and controlled intracellular release of encapsulated
hydrophilic substances. With this novel delivery tool, it is
possible to inhibit the endocytotic activity of macrophages
defined by the uptake of known scavenger receptor ligands.
With free pravastatin, the same effect can only be achieved
with much higher doses that would lead to life-threatening side
effects in humans. Polymer vesicles with or without encap-
sulated pravastatin exhibit no toxic effects in cell cultures in
high concentrations and are known to be stable and target-
specific drugs delivery tools. Due to their protein-repellent
polymeric surface layer and specific ligand functionalization,
the vesicles are only taken up by the desired target cell, but not
by other cell types that might cause side effects in organisms.
After uptake into macrophages, the polymer vesicles are
gradually degraded in intracellular compartments and release
their encapsulated load in a time-dependent way. Released
FIGURE 3. Inhibition of acLDL uptake into macrophages by pravastatin vesicles. Acetylated low density lipoproteins (ac-LDL)
labeled with a green fluorescent dye were given to populations of THP-1 macrophages for 1 hour. The lower row shows the
localization of the cells determined by nuclear staining. The upper row shows the presence of ac-LDL in untreated cells (left) and
populations pretreated (for 24 h) with either 4 nmol/L pravastatin-containing polymer vesicles (middle) or 4 nmol/L empty
polymer vesicles (right). In the untreated population, only about 20% of the cells take up significant amounts of ac-LDL, indicating
an inhomogeneous endocytotic activity. Cells treated with pravastatin-containing vesicles show a clear decrease of ac-LDL uptake,
whereas cells treated with the empty vesicles show only a minimal decrease of ac-LDL uptake. The images prove the inhibition of
ac-LDL uptake into macrophages by pravastatin-containing polymer vesicles.
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drug molecules such as pravastatin reach instantly the cytosol
and can exhibit strong effects on cell metabolism and
immunological activity.
Until now, statins have scarcely been administered in
controlled release or drug delivery formulations27–29 due to
their overall low toxicity when used in lipid-lowering con-
centrations. However, the application of higher doses seems to
be profitable for the treatment of inflamed vulnerable plaques
and is only limited by the adverse side effects. Encapsulation
of extremely high doses of statins into target-specific poly-
meric vesicles promises to be useful for a selective inhibition
of highly active macrophages in vulnerable plaques.
However, the current study has several important lim-
itations that have to be investigated in future experiments. At
the moment, the targeted polymer vesicles were only tested in
cell cultures and there are no published results about the
behavior of this type of polymer vesicles in animals. Crucial
points for future experiments are in vivo targeting and bio-
distribution, biodegradability, efficacy, and short-term and
long-term toxicity. Furthermore, in the current experimental
setup, we only studied the effects of vesicle targeted pravastatin
on the endocytotic activity of macrophages. In future, it will be
interesting to see the effect of this treatment on cytokine
production, cell motility, and survival and other important
FIGURE 4. Inhibition of endocytotic activity and substance release. A, Quantification of the endocytosis inhibitory effect of
pravastatin-containing polymer vesicles was performed with different drug concentrations. Macrophages with a significant
(stronger than background) uptake of labeled ac-LDL were taken as quantification parameter. The necessary drug concentration to
inhibit the endocytotic uptake of ac-LDL by 50% (ED50) is 0.25 mmol/L. B, The same experiment as in a) was repeated with the
labeled oligonucleotide polyG instead of ac-LDL as an activity marker. For free pravastatin, ED50 is 11 mmol/L, whereas for the
polymer vesicles containing pravastatin the ED50 is only 0.15 mmol/L. C, The effect on polyG uptake of pravastatin-containing
polymer vesicles was compared to empty polymer vesicles. Pravastatin-containing polymer vesicles show again a strong inhibition
of endocytotic activity, whereas empty vesicles exhibit no significant inhibitory effect on macrophage endocytosis. The results
indicate that the inhibition of endocytotic activity is mainly due to the drug molecule and not due a blockade of scavenger
receptors with the polymer vesicles. D, Release of self-quenching calcein from polymer vesicles inside the macrophages indicates
the integrity of the vesicles. No fluorescence inside the cells indicates intact vesicles; strong green fluorescence indicates the
disintegration of the vesicles and the controlled release of the hydrophilic content. After 6 hours of incubation, only few cells show
fluorescence, whereas after 24 hours, almost 80% of the cells show significant fluorescence. The polymer vesicles are stable inside
the cells for at least 6–12 hours and are degraded after 1 day. The encapsulated content is released in a controlled way. In graphs
A–C, the number of untreated living cells was normalized to 1.0; the error bars represent the standard deviation over a series of
experiments; curves represent the mathematical approximation to the data; in A–C, the x-axis is logarithmic.
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functions of macrophages that play crucial roles in the
progression of vulnerable plaque inflammation and rupture.
Nevertheless, the current results build a strong basis of
evidence that extremely high doses of statins that are targeted
directly to macrophages might have hitherto unknown bene-
ficial effects in vivo. The target specificity might help to
increase the drug concentrations at sites such as the vulnerable
plaques while sparing healthy tissues sensitive to the drug such
as the skeletal muscle cells.
In future, this novel polymer vesicle based pravastatin
formulation might be used in patients with a high load of
vulnerable plaques in coronary or cranial arteries and may help
to lower the inflammatory burden and prevent potentially
deadly plaque ruptures.
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FIGURE 5.Cytotoxicity evaluation. Rat skeletal muscle cells were
incubated with high concentrations of pravastatin-containing
polymer vesicles or free pravastatin to determine toxic effects of
the drug with two different assays (see Methods section for
details). The free pravastatin shows strong acute toxic effects in
concentrations necessary to inhibit macrophage endocytic
activity with an estimated LD50 (dosage that induces cell death
in half of the myocyte population) of 4 to 5 times ED50. The
polymer vesicles containing encapsulated pravastatin on the
other hand show no significant toxic effects in this assay even at
concentrations up to 15 times ED50. (The number of untreated
living cells was normalized to 1.0; curves represent the math-
ematical approximation to the data).
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Biologically derived compartments are constrained in design
by their biological functions to ensure life at ambient
temperature. Polymer vesicles can be designed to match
application demands, such as mechanical stability, organic
solvent, substrate and product tolerance, and permeation
resistance, that are out of reach for biologically derived
vesicles.[1] Synthosomes use, in contrast to polymersomes, a
transmembrane channel for controlling the in and out
compound fluxes. The block copolymers in synthosomes
prevent compound penetration through the polymer shell,
whereas polymersomes depend on the diffusion of substrate
and product molecules through the polymer shell.
The main advantage of synthosomes over polymersomes
is that, through protein engineering, it is possible to design
functionalized protein channels. A protein channel that can
function as an on/off switch offers opportunities for the design
of functional nanocompartments with potential applications
in synthetic biology (pathway engineering), medicine (drug
release), and industrial biotechnology (chiral nanoreactors,
multistep syntheses, bioconversions in nonaqueous environ-
ments, and selective product recovery).
The channel proteins FhuA,[2] OmpF,[3–5] and Tsx[6] have
been incorporated, in functional active form, into block-
copolymer membranes. FhuA, ferric hydroxamate uptake
protein component, is a large monomeric transmembrane
protein of 714 amino acids folded into 22 antiparallel b
strands and made up of two domains. Crystal structures of
FhuA have been resolved,[7,8] and a large passive diffusion
channel (FhuA D1–160) was designed by removing a capping
globular domain (deletion of amino acids 5–160).[9,10] FhuA
and Tsx were crystallized as monomers and OmpFas a trimer.
FhuA and its engineered variants have a significantly wider
channel than OmpF (OmpF 27–38 5, FhuA 39–46 5)[11]
and this allows even the translocation of single-stranded
DNA.[12]
The aim and novelty of our work is the introduction of a
triggering system, by means of a reduction-triggered “release
switch” based on an engineered FhuA channel variant. To the
best of our knowledge, in none of the reported triggered
systems, was a channel protein employed as a switch.
In fact, for polymersomes, a pH trigger,[13] a temperature-
assisted pH trigger,[14] and a combined pH/salt trigger[15,16]
have been developed. Furthermore, hydrogen peroxide gen-
eration was used for polymer-vesicle degradation by glucose
oxidase catalyzing glucose oxidation,[17] and a pH-triggered
release system for a polypeptide vesicle has been reported.[18]
For synthosomes, the activation of an encapsulated phospha-
tase after a change in the pH value has been reported.[19]
To build up a reduction-triggered release system in
synthosomes, the amino-group-labeling agents 3-(2-pyridyl-
dithio)propionic acid N-hydroxysuccinimide ester (pyridyl
label) and (2-[biotinamido]ethylamido)-3,3’-dithiodipro-
pionic acid N-hydroxysuccinimide ester (biotinyl label) were
selected, due to size considerations and the presence of a
cleavable disulfide bond within the labeling reagents.
Reagents for the specific labeling of amino, hydroxy,
carboxyl, and sulfhydryl groups have been well studied and
are routinely used for protein modifications.[20–22]
The synthosome calcein release system proposed herein is
a triggered release system in which the entrapped compound
(calcein) is liberated through an engineered transmembrane
channel (FhuA D1–160) upon addition of a reducing agent.
Interestingly, label size played an important role in calcein
release. A detection protocol for calcein release from lip-
osomes through wild-type FhuA and FhuA D1–160 has been
reported.[2] The liposomes were loaded with calcein at a self-
quenching concentration (50 mm) and calcein release was
achieved by addition of wild-type FhuA and FhuA D1–160.
The fluorescence generation upon calcein release was used to
record the release kinetics.
In order to build a reduction-triggered release system, the
amino groups of lysine residues in FhuA D1–160 were
modified with either a pyridyl or a biotinyl label (see
above). Figure 1 illustrates the reactions for FhuA D1–160
with eight lysine residues (L167, L226, L344, L364, L455,
L537, L556, and L586) chemically modified with pyridyl (left)
or biotinyl labels (right).
Upon disulfide-bond reduction with DTT, a 3-thiopro-
pionic amide group remains on the lysine residues of the
FhuA D1–160 with both labels (Figure 1, upper part). Details
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of the chemistry of the pyridyl and biotinyl labeling of
FhuA D1–160, the protein stability, vesicle dimensions, and
FhuA D1–160 model generation can be found in the Support-
ing Information. The top view of the FhuA D1–160 channel in
Figure 1 provides an impression of how the pyridyl and
biotinyl labels restrict translocation after the lysine modifi-
cation, especially the sterically more demanding biotinyl
label. Figure 1 clearly shows how the transmembrane channel
might open up after DTT-induced release of the pyridyl and
biotinyl labels. However, the FhuA D1–160 models do not
take into account the possible channel dynamics that have
been recorded by conductance measurements.[10]
Figure 2 shows the calcein-release kinetics (upper panel)
and the absolute calcein concentrations (lower panel) in the
synthosomes before and after addition of the reduction
trigger (DTT). There is no detectable calcein release before
and after DTT addition in absence of the FhuA D1-160
(Figure 2, data set 1). In the case of the unlabeled FhuA D1–
160, one would expect that the calcein would translocate
through FhuA D1–160 as previously shown,[2] and it is there-
fore lost during synthosome purification (Figure 2, data set 2).
For the biotinyl-labeled FhuA D1–160, a linear release kinetic
is observed after DTTreduction. A greater than 30-fold faster
and exponential initial calcein release is observed upon
reduction of the less bulky pyridyl label, which leads to the
same 3-thiopropionic amide labeled FhuA D1–160 (Figure 1).
The strong size dependence of the initial release kinetics
indicates that the biotinyl labels stay bound to the FhuA D1–
160 channel upon DTT reduction. Interestingly, after approx-
imately six minutes, the release kinetics reached a nearly
constant increase for both labels, and this increase remained
constant for 2 h (data not shown). The release kinetics trend is
characteristic of passive diffusion processes and can be
modeled by the monoexponential defined in Equation (1),[23]
in which C is the calcein concentration versus time (t) and P1,
P2, and P3 are fitting constants (Figure 2; Table 1).
C ¼ P1exp

 t
P2

þP3 ð1Þ
Constant P1 depends on the calcein concentration gra-
dient inside and outside of the nanocompartments in the bulk
suspension (Table 1). The significantly higher values for the
pyridyl-labeled FhuA D1–160 channel (28.53 m for pyridyl
versus 7.24 m for biotinyl) can be attributed to FhuA D1–160
Figure 1. Reduction-triggered release system based on transmembrane
channel FhuA D1–160. FhuA D1–160 is chemically modified with
pyridyl or biotinyl labels at lysine residues in the barrel interior and at
the rim. The translocation of the calcein molecule (red) through the
pyridylated or biotinylated FhuA D1–160 is sterically hindered. Upon
reduction with 1,4-dithio-d,l-threitol (DTT), the disulfide bond in the
linker of the pyridyl or biotinyl label is broken and this results in
calcein release. The FhuA D1–160 model was prepared from the crystal
structure (Protein Data Bank entry: 1BY3) and all lysine residues have
been labeled in the model. Further details can be found in the
Supporting Information.
Figure 2. Upper panel: For the recording of the calcein-release kinetics,
quadruple sets of data were measured and averaged in all four
experiments. For each experiment, a data set with and without DTT
addition was recorded for nanocompartments loaded with 50 mm
calcein. Each experiment is specified by a number (1–4): 1) Nano-
compartments without FhuA D1–160 before (c) and after (c)
DTT addition; 2) synthosomes harboring FhuA D1–160 before (c)
and after (c) DTT addition; 3) biotinylated FhuA D1–160 syntho-
somes before (c) and after (c) DTT addition; 4) pyridylated
FhuA D1–160 synthosomes before (c) and after (c) DTT addi-
tion. Lower panel: calcein release in micromolar concentrations upon
DTT reduction as calculated from the results in the upper panel:
1) Nanocompartments without (c) and 2) with (c) FhuA D1–
160, 3) biotinyl-labeled FhuA D1–160 (c), and 4) pyridyl-labeled
FhuA D1–160 (c).
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limited diffusion because the employed samples were ana-
lyzed after purification with a Zeta-Sizer and, in quantity,
were normalized by elution areas. The P2 value represents the
time constant of the calcein-release process and describes the
efflux from the nanocompartment sample through the
FhuA D1–160 channel protein (Table 1); it is dependent on
the number of FhuA D1–160 molecules per nanocompart-
ment, the channel properties (size, charge, dynamics, chem-
ical labeling), and the DTT concentrations. Upon unblocking,
pyridyl-labeled FhuA D1–160 shows a time constant
(3.99 min) that is four times shorter than that of biotinyl-
labeled FhuA D1–160 (13.88 min). Apart from the labeled
amino groups, all other factors were identical and, therefore,
differences are directly connected to the nature of the
labeling reagents. The P3 constant describes the background
fluorescence of the nanocompartment systems (Table 1). The
significantly higher background values for the pyridyl-labeled
FhuA D1–160 channel (Figure 2) can be attributed to a slow
release of calcein during storage. The pyridyl-labeled
FhuA D1–160 suspension shows a calcein fluorescence
buildup after storage overnight, which is in contrast to the
biotinyl-labeled FhuA D1–160 suspension. A 4 h incubation
period after DTT addition results in a further increase in the
absolute fluorescence difference of less than 15% for both
pyridyl- and biotinyl-labeled FhuA D1–160 synthosomes.
At the moment, it is unknown which lysine residue(s) is
(are) decisive for blocking the calcein translocation in pyridyl-
and biotinyl-labeled FhuA D1–160. The biotinylation degree
found per single FhuA D1–160 molecule is 3.6 (see the
Supporting Information). Over the 29 lysines contained in
FhuA D1–160, 19 are on the protein surface which might be
covered by detergent; and probably not avoidable to biotin-
ylation. Another six are located in the channel interior and
only four are on the channel rim. It is reasonable that the
biotinylation occurs on the latter group because they are more
accessible to the reagent. Future investigations by lysine-site-
specific mutagenesis and modeling studies will shed light onto
this problem.
In summary, a synthosome reduction-triggered release
system with an engineered and chemically labeled FhuA D1–
160 channel has been developed and validated by calcein
release. Two labeling reagents of different sizes have been
used. The release kinetics of calcein were strongly modulated
by the size of the lysine-labeling reagents. In general, such on/
off switches would be of high value for controlling and
modulating cellular biosynthetic pathways and might become
attractive for applications in the pharmaceutical and/or
chemical industries. In ongoing studies, we aim to generate
a reversible switch by chemically “remodifying” the free
sulfhydryl groups that are formed upon reduction in the
FhuA D1–160 transmembrane channel protein.
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Table 1: P1, P2, and P3 constants from Equation (1), calculated by fitting
the recorded release kinetics data (Figure 2).
Nanocompartment system P1
[mm][a]
P2
[min][a]
P3[a]
nanocompartments without FhuA D1–160 – – 11.58
synthosomes with FhuA D1–160 – – 14.53
synthosomes with FhuA D1–160 and bio-
tinyl label
7.24 13.88 23.76
synthosomes with FhuA D1–160 and pyr-
idyl label
28.53 3.99 165.72
[a] Further details given in the text.
Angewandte
Chemie
7031Angew. Chem. Int. Ed. 2008, 47, 7029 –7031 	 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.angewandte.org
118 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
119 
 
2.4.7 Monolayer Interactions between Lipids and Amphiphilic Block Copolymers 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1
Monolayer Interactions between Lipids and Amphiphilic Block Copolymers 
 
Katarzyna Kita-Tokarczyka,*, Fabian Itelb, Mariusz Grzelakowskia, Stefan Eglia, Peggy Rossbachc, 
Wolfgang Meiera,* 
 
a University of Basel, Department of Chemistry, Klingelbergstrasse 80, 4056 Basel, Switzerland 
b University of Basel, Swiss Nanoscience Institute, Klingelbergstrasse 82, 4056 Basel, Switzerland 
c Swiss Federal Laboratories for Materials Testing and Research (Empa), Nanoscale Materials 
Science, Überlandstrasse 129, 8600 Dübendorf, Switzerland 
 
* corresponding authors: k.kita@unibas.ch; phone: +41 61 2673832; fax: +41 61 2673855; 
wolfgang.meier@unibas.ch; phone: +41 61 2673802; fax: +41 61 2673855 
 
Abstract 
 
 Interactions in binary mixed monolayers from lipids: 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC) and 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), and amphiphilic poly-
(2-methyloxazoline)-block-poly-(dimethylsiloxane)-block-poly-(2-methyloxazoline) block copolymers 
were studied using the Langmuir balance technique and Brewster angle microscopy. It is shown that 
monolayers from the saturated lipid (DPPC) are more sensitive to the presence of polymers in the film, 
resulting in phase separation and the formation of pure lipid domains at high surface pressure. The 
morphology and composition of such phase separated lipid-polymer films were studied by 
fluorescence microscopy and ToF-SIMS. In contrast, in DOPC-containing monolayers, the polymers 
tend to phase-separate at low surface pressures only and homogeneous films are obtained upon 
further compression, due to higher lipid fluidity. The analysis of excess energy of mixing shows, that 
while the separation effect in densely packed DPPC-containing films is strongly dependent on the 
polymer size (with the larger polymer having a much stronger influence), in the case of monolayers 
with DOPC much smaller effects are observed. The results are discussed in terms of the monolayer 
composition, lipid fluidity and polymer size. 
 
1. Introduction 
 
 Self-assembly properties of amphiphilic block copolymers make them an emerging platform 
for applications in biosciences. In particular, similarly to small amphiphiles, they aggregate in solution, 
the process being controlled, among others, by the polymer chemistry and block size 1. So far, sub-
micrometer sized structures like micelles and vesicles were studied in the context of drug delivery 2-5. 
Micelles and vesicular membranes are preferentially used to host hydrophobic drugs, while the 
aqueous cavities of the vesicles encapsulate water-soluble drugs. Literature data show, that drug-
loaded self-assemblies (vesicles) are able to enter cells and release their cargo 6, which subsequently 
leads to effects such as tumor size decrease 7. All those phenomena involve the vesicle integration 
with cells: at some stage of that process the vesicular membrane will come into close contact with a 
cellular membrane (either outside or inside the cell) and interactions between the two membranes can 
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be expected. This process may be critical for the drug delivery process and depending on the synergy 
/ antagonism between the cell membrane components and the polymeric amphiphile may lead to 
stabilization or disruption of the cell membrane. Therefore, it is important to study the membrane 
interactions in such mixed lipid-polymer systems, in order to optimize the delivery vehicles and avoid 
unwanted effects on the cell membranes. 
 The goal of our work was to investigate interactions between lipids and amphiphilic block 
copolymers by a monolayer technique. This method allows for simultaneous monitoring of the 
morphology of spread films (by Brewster angle microscopy) and energetic effects associated to the 
mixing / demixing phenomena in two-dimensional binary systems. This is, to our best knowledge, the 
first report presenting the behavior of mixed assemblies consisting of natural (lipid) and artificial 
(polymer) components. Earlier work in this field essentially focused on lipid-lipid interactions 8 and 
influence of soluble surfactants 9, 10 and insoluble amphiphiles 11 on lipid monolayers. 
Concerning adsorption of polymers to lipid Langmuir monolayers, those systems are different 
from the one studied here. In particular, partitioning of a surfactant between a monolayer and solution 
(subphase) depends on the surface pressure, and at high lipid packing density the equilibrium will be 
well shifted towards solution due to steric hindrance. This way, the amount of polymer in the film 
cannot exceed a certain limiting value, dependent on the initial polymer concentration and surface 
pressure. In this manuscript, we use amphiphilic polymers, which build stable Langmuir monolayers 
on their own – therefore, the lipid to polymer ratio can be changed freely. Moreover, to our best 
knowledge, this is the first report presenting quantitative data on phase separation in spread lipid-
polymer films. 
Certain literature evidence exists concerning the behavior of amphiphilic block copolymers at 
the air-water interface. In particular, monolayer characterizations were presented of poly(ethyl 
acrylate)-block-poly(styrene) 12, poly(ethylene oxide)-block-poly(styrene) (and their pH-controlled 
interpolymer complexes with poly(acrylic acid) in the subphase) 13, poly(ethyl ethylene)-block-
poly(ethylene oxide) 14, poly(ethylene oxide)-block-poly(butylenes oxide) 15 and polystyrene-block-
poly(ethylene oxide) 16. Molecular orientation of hydrophobic polyleucine helices of polyleucine-block-
poly(ethylene oxide) at the air-water interface was analyzed by FT-IR and circular dichroism on 
Langmuir-Blodgett films 17. Eisenberg et al. investigated interfacial micelle formation from block 
polyelectrolytes 18.Finally, the monolayer behavior of poly-(2-methyloxazoline)-block-poly-
(dimethylsiloxane)-block-poly-(2-methyloxazoline), PMOXA-PDMS-PMOXA, block copolymers was 
described in the context of monolayer interactions with alamethicin, an amphiphilic peptide 19. 
 PMOXA-PDMS-PMOXA polymers spread at the air-water interface from organic solvents to 
produce fluid, yet exceptionally stable monolayers. The detailed analysis of monolayer phases shows 
a possibility of conformational transitions in the PDMS block, which are mostly responsible for film 
fluidity. Depending on the polymer size, these rearrangements are reflected in an extensive plateau 
region in surface pressure-area isotherms. It was also shown 19, that such polymers are able to 
rearrange to adapt to the presence of more rigid species in the film (like peptide helices), without large 
energetic expenses. 
 In this work, we analyzed monolayer interactions between two PMOXA-PDMS-PMOXA 
polymers (with distinctly different molar masses) and two lipids, 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC) and 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC). The lipids were 
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chosen based on differences in their monolayer packing, i.e. DPPC, being saturated, tends to form 
liquid crystalline monolayers, while DOPC, containing double bonds, forms condensed liquid films. We 
compare the monolayer morphology at different surface pressures depending on the lipid-polymer 
ratio in the film and discuss the energetic effects related to monolayer mixing / phase separation and 
their dependence on the lipid structure (fluidity) and the polymer size. 
 
2. Materials and Methods 
 
Block copolymers were synthesized and purified as described previously 20. We used two 
symmetric poly-(2-methyloxazoline)-block-poly-(dimethylsiloxane)-block-poly-(2-methyloxazoline) 
copolymers: PMOXA15-PDMS110-PMOXA15, further referred to as A15B110A15 (mass 10700 g/mol, 
polydispersity index 1.62), and PMOXA65-PDMS165-PMOXA65, further referred to as A65B165A65 (mass 
23200 g/mol, polydispersity index 1.63). For visualization of polymer phases in A15B110A15-containing 
monolayers, we used up to 5 mole % of an analogous polymer, A10B85A10 (mass 7200 g/mol), 
covalently labeled with sulforhodamine B (SRB) 21. 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine 
(DPPC, M = 734.05 g/mol), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC, M = 786.15 g/mol) and 
fluorescent 1-palmitoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sn-glycero-3-
phosphocholine (NBD-PC, M = 856.05 g/mol) were purchased from Avanti Polar Lipids, Inc. as 
chloroform solutions. 
Polymer and lipid solutions were prepared using HPLC-grade chloroform (Sigma Aldrich). 
Langmuir troughs were cleaned with HPLC-grade chloroform, ethanol purum ≥ 99.8% (Sigma Aldrich) 
and bi-distilled water, and the barriers were washed with ethanol and bi-distilled water. Langmuir 
monolayers were spread on bi-distilled water subphase. Silicon surfaces were cleaned in hot ‘piranha’ 
solution (concentrated hydrogen peroxide / sulphuric acid, 1:1 v/v) for 10 minutes, rinsed with bi-
distilled water and dried with nitrogen. Glass microscopy slides were washed with ethanol, bi-distilled 
water and dried under a nitrogen stream. 
 Monolayers were investigated with a KSV Inc. (Finland) Langmuir Teflon TM trough, area 420 
cm2, equipped with two symmetric, hydrophilic Delrin TM barriers, and a Wilhelmy plate (ashless filter 
paper, perimeter 20 mm) surface pressure sensor, accuracy of 0.1 mN/m. The trough was housed in a 
plastic cabinet to prevent dust contaminations, in an air-conditioned lab (200C). Before spreading a 
film, the cleanliness of the subphase was carefully checked by recording surface pressure of clean 
water and monitoring the surface by Brewster angle microscopy. Monolayers were spread drop-wise 
on the water surface as chloroform solutions (typically 0.5-1.0 mg/mL). The solvent was allowed to 
evaporate for 10 min, and the monolayers were compressed at the rate of 10 mm/min. After each 
measurement, the surface was cleaned and checked for impurities. 
 Monolayer transfers on solid substrates (silicon and glass) were performed by the Langmuir-
Blodgett (LB) technique, using a KSV Inc. (Finland) mini-LB trough (area 242 cm2), equipped with an 
identical surface pressure sensor as the large Langmuir trough. Prior to film spreading, the substrate 
was dipped down and the water surface was checked for impurities again (and cleaned if necessary). 
After compressing a film to a desired pressure, a monolayer was transferred upon dipper upstroke at 
0.5 mm/min. 
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 An EP3 system (imaging ellipsometer and Brewster angle microscope, BAM) from Nanofilm, 
Göttingen, Germany, was used for monolayer visualization at the air-water interface and silicon 
wafers, as well as for film thickness determination. The EP3 system, equipped with a Nd-YAG laser 
(532 nm), Nikon 20x objective, and monochrome CCD camera attached to real-time frame grabber 
was used, mounted over the Langmuir trough (or solid sample stage). Ellipsometry measurements on 
silicon were performed at the angle of incidence range from 40 to 700 in steps of 50 in four-zone mode, 
and fitted with an n_k_fix algorithm using database parameters for silicon and silicon oxide, and silicon 
oxide thickness of 2.2 nm, as determined independently. Best fits were obtained using the refractive 
index of the material equal to 1.2. 
 Fluorescence microscopy of monolayers transferred to glass surfaces was performed using a 
Leica DM-RP microscope. Fluorescence from SRB-labeled polymer was monitored at 586 nm, while 
from NBD-labeled DPPC at 534 nm. 
ToF-SIMS measurements (Time of Flight - Secondary Ion Mass Spectrometry) were done 
using a ToFSIMS5 spectrometer from ION-TOF, Münster, Germany. We used Bi3++ ions, energy of 25 
kV, as primary ions for both spectra and imaging acquisition. All spectra (references and A15B110A15-
DPPC mixed film) were acquired with high mass resolution and characteristic peaks were identified for 
the DPPC and the polymer using negatively charged secondary ions. The imaging of the A15B110A15-
DPPC mixed monolayer was done in the so-called burst alignment mode, which gives very good 
lateral resolution (between 0.5 and 1 µm) at unit mass resolution in a reasonable acquisition time. 
 
3. Results and Discussion 
 
3.1 Monolayers from pure amphiphiles 
 
Langmuir monolayers from lipids and triblock copolymers were measured first as reference 
systems. Since those compounds were extensively investigated earlier and literature data are 
available (DPPC 22, 23; DOPC 24, 25, analogous block copolymers 19), we present their surface pressure-
area isotherms as supporting information (Figure S1), and shortly discuss the details most relevant for 
further experiments. 
The main difference between DOPC and DPPC is the structure of alkyl chains, namely, DPPC 
contains two saturated hydrocarbon chains, while DOPC has one double bond in each chain. This 
structural difference influences the organization properties of the two lipids at the air-water interface 
(Figure S1 A). At room temperature, DPPC forms a liquid crystalline phase at surface pressure above 
10 mN/m, manifested by an almost vertical slope of the isotherm, corresponding to mean molecular 
area of ca. 0.5 nm2/molecule. On the other hand, the unsaturated DOPC chains lead to a less 
condensed Langmuir film, the isotherm of which is characterized by a smaller slope and the smallest 
molecular area to which the film can be compressed is considerably lower (ca. 0.7 nm2/molecule at the 
collapse pressure) than in the case of DPPC (~0.45 nm2/molecule). Thus, the monolayer can be 
described as more fluid, and no long-range crystalline packing of molecules can be observed. 
 Concerning the triblock copolymers (Figure S1 B), monolayer behavior of very similar 
polymers was discussed previously 19, and no major differences were observed here apart from 
changes in lift-off areas consistent with different molar masses of the investigated block copolymers. 
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For this work, we performed additional control experiments on A15B110A15 and A65B165A65 monolayers 
to investigate the influence of certain experimental conditions on the film behavior. In summary, our 
data show that the surface pressure-area isotherms are insensitive to the amount of material spread at 
the air-water interface, meaning that the material efficiently spreads to form monolayers, and also that 
the polymer does not dissolve in the subphase. Additionally, isotherms from block copolymers do not 
show any temperature dependence in the range from 10 to 350C, which confirms our previous 
conclusion 19 that the broad plateau region is not related to a first order phase transition, and can be 
attributed to conformational rearrangements of the polymer molecules. The isotherms are fully 
reversible upon multiple compression-expansion cycles - we could not observe any hysteresis, which 
means that the polymer does not dissolve in water, and also that the film elastically responds to area 
changes. We also monitored polymer film stability at constant area and at different surface pressures 
(from 5 to 45 mN/m), at 200C. Even at the highest surface pressure (45 mN/m), the films were 
excellently stable and maintained the pressure for longer than 30 minutes. This result is significant for 
our further LB film preparation, where the film stability is essential for successful transfers. The 
calculations of compressibility modulus for different phases of the polymer monolayers were also 
performed 19, from which we conclude that the polymer molecules are in a liquid state throughout the 
compression (Cs-1 ~ 40 - 50 mN/m), and no solid (crystalline) packing is observed. 
 
3.2 Mixed systems A15B110A15-DPPC and A65B165A65-DPPC 
 
 In this section, we discuss the behavior of mixed monolayers containing a triblock copolymer 
(A15B110A15 or A65B165A65) and DPPC, at the whole range of the components’ molar ratios. The 
monolayers were characterized by surface pressure-area isotherms and imaged with Brewster angle 
microscopy. Isotherm data were used to calculate excess free energy of mixing between the two 
components at low (7.5 mN/m) and high (25 mN/m) surface pressure. 
 
 Langmuir monolayers and Brewster angle microscopy 
 
 Figure 1 presents surface pressure-area isotherms from DPPC mixtures with A15B110A15 (A) 
and A65B165A65 (B), respectively, at different molar ratios. Obviously, the lift-off area of the films 
decreases stepwise with the addition of lipid. The A15B110A15-containing system (Figure 1 A) displays 
equal decrease steps with the addition of lipid (i.e. when the molar ratio of DPPC increases), from 
polymer molar ratio of 1.0 to 0.2. For the mixtures with A15B110A15 ratio of 0.2 and 0.1, a large gap is 
observed, which corresponds to the change of miscibility properties, as will be visualized later with 
BAM and showed by excess free energy calculations. A similar gap is also present for A65B165A65-
containing mixtures (Figure 1 B), this time for the A65B165A65 molar ratio between 0.3 and 0.4. This 
shift, compared to the A15B110A15, is explained by the size difference between the two polymers. If the 
large step in the lift-off area corresponds to a change of monolayer organization, it should be more 
pronounced at a yet smaller lipid ratio when a larger polymer is present in the system, as is indeed 
observed. 
For all lipid-polymer mixtures, the characteristic plateau visible in DPPC isotherms (at 6-7 
mN/m) disappears, indicating good polymer-lipid miscibility in the low surface pressure region. Such 
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behavior was observed before for mixtures of: polymers 26, aliphatic alcohols and polymers 27, and 
lipids and calixarenes 28. On the other hand, the plateau present in isotherms from pure polymers (at 
10 to 17 mN/m), and corresponding to the conformational rearrangement of the polymer chains, is still 
present in all isotherms from polymer-lipid mixtures. Due to a decreasing amount of polymer 
molecules with the addition of lipid, the span of the plateau decreases. Since this isotherm feature is 
not associated with a polymer first-order phase transition, its surface pressure should not be affected 
by the addition of a second component. Obviously, the lipid molecules may affect the packing and 
chain rearrangements of the macromolecules, however, given the large difference in size between the 
lipid and the polymer (one order of magnitude difference in molar mass between DPPC and 
A15B110A15), it would rather be expected that the packing and organization of lipid will be more affected 
by the presence of the polymer, than the other way around. This is shown by BAM micrographs, both 
at low and high surface pressure. 
 
 
Figure 1 Isotherms from, respectively, A: A15B110A15 (largest area), DPPC (smallest area), and 
A15B110A15–DPPC mixtures at different molar ratios (in steps of 0.1); and B: A65B165A65 
(largest area), DPPC (smallest area), and A65B165A65–DPPC mixtures at different 
molar ratios (in steps of 0.1), at 200C on aqueous subphase. The lines in the graphs 
from left to right correspond to (molar ratios DPPC): DPPC 1.0; DPPC 0.9; DPPC 0.8; 
etc., DPPC 0.0 
 
The isotherm behavior at high (20 – 30 mN/m) surface pressures for all DPPC-polymer 
mixtures corresponds to well-packed polymer-lipid monolayers. All isotherms display slopes in the 
range between the respective values for the polymer and DPPC monolayers, the former being smaller 
due to the fact that the polymers form a condensed liquid phase, while DPPC forms a liquid crystalline 
phase. On the other hand, depending on the mixture composition, BAM imaging reveals very 
interesting morphological features in this surface pressure region. 
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Figure 2 presents BAM micrographs of DPPC-A15B110A15 monolayers at low (A) and high (B-
D) surface pressure, respectively. It needs to be stressed that the features visible here are only 
characteristic for particular compositions of the lipid-polymer mixtures, as described below. For any 
other mixture composition, as well as for the pure components, homogeneous monolayers are 
observed, the only features being small bright aggregates which are always present in polymer films 
(presumably surface micelles, as reported previously 18, 29). We need to mention here, however, that 
BAM resolution with the 20x objective is 1 μm, and therefore any features at the nanoscale will not be 
visible with this technique, yet cannot be ruled out completely. We will return to this point when 
discussing free excess energy of mixing. 
 
 
Figure 2 Brewster angle microscopy images of monolayers from A15B110A15-DPPC: A - 0.1-0.9 
at 10 mN/m; B - 0.3-0.7 at 25 mN/m; C - 0.2-0.8 at 25 mN/m; D - 0.1-0.9 at 25 mN/m. 
Image width: 220 μm. 
 
Concerning the low surface pressure region (Figure 2 A), we can observe four different 
grayscale levels, corresponding to four different film thicknesses: black (the smallest film thickness), 
dark gray, light gray (the largest film thickness), and very bright dots. Given the size difference 
between the film components, we interpret the black regions as aqueous subphase (not covered by a 
monolayer), dark gray regions as a lipid film, perhaps containing some polymer and the light gray 
domains as the polymer phase, which may also contain some lipid. This interpretation is plausible 
when one considers fluid-in-fluid, partially miscible binary monolayers 30, and literature examples of 
three-phase coexistence at similar surface pressures 31. Alternatively, the domain formation could 
result from polymer film viscosity; however this interpretation is not supported by excellent reversibility 
of the polymer monolayers, even at high compression-expansion rates. 
As mentioned before, the bright white structures are characteristic to the polymer monolayers 
and appear also in the films from pure polymers. Upon compression, the black regions disappear with 
the pressure increase and turn into a mixture of dark and light gray, until the film becomes 
homogeneous along the plateau region. This phase separation at low surface pressure is consistent 
with the miscibility gap visible in the surface pressure-area isotherm at the same lipid-polymer 
composition. The important fact is that at this surface pressure, both components are in a liquid state. 
Therefore, the features observed by BAM also display liquid-like character, which is manifested by 
A B C D 
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round shapes of the domains resulting from the fact that both components try to minimize their contact 
area. This will no longer be the case when the lipid’s crystallinity comes into play. 
At higher surface pressures (25 mN/m and above), mixed monolayers phase-separate at the 
polymer molar ratio of 0.3 and below. This means, it is necessary to have an amount of lipid in the film 
large enough so that the crystalline packing (and the corresponding alkyl chain interactions) prevails 
over the hydrophobic interactions present in large polymer chains. The resulting structures are 
presented in Figure 2 B-D. We can essentially see a dark-gray film, in which bright dots and black 
star-like structures (10 to 20 μm) appear. In contrary to Figure 2 A, the black structures do not 
correspond to the pure aqueous subphase anymore: due to the fact, that the polymer film becomes 
thicker upon compression, there is a larger amount of the reflected light entering the camera, which at 
some point becomes saturated. Therefore, it is necessary to decrease the camera gain in order to 
obtain the images, and as a result, the film regions of lower thickness will now appear very dark. From 
the light reflectivity, and thus the monolayer thickness, we interpret the star-like structures as DPPC 
domains, the gray region as the polymer film (which may also contain the lipid), and the bright dots 
again correspond to interfacial polymer aggregates. Further on we show detailed surface analysis to 
support this interpretation, and here we will discuss the formation of DPPC star-shaped domains. 
As mentioned before, DPPC domains appear at 25 mN/m at the polymer ratio 0.3 and lower. 
Contrary to the low pressure separation presented in Figure 2 A, we do not observe round features 
anymore, due to the fact that at such high surface pressure, the lipid, if it is able to form a monolayer 
phase on its own, will preferentially pack in a liquid-crystalline fashion within that phase. The size of 
the domains, contrary to their surface density, is not influenced by the polymer content in the mixture 
(in the 0.3-0.1 polymer molar ratio range), which suggests that the stars are not an intermediate 
phase, but rather stable lipid domains. Their size and shape do not change with film compression up 
to the collapse pressure, which is indicative of the most condensed packing state the lipid molecules 
can adopt, i.e. the liquid crystalline state. Their appearance in the film is also very sudden: they 
virtually show in the image from one second to another, even at very slow compression rates (3 
mm/min), and grow instantly to their final dimensions. The domain size is influenced by temperature: 
at 350C they grow to 30-40 μm. As the polymer monolayers are temperature-insensitive in this range, 
this suggest a fluidizing temperature effect on the lipid domains (Tc for DPPC is 410C) and subsequent 
expansion of the liquid crystalline lipid domains. As shown later, the dimensions of DPPC domains can 
be regulated to some extent by the polymer size, and it is obvious that the amphiphilic block 
copolymer has a stabilizing effect on both size and shape of the lipid stars. The polymer, as soft 
material, may also lead to edge ‘softening’ of those structures, yet this effect could be also due to the 
fact that DPPC is in a liquid crystalline, and not truly crystalline state, for which sharp edges would 
rather be favored. Additionally, we expect this effect to result from low interfacial tension between the 
two phases, especially if the polymer phase also contains a certain amount of DPPC, as shown later 
by Tof-SIMS experiments. 
 Due to the fact that A65B165A65 is twice as big as A15B110A15, phase separation in mixed 
monolayers containing this polymer is even more pronounced. Again, at low surface pressure (10 
mN/m), we observe the formation of circular polymer domains (Figure 3 A-C), which appear already at 
the polymer molar ratio of 0.3, which is consistent with the surface pressure-area isotherm shift for this 
system, as seen in Figure 1 B. With the increase of the polymer content, the separation effect leads to 
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smaller domains and their increased surface density. Throughout the plateau region, the domains 
merge to a homogeneous film, and similarly to mixtures containing A15B110A15, star-like lipid structures 
appear above 25 mN/m (Figure 3 D-H). With this bigger polymer, the star formation is present at yet 
lower lipid content in the mixture, starting from lipid molar ratio of 0.5 (0.7 for A15B110A15). This effect is 
explained by the larger size mismatch between the two components. 
 
 
Figure 3 Brewster angle microscopy images of monolayers from A65B165A65-DPPC at 10 mN/m 
(A – C): A - 0.3-0.7, B - 0.2-0.8, C - 0.1-0.9 and at 25 mNm (D – H): D - 0.5-0.5, E - 
0.4-0.6, F – 0.3-0.7, G – 0.2-0.8, and H – 0.1-0.9. Image width: 220 μm 
 
Brewster angle microscopy reveals essentially the same DPPC structures as described for 
A15B110A15. The only difference is a slightly larger size of the stars, up to ca. 25 μm, and the behavior 
of the mixture containing the molar ratio of the polymer of 0.1 (Figure 3 H). In this case, the lipid 
domains adopt more circular shapes and distribute homogeneously in the polymer matrix to form a 
network-like morphology. Worth mentioning is the size monodispersity of the domains, presumably 
due to a better thermodynamic stabilization, as compared to star-like structures. The increase of the 
interfacial (contact) area can be explained by the better phase separation, i.e. more lipid molecules 
being expelled from the polymer phase, leading to a two-dimensional emulsion analogue. There also 
seems to be a certain order concerning the organization of lipid domains: in particular, they tend to 
form necklace-like chains where the distances between the chains are always larger than between the 
domains within one chain. This particular lipid-polymer system will be investigated in more detail after 
we have measured the surface pressure effect on component distribution in the film – we hope to 
conclude on thermodynamic equilibrium (in the sense of time-dependent domain composition 
A B C 
D E F G H 
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changes). In the next section, we will analyze the excess free energies of mixing in lipid-polymer films, 
in order to explain the thermodynamic effects leading to the observed morphologies. 
 
Interaction analysis 
 
 Excess free energy of mixing in binary monolayers, ∫
π
π=∆
0
excexc dAG , where Aexc is excess 
molecular area resulting from system non-idealities, and π is surface pressure, is indicative of 
interactions and stability of the mixed film 32. For a given surface pressure, the excess molecular area 
is calculated as Aexc = A12 – (X1A1 + X2A2), where A12 is the mean molecular area in a mixed film, X1 
and X2 are molar ratios of components 1 and 2 in the mixed monolayer, and A1 and A2 are mean 
molecular areas of the pure components 1 and 2 at this surface pressure. Similarly to three-
dimensional binary mixtures, ∆Gexc = 0 means ideal miscibility, ∆Gexc > 0 indicates repulsion, while 
∆Gexc < 0 indicates attractive interactions between the mixture components. In the case of Langmuir 
monolayers, repulsion means expansion of the film, while attractive interactions lead to ‘contraction’ 
(or ‘condensation’) of the monolayer, and negative ∆Gexc means thermodynamic stabilization of the 
system. On the other hand, phase separation may also lead to negative Aexc, especially when one or 
both components have very good packing properties, like in the case of DPPC. 
 Figure S2 presents the excess free energies of mixing for DPPC-containing mixed monolayers 
with A15B110A15 (Fig. S2 A) and A65B165A65 (Fig. S2 B), at two different surface pressures, i.e. 7.5 
mN/m, and 25 mN/m, plotted versus monolayer composition. We will be mostly interested in 
discussing the thermodynamic effects for those monolayer compositions, which display distinct 
features by BAM imaging. For clearer visualization, schematic phase diagrams for DPPC-polymer 
mixtures are shown in Figure 4 (for phase description of pure components, see 19, 22, 23). 
 
 
Figure 4 Schematic phase diagrams (surface pressure versus mixture composition) for the 
polymer-DPPC mixtures 
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 Concerning the A15B110A15-DPPC monolayers, we observe the formation of polymer domains 
at low pressures for the polymer molar ratio of 0.1 only. This feature is reflected by negative ∆Gexc for 
this composition. The minimum ∆Gexc value is not exceptionally large, however, it is distinctly lower 
than the values for all other compositions at this pressure, which fall in the semi-ideal (∆Gexc close to 
zero) miscibility regime. Curiously, the high pressure (25 mN/m) effect, visualized as star-like domain 
formation, is not significantly pronounced in the ∆Gexc values. Given the phase separation, one could 
expect large positive values for the polymer molar ratio 0.3 and lower; instead only the maximum of 
235 J/mol is observed for the A15B110A15 molar ratio of 0.2. This result is consistent with our discussion 
on the thermodynamic stabilization of the lipid star domains by the block copolymer, as the energetic 
effect connected to the phase separation is very small. Additionally, the miscibility between the two 
components at high surface pressure and at the polymer ratio above 0.3 increases as compared to 
low surface pressure and is reflected by negative ∆Gexc, indicative of attractive interactions between 
the lipid and polymer. 
 The energetic contributions to miscibility between DPPC and the large polymer, A65B165A65, 
(Figure S2 B) are substantially larger, up to 2.5 kJ/mol, resulting from the fact that the chemical and 
size incompatibility between the mixture components is more pronounced than with A15B110A15. Most 
importantly, at low surface pressure (7.5 mN/m), we observe a large ∆Gexc minimum (-1.5 kJ/mol) 
exactly where BAM reveals the formation of polymer circular domains, i.e. at the molar ratio of 
A65B165A65 of 0.3 (Figure 4). At higher polymer content, the mixing seems unfavorable, and can be 
interpreted as a nanoscale phenomenon, where either the lipid would have preferred to form a film on 
its own, but is at the same time disturbed by large macromolecules, or the lipid molecules hinder free 
conformational changes of A65B165A65, and therefore we observe the film expansion, and thus positive 
values for the excess free energy. 
 At the high surface pressure, 25 mN/m, the situation is different: we never observe negative 
∆Gexc. This suggests unfavorable mixing in the whole composition range, and especially for the 
polymer molar ratio of 0.4 – 0.5, where the star domains of DPPC first appear. It seems that the 
stabilization of those structures is more efficient with the smaller polymer, A15B110A15, which can be 
explained by the smaller size of A15B110A15 and thus smaller size mismatch. On the other hand, the 
bigger A65B165A65 could be expected to have more conformational possibilities to adapt to the lipid 
phase and stabilize it further, yet it seems that the area constraints in the high surface pressure region 
hinder any conformational rearrangements, and thus the polymer frustration is demonstrated as 
positive ∆Gexc. 
 
 Langmuir-Blodgett film analysis: composition of phase-separated monolayers 
 
 So far we discussed the polymer-lipid phase separation based on the BAM observation of 
star-like structures, assuming that those film domains, characterized with smaller film thickness than 
their surrounding, should be formed by DPPC, which at high surface pressure organizes in a liquid-
crystalline fashion. Since the star structures appear very dark in BAM in contrast to the surrounding 
film, it could be argued that micrometer-sized holes are produced in the film upon compression. As 
unlikely as it sounds (we would not know why the holes should have star-like shapes, and why the 
very elastic polymer would not instantly expand to occupy the empty areas in the film), we found it 
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important to perform the analysis of the films in order to definitely determine the component 
distribution in the film. We analyzed Langmuir-Blodgett monolayers from polymer-DPPC mixtures at 
the molar ratios where star structures were visible, transferred from the air-water interface at 25 mN/m. 
 Firstly, we performed ellipsometry studies of monolayers transferred on silicon (Figure 5 A). 
Imaging ellipsometry of a A65B165A65-DPPC monolayer shows that the structures visible by BAM do not 
become destroyed during the transfer, and that the film morphology is retained. Film thickness was 
measured at various regions, corresponding to different light reflectivity (and thus different 
thicknesses). For DPPC-containing mixtures (with both polymers), the gray film has the thickness of 
5.0-6.5 nm, consistent with the polymer size assuming a ‘cigar’ phase, as described earlier 19. The 
dark, star-like structures always have the thickness of ca. 1.5-2.2 nm, which is consistent with the 
thickness of a lipid monolayer. This result also shows that the dark regions do contain some material. 
The problem here, however, is that the silicon surface is always covered by a silicon oxide layer. We 
have obviously included the silicon oxide layer in the fitting procedure; yet it can be argued that the 
silicon oxide thickness is not homogeneous throughout the whole surface, and produces artifacts 
during ellipsometry data fitting. 
 
 
Figure 5 (A) Ellipsometry image of a Langmuir-Blodgett monolayer from A65B165A65-DPPC, 
molar ratio 0.2-0.8, transferred to silicon surface at 25 mN/m. Image width: 220 μm. 
(B) Fluorescence microscopy image of a Langmuir-Blodgett monolayer from 
A15B110A15 (labelled with sulforhodamine)-DPPC, molar ratio polymer-lipid 0.3-0.7. The 
monolayer was transferred to a microscopy glass slide at 25 mN/m. Image width: 250 
μm 
 
In order to show where the polymer and lipid are present in the LB films, we used fluorescently 
labeled polymer and lipid as markers, and performed fluorescence microscopy after film transfer on 
microscopy glass slides. The fluorescence image of a labeled polymer-containing mixed film is 
presented in Figure 5 B. We can see here that transfer on glass surfaces also retains the film 
morphology, and that the labeled polymer distributes exclusively outside the star-like domains, which 
must therefore be either holes in the film or purely lipid domains. The bright ridges visible across the 
picture may be due to the polymer experiencing shear stress during the LB transfer or a dewetting 
effect, as the sample was imaged in the dry state a few hours after the transfer. 
We performed an analogous experiment using a fluorescently labeled lipid, NBD-PC (Figure 
S3), which lead to somewhat confusing results. Namely, we observe the NBD fluorescence from 
A B
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exactly the same regions where the SRB-labeled polymer emits, i.e. outside the stars. The explanation 
of that effect could be that indeed, holes are produced in the film while some molecules are squeezed 
out into the subphase, and the remaining lipid material is mixed with the polymer phase. On the other 
hand, the stability of such holes could not be explained, and especially not as a long-term effect, and 
not in the presence of materials as elastic as our block copolymers. Literature data on lipid 
monolayers studied with fluorescence microscopy 33, 34, however, describe the dye exclusion from 
organized lipid phases, which therefore always appears black in fluorescence micrographs. Knowing 
that DPPC tends to build a liquid crystalline phase at room temperature, we can expect that NBD-PC, 
which contains a bulky dye attached to one of the alkyl chains, would have different packing properties 
due to its smaller symmetry. It is therefore possible, that NBD-PC preferentially accumulates in the 
more liquid polymer phase, and we visualize the DPPC domains as black. 
In order to solve this problem, we analyzed the mixed LB films by ToF-SIMS. In control 
experiments, we first recorded mass spectra from a clean silicon wafer, an A15B110A15 film, and a lipid 
film. We identified the following peaks, which will further help to differentiate between lipid and polymer 
regions in the mixed film: for A15B110A15, the characteristic peaks are CN- (m/z = 26.00), and CNO- 
(m/z = 42.00), while for DPPC we observe a PO2- peak at m/z = 62.97, a PO3- peak at m/z = 78.92, 
and a peak corresponding to alkyl chains, C16H31O2-, at m/z = 255.25. To determine the spatial 
distribution of the two components in the film, we performed ToF-SIMS imaging, results are presented 
in Figure 6. In Fig. 6 A, the yellow color intensity corresponds to the CN- peak characteristic to 
A15B110A15, while in Fig. 6 B-D, the yellow color corresponds to, respectively, PO2- (Fig. 6 B); PO3- (Fig. 
6 C), and C16H31O2- (Fig. 6 D). 
 
 
Figure 6 ToF-SIMS images (100 x 100 μm) of Langmuir-Blodgett monolayers from A15B110A15-
DPPC, molar ratio 0.3-0.7 on silicon surface. The intensity of yellow color corresponds 
to, respectively: A – CN-, B - PO2-, C - PO3-, and D - C16H31O2-. 
 
The analysis of surface coverage shows that in star-like structures there is 4.5 % of the overall CN- 
intensity, 31.2 % of PO2- intensity, 37.3 % of PO3- intensity, and 41.5 % of C16H31O2- intensity (mean 
values from three measurements at different sample regions). This result indicates that while there 
might still be a very small amount of A15B110A15 present in the star-like structures (especially visible on 
the edges, as the lateral resolution is 0.5-1.0 μm), they are composed predominantly of DPPC, around 
40 % of which is expelled from the monolayer and phase-separates, while the remaining lipid (60 %) 
forms a mixed film with A15B110A15. Therefore, at surface pressure of 25 mN/m, the limiting DPPC 
amount in the monolayer is 70 mole %, and 28 mole % would be found in star structures. 
A B C D 
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In summary, we have shown that the phase separation in polymer-DPPC mixed monolayers at 
high surface pressure leads to the exclusion of some lipid from the film and the formation of 
characteristic star-like structures. This phenomenon is related to the chemical structure of the lipid and 
the resulting ability to form liquid crystalline phase at the air-water interface. 
 
3.3 Mixed systems A15B110A15-DOPC and A65B165A65-DOPC 
 
As presented before, miscibility of DPPC with soft, liquid-like polymer monolayers can be 
discussed as long as the amount of lipid in the film is small enough not to build lipid domains. At large 
lipid content, phase separation occurs, as the interactions present in the liquid crystalline packing state 
of the lipid are strong enough to lead to the formation of exclusively lipid-containing domains. We were 
also interested in the properties of polymer-lipid assemblies when a more fluid lipid were used, like 
DOPC. The properties of DOPC monolayers are discussed shortly in section 3.1, and here we will 
analyze mixed monolayers of DOPC with the same polymers as used with DPPC mixtures, i.e. 
A15B110A15 and A65B165A65. 
 
 Langmuir monolayers and Brewster angle microscopy 
 
 Surface pressure-area isotherms of DOPC-containing monolayers are presented in 
Supporting Information, Figure S4. In general, the pattern of the isotherms is the same as seen for 
DPPC-containing lipid-polymer mixtures (Figure 1). The difference is that we do not observe the 
isotherm shift corresponding to a change in miscibility at low surface pressure. In the case of DOPC-
containing monolayers, the distances in mean molecular area for the mixtures differing (by equal 
steps) in the molar ratio of the components, are equal. From this observation, we would not expect 
any polymer-lipid phase separation at low surface pressure, however when we analyze Brewster 
angle microscopy images, we can observe the formation of two phases below 10 mN/m. 
 BAM micrographs for DOPC-containing monolayers at low surface pressure are presented in 
Figure 7. Compared to DPPC-containing mixtures described in the previous sections, the main 
difference is that the lipid induces the formation of circular (thicker, therefore containing mostly the 
polymer) domains for both polymers, and that the domains appear at exactly the same lipid-polymer 
ratio (0.3-0.7) with both investigated polymers. With the increasing lipid content, the effect is stronger 
as demonstrated by the increasing size of the polymer domains. When the monolayers are 
compressed to higher surface pressure, the domains merge (throughout the plateau region), which 
means that the lipid becomes accommodated and ‘buried’ in the polymer phase, and this is possible 
due to the liquid properties of DOPC. Finally, at surface pressures where DPPC phase-separates to 
star-like domains, i.e. at 25 mN/m, smooth films are observed and no structural details can be 
visualized by BAM. 
 Obviously, we cannot expect exactly the same mixing behavior of the polymers with DOPC as 
with DPPC, since these two lipids have markedly different organization properties at the air-water 
interface. Interestingly, in the expanded fluid phase, DOPC seems to have identical influence on the 
polymers independent from the polymer size. This effect can be explained by the interplay of two 
phenomena: firstly, even at low surface pressure, DOPC has a more liquid character (and thus poorer 
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organization properties) than DPPC. The calculation of the compressibility modulus for the polymer 
monolayers indicate 19, that the organization of polymer chains is already quite high at this surface 
pressure, and therefore strong hydrophobic attraction will be the prevailing force leading to the 
separation of polymer domains from the lipid (or possibly lipid-polymer) film. The second effect results 
from the fact that the two polymers of markedly different dimensions will have different possibilities of 
chain rearrangements, with A65B165A65 being more flexible, and thus they will differently adopt to the 
presence of a second (lipid) component in the film. It seems that the A65B165A65 is somewhat less 
sensitive to the presence of a fluid lipid than A15B110A15, which means that it is easier for the large 
chains to find their energetically most favorable state, and therefore we observe the separation only 
starting from the polymer molar ratio of 0.3, i.e. at the same composition as with A15B110A15. In both 
cases, the decrease of polymer ratio leads to increased extent of phase separation, as manifested by 
the growth of the domains. This effect may seem counter-intuitive, yet considering the molar ratios in 
the mixed film, the polymers, as considerably larger components, will occupy more space at the air-
water interface than lipid molecules, even if the polymer content is considerably small. It should be 
also remembered, that at polymer molar ratios of 0.3, there may be a certain number of polymer 
molecules in the thinner phase, while with the increasing lipid content more polymer will be phase-
separated, and therefore we observe larger domains. 
 
 
Figure 7 Brewster angle microscopy images of monolayers (at 8 mN/m) from A15B110A15-DOPC 
(A, B): A - 0.3-0.7, B - 0.2-0.8; and A65B165A65-DOPC (C – E): C - 0.3-0.7, D - 0.2-0.8, 
E - 0.1-0.9. Image width: 220 μm 
 
A B 
C D E 
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 Interaction analysis 
 
Mixing of the two components at low surface pressure and at the polymer molar ratio of 0.3 
and lower is characterized by the domain formation, and therefore film contraction, leading to a small 
energy gain, as demonstrated by excess free energy calculations, Figure 8. While for A15B110A15, the 
∆Gexc is always small and negative (Fig. 8 A), for A65B165A65 negative values are only obtained for 
polymer molar ratios below 0.3 (Fig. 8 B). Especially with the large polymer, this result clearly 
demonstrates the difference in energetic contributions to the film organization resulting from different 
packing preferences of the lipid. 
 
 
Figure 8 Excess free energy of mixing for A: A15B110A15-DOPC and B: A65B165A65-DOPC 
monolayers versus mixture composition, at 5 mN/m (solid lines) and 25 mN/m (dotted 
lines) 
 
 Concerning the ∆Gexc values at high surface pressure (25 mN/m), we can instantly observe 
more favorable mixing of the liquid lipid with a smaller polymer, as could be actually expected 
considering that both components are in the condensed liquid region at this pressure, and both have 
certain possibilities for conformational changes in the film. With the larger polymer this effect is only 
seen at small molar ratios of the polymer, while at the compositions above 0.4 (polymer molar ratio), a 
positive energetic contribution is observed (Fig. 8 B). This result should be interpreted in the context of 
BAM images presented above: film contraction, and thus area decrease and negative ∆Gexc are seen 
exactly in the same region where the circular domains appear, and at the higher polymer content the 
amount of lipid is apparently too small to induce a phase separation on micrometer-scale, yet 
molecularly the components are not compatible and therefore their repulsion leads to positive excess 
energy of mixing. With A15B110A15, the small negative ∆Gexc contribution (Fig. 8 A) must be related to 
the fact that with the smaller polymer the lipid molecules can be more comfortably accommodated and 
the system is finally relatively stable. 
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4. Conclusions 
 
 Artificial block copolymers attract increasing attention in biomedical applications such as drug 
delivery 35, tissue engineering 36, 37 and diagnostics 38. Despite extensive research activities in this 
area, certain basic aspects have not been investigated so far, in particular interfacial effects such as 
membrane interactions. It is obvious, however, that interactions of cellular membrane components 
with polymers in the body may have important implications on the performance of polymer-based 
materials. Depending on the size and chemical structure of the polymer, different effects can be 
expected (and thus optimized), as shown in this report. 
 In summary, by studying Langmuir monolayers as membrane models, we have demonstrated 
that the behavior of cell membrane lipids is influenced by the presence of a polymer, in particular 
when the lipid, such as DPPC, has a tendency to form condensed phases in the membrane. What is 
more, relatively small amount of the polymer inserted in the membrane may be enough to force DPPC 
molecules to phase separate and form domains at high surface pressure. We have analyzed such 
phase separation phenomena in the context of domain shape, composition, and energetic 
contributions resulting from the polymer-lipid mixing / demixing process. 
In general, when we consider the cell membrane components of liquid crystalline character, 
smaller polymers, like our A15B110A15, have a moderate energetic effect, and in a narrower lipid-to-
polymer composition range. The success of applications such as vesicular drug delivery will strongly 
depend on this composition: when the polymer membrane comes into contact with a cellular 
membrane, a number of polymer molecules per cell membrane area can be directly correlated to our 
experiments and the energetic and morphological effect predicted. On the other hand, the fluid cell 
membrane component, DOPC, does not display strong energetic effect at high surface pressures, 
which means that the more fluid the cell membrane, the more resistant it should remain to the 
presence of macromolecular entities. 
 In this work, we focused on energetic contributions resulting from mixing amphiphilic triblock 
copolymers with individual lipids. At this stage, our results cannot be directly translated to cell 
membranes as a whole, due to cell membrane compositional complexity: in particular, we have not 
considered charged lipids, abundantly present in cell membranes, cholesterol, and any membrane 
proteins. On the other hand, we believe that studying individual membrane components provides basic 
information leading to straightforward comparison of thermodynamic data and should serve as the 
basis for the future research in this fascinating field. 
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Supporting Information 
 
 
Figure S1 Isotherms from lipids (A: DPPC (solid line) and DOPC (dotted line)), and polymers (B: 
A15B110A15 (solid line) and A65B165A65 (dotted line)); at 200C on aqueous subphase 
 
 
Figure S2 Excess free energy of mixing for A: A15B110A15-DPPC and B: A65B165A65-DPPC 
monolayers versus mixture composition, at 7.5 mN/m (solid lines) and 20 mN/m 
(dotted lines) 
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Figure S3 Fluorescence microscopy image of a Langmuir-Blodgett monolayer from A15B110A15 – 
NBD-PC, molar ratio polymer-lipid 0.3-0.7. The monolayer was transferred to a 
microscopy glass slide at 25 mN/m. Image width: 250 µm. 
 
 
Figure S4 Isotherms from respectively: A: A15B110A15 (largest area), DOPC (smallest area), and 
A15B110A15–DOPC mixtures at different molar ratios (in steps of 0.1), and B: A65B165A65 
(largest area), DOPC (smallest area), and A65B165A65–DOPC mixtures at different 
molar ratios (in steps of 0.1), at 200C on aqueous subphase. The lines in the graphs 
from left to right correspond to (molar ratios DOPC): DOPC 1.0; DOPC 0.9; DOPC 
0.8; ...; DOPC 0.0 
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3. Conclusions 
Biomimetic, membrane-forming PMOXA-PDMS-PMOXA block copolymers library was successfully 
synthesized and characterized with appropriate spectroscopic and chromatographic techniques. 
Previously published synthetic route for synthesizing PMOXA-PDMS-PMOXA copolymer was 
modified in order to get full control over the molecular weight of each of the blocks of the resulting 
block copolymer, reduce the level of contaminants and molecular weight polydispersity. To introduce 
additional functionality, expanding the utility of the synthesized block copolymers, the end-groups 
were modified with biotin (enabling specific binding) and methacrylate (enabling crosslinking). End 
functionalization was confirmed by FCS and FTIR experiments. The self-assembly properties of the 
synthesized ABA block copolymers into vesicular structures in dilute aqueous solutions were studied 
and cross-confirmed by light scattering, fluorescence correlation spectroscopy, electron microscopy, 
atomic force microscopy, encapsulation studies and indirectly by stopped-flow spectroscopy. It was 
also found that the choice of the appropriate technique to trigger the self-assembly process influences 
the ratio of resulting morphologies (micelles vs. vesicles). Film hydration method was preferentially 
used to generate aggregates resulting in up to 99.8 % of monodisperse vesicles in the case of dilute 
solutions of A12B55A12.  
Membrane forming capabilities of the synthesized block copolymers were employed together with 
functionality of natural membrane proteins and enzymes in the design of novel functional polymer-
protein hybrid materials and as a stable biomimetic platform for conducting basic research over the 
proteins themselves.  
We have shown successful incorporation of the bacterial water-channel protein Aquaporin-Z 
into an ABA triblock copolymer resulting in biomimetic membranes of high water permeability and 
selectivity for small solutes. The magnitude of increase in permeability and the excellent solute 
rejection capabilities demonstrate the potential benefit of such membranes for water treatment.  
We have used the ABA block copolymer membrane as a platform for investigating the 
properties of Aquaporine-Z. Aquaporin Z (AqpZ) was reported to be not gated in a narrow pH range in 
previous studies, and the physiological relevance of this protein is unknown.  The use of a synthetic 
biomimetic polymer of low permeability allowed sensitive examination of AqpZ permeability over a 
wide pH range.  AqpZ incorporated in this polymer was gated between pH values of 4 and 6 and this 
gating was reversible.  Whole experiments with E. Coli AqpZ mutants confirmed this observation.  
Furthermore, AqpZ mutants exhibit reduced survival under acid stress. pH gating of AqpZ may be 
important for cell survival at low pH values. 
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We have demonstrated that the immobilized biotinylated ABA block copolymer vesicles 
permeabilized with bacterial outer membrane protein F can serve as a novel tool to generate 
chemically/biologically active surfaces. This enables precise control over reaction environment and 
location and may be relevant for studies involving sensitive enzymes, single molecule spectroscopy, 
sensors and drug delivery. 
We have also demonstrated that synthetic membranes of amphiphilic triblock copolymer vesicles can 
be actively reconstituted with NADH:ubiquinone oxidoreductase (complex I), to form hybrid systems 
at the nanoscale that allow site-specific reactions driven by location and  redox-potential differences. 
Nanoscale devices involved in energy conversion require the transfer of electrons from one 
compartment to another in order to properly function. These electron transfer nanodevices are suitable 
for a variety of applications such as signaling devices or nanoreactors for follow-up redox reactions 
inside the synthetic membrane.  
The drug delivery application potential of vesicles prepared from ABA triblock copolymers was 
demonstrated in receptor-specific targeting using statin-loaded triblock copolymer vesicles with 
targeting moieties promising advancement in high-dose treatment for improved efficacy, while 
minimizing toxicity in other cells. Vesicle uptake by target cells but not other cell types and slow 
intracellular content release was observed. A major improvement in biologic efficacy was observed for 
polymer vesicles compared to free drug, whereas no increased cytotoxicity was observed in muscle 
cells. Such targeted therapy through cell-specific polymer vesicles allows novel treatment for a wide 
range of drugs and diseases. In addition, we have reported a potential drug delivery triggered release 
system based on engineered FhuA channel variant incorporated into ABA block copolymer vesicles. 
This engineered membrane protein releases the cargo of the vesicle in response to reductive stimuli 
(dithiothreitol) upon disulfide bond reduction. 
Due to drug delivery potential application of PMOXA-PDMS-PMOXA block copolymer vesicles, 
where interactions between polymeric and natural cell membranes are crucial and furthermore, due to 
the  fact that membrane proteins extracts contain certain amount of lipids, the interactions between two 
types of lipids and synthesized ABA block copolymers were investigated using Langmuir monolayers 
as membrane models. We have demonstrated that the behavior of cell membrane lipids is influenced 
by the presence of a polymer, in particular when the lipid, has a tendency to form condensed phases in 
the membrane. We analyzed phase separation of lipids/block copolymers in the context of domain 
shape, composition, and energetic contributions resulting from the polymer-lipid mixing / demixing 
process. 
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In summary we synthesized and characterized PMOXA-PDMS-PMOXA amphiphilic block 
copolymer library, studied their self-assembly properties and further applied the biomimetic polymer 
in development of novel polymer-protein hybrid materials promising new advancements in areas of 
water treatment, microfluidics, sensors and drug delivery.  
  
4. Outlook 
The Aquaporin-Z protein-polymer membranes developed here have salt rejection properties and 
excellent control over the permeability of polymers, ideal for desalination. Incorporation of AQPs (or 
suitable molecular mimics) into compatible synthetic polymers (such as the block copolymer system 
investigated in this study) is an innovative approach for making membranes for medical, industrial, 
and municipal desalting applications. For this new type of membranes to become useful for industrial 
water treatment and desalination, they have to be formed in flat sheets of large surface area, rather than 
vesicular aggregates. This can be achieved either by immobilization of aggregates or templating of 
membrane growth on supported porous membranes. Additionally, it is planned to fluorescently label 
the N-terminus of AQP-Z in order to quantify the reconstitution efficiency ofmembranes from block 
copolymers of different block lengths ratios.   
The methodology developed for novel immobilized nanoreactors enabling investigation of water 
soluble enzymes may serve as an investigation tool for studies over a wide range of different reactions 
or bioconversions and can be applied as a novel method for construction of chemically/biologically 
active surfaces for analytics, sensors and even controlled reactions. The studied immobilization 
methodology can be easily extended by the use of covalent attachment onto different types of 
substrates, by modifications of the functional end-groups of the block copolymer with control over the 
density of reactive species. In addition, post modification of the block-copolymer may lead to 
introduction of further functionality at the surface of the nanoreactors and accompanied by insertion of 
active compounds in the hydrophobic part of the membrane - enabling studies of cascade reactions. 
The morphology of the reactive surface is dependent on the structure of the PDMS mask used and may 
be chosen for specific application. 
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5. Materials and methods 
In this chapter information on materials and methods not included in the original publications are 
discussed.  
5.1 PMOXA-PDMS-PMOXA triblock copolymer synthesis and modifications 
The ABA block copolymer synthetic route is discussed on the example of A12B55A12 block copolymer.  
5.1.1 α,ω-Bis(4-hydroxybutyl) polydimethylsiloxane synthesis.  
250 ml round-bottom flask, equipped with reflux condenser and magnetic stirrer, was charged with 
100 g (0.8317 mol) of dimethoxydimethylsilane, 5.1482 g (0.01848 mol) of  
1-3-Bis(hydroxybutyl)tetramethyldisiloxane and 14.97 g (0.8317 mol) of bi-distilled water. 2 ml of 
concentrated HCl was injected and the reaction mixture was heated at 60°C for 1 h. Methanol was than 
distilled of and 66 ml were collected. The stirring was changed to mechanical and upon addition of 66 
ml of 6 M HCl, the reaction mixture was stirred at 1920 RPM, 60°C for 4 h. The crude product was 
separated from the aqueous layer. Diethyl ether was added and the solution was extracted with 
saturated solution of sodium bicarbonate twice and with bi-distilled water, until washings were 
neutral. Upon removal of solvent, the product was vacuum stripped at 80°C for 1 h. The purified 
product was added dropwise to vigorously stirred equal weight  mixture of methanol and bi-distilled 
water. Product was than extracted with diethyl ether and the precipitation procedure was repeated 
twice. To the last precipitation mixture small amount of diethyl ether (20 ml) was added to enable 
removal of small molecular weight oligomers not removed by first vacuum stripping procedure. The 
product was further high-vacuum stripped, at 80°C in the rotary ball tube distiller (Buechi) for 8 h. 
The reaction yield including purification steps was found to be 60% of the polymer of Mn = 
4070g/mol. 
5.1.2 Symmetric attachment of poly-2-methyl-2-oxazoline 
250 ml three neck round-bottom flask was charged with 33.82 g (8.3096 x 10-3 mol) of  
α,ω-bis(4-hydroxybutyl) polydimethylsiloxane and kept under high vacuum for 24 h. Upon multiple 
freeze drying cycles a Soxhlet extractor filled with dried molecular sieves (3A) and reflux condenser is 
mounted under argon flow onto the three neck flask containing dried PDMS. Dry hexane (150 ml) was 
added under argon flow to the PDMS. The solvent was recirculated for 48h under argon in order to 
remove the last traces of water. Upon removal of Soxhlet extractor the hexane solution of PDMS was 
cooled down to -10 ̊ C and 1.8078 g (1.7865 x 10-2 mol, 7.5 % excess in respect to hydroxyl groups of 
PDMS) of dry triethylamine was added. Than 4.9261 g (1.745 x 10-2 mol, 5% excess in respect to 
hydroxyl groups of PDMS, in 19 ml of hexane) of trifluoromethanesulfonic anhydride was added 
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dropwise to the stirred  and cooled reaction mixture. After 3 h, the solvent was removed under high 
vacuum and a fresh portion of dry hexane was added. The reaction mixture was filtered under argon 
via home-made G4 ceramic filtration unit equipped with the cooling envelope. Solvent was then 
removed under high vacuum resulting in colorless triflate activated PDMS. Dry ethyl acetate (100 ml) 
was added, followed by addition of 27.1422 g (0.3193 mol, 20% excess in respect to hydroxyl groups 
of PDMS, 16 units of PMOXA targeted) of 2-methyl-2-oxazoline. Ring opening polymerization was 
terminated by addition of 33.23 ml (9.3096 x 10-3 mol) of 0.5M KOH in methanol. Upon removal of 
solvents the resulting ABA block copolymer was purified in small parts (c.a. 5 g) by subsequent 
ultrafiltration in 1:5 (w/w) ethanol-water mixture, until washings did not show any dissolved solids. 
The purified product was further dissolved in 1:5 water ethanol mixture and most of the ethanol was 
removed by rotary evaporation. The remaining solution was freeze-dried to obtain fine powder. Traces 
of unreacted PDMS were removed by subsequent precipitation in hexane. 
5.1.3 End-group methacrylation 
A15B110A15 - methacrylation 
In a three neck round-bottom flask, equipped with reflux condenser, 2 g (1.8691 x 10-4 mol) of the 
hydroxy-terminated A15B110A15 triblock copolymer was dissolved at room temperature, under argon in 
20 mL of dry ethyl acetate. To this solution 60 mg (4.0044 x 10-4 mol, 3.5% excess) of 2-
isocyanatoethylmethacrylate (IEM) and about 40 mg of dibutyltin dilaureate were added. The solution 
was stirred for 48 h in the absence of light at 40°C. Solvent was evaporated under high vacuum and 
the raw product was purified by ultrafiltration in a 1:5 (w/w) water-ethanol mixture to remove low 
molecular weight impurities.  
A12B55A12 – methacrylation 
In a three neck round-bottom flask, equipped with reflux condenser 4 g (6.5466 x 10-4 mol) of the 
hydroxy-terminated A12B55A12 triblock copolymer was dissolved at room temperature, under argon in 
40 mL of dry ethyl acetate. To this solution 210 mg (1.3552 x 10-3 mol, 3.5% excess) of 2-
isocyanatoethylmethacrylate (IEM) and about 40 mg of dibutyltin dilaureate were added. The solution 
was stirred for 48 h in the absence of light at 40°C. Solvent was evaporated under high vacuum and 
the raw product was purified by ultrafiltration in a 1:5 (w/w) water-ethanol mixture to remove low 
molecular weight impurities. 
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5.1.4 End-group biotinylation 
A14B110A14 – biotinylation 
In a three neck round-bottom flask, equipped with reflux condenser 1 g (9.4056 x 10-5 mol) of the 
hydroxy-terminated A65B165A65 triblock copolymer was dissolved at room temperature, under argon in 
20 mL of dry chloroform. To this solution 213 mg (8.7184 x 10-4 mol, 4 fold excess) of D-biotin, 300 
mg of N,N'-dicyclohexylcarbodiimide and catalytic amout of 4-dimethylaminopyridine were added. 
The solution was stirred for 48 h at 40°C. Solvent was evaporated under high vacuum and the raw 
product was purified by ultrafiltration in a 1:5 (w/w) water-ethanol mixture to remove low molecular 
weight impurities. 
A65B165A65 – biotinylation 
In a three neck round-bottom flask, equipped with reflux condenser 2 g (8.5984 x 10-5 mol) of the 
hydroxy-terminated A65B165A65 triblock copolymer were dissolved at room temperature, under argon 
in 20 mL of dry chloroform . To this solution 167.9 mg (6.8788 x 10-4 mol, 4 fold excess) of D-biotin 
and 141.8 mg of N,N'-dicyclohexylcarbodiimide and catalytic amout of 4-dimethylaminopyridine was 
added. The solution was stirred for 48 h at 40°C. Solvent was evaporated under high vacuum and the 
raw product was purified by ultrafiltration in a 1:5 (w/w) water-ethanol mixture to remove low 
molecular weight impurities. 
5.2 Polymer characterization 
 
5.2.1 NMR 
NMR spectra were acquired on a Varian Unity 400 NMR spectrometer, operated at 400 MHz with 
a sweep width of 8278.146 Hz and 22° pulse width of 2.96 µs. CDCl3 was used as solvent. 
5.2.2 GPC 
GPC measurements were performed with a PLgel Mixed-C (5 Оm particle size) column (300x7.5 
mm) and THF as eluent in an Agilent modular system (Agilent 1100 Series Module GPC). Two 
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detectors were used, a UV fixed wavelength (Н=254 nm) and a refractive index (RI). Polystyrene 
standards of narrow molecular weights (Polystyrene Easical vials, Agilent technologies) were used for 
calibration. Injection volumes were 50 ОL and polymer concentrations 1 mg/ml. Samples were 
filtered through 0.2 µm milipore filters. Flow rates were 1ml/min and measurements were performed 
in thermostized columns at 23°C. Chromatograms, molecular weight distributions, and molecular 
weight averages were analyzed with the software ChemStation for GPC.  
 
5.2.3 Fourier Transform Infrared (FTIR) spectroscopy.  
A 30-50  mg sample of polymer was dissolved in 5 ml CHCl3 and transferred to a glass slide.  In the 
case of A15B110A15 it was left overnight to dry and form a thick film. For A12B55A12 the glass slide was 
put in a vacuum evaporator to dry off the CHCl3. Attenuated total reflectance Fourier transform 
infrared (ATR-FTIR) spectrometry was used to assess changes in characteristic functional groups of 
the methacrylated triblock co-polymer during UV crosslinking. Analyses were performed with a 
NEXUS 670 FTIR spectrometer (Thermo Nicolet Corporation, Madison, WI) equipped with a smart 
golden gate accessory, DTGS-KBr detector, KBr beam-splitter and diamond crystal. An IR source at 
45° incident angle was employed.  Samples of polymer were put in direct contact with the diamond 
crystal and 32-64 scans were conducted in the range of 600 to 4000 cm-1 for each sample. The 
information from these scans was averaged by the instrument to provide IR spectra which were then 
analyzed.   
 
5.3 Native polymers self assembly: physico-chemical characterization 
5.3.1 Vesicles preparation methods 
Vesicles preparation methods involve solvent free-techniques and techniques where an 
amphiphilic block copolymer is initially solubilized in organic solvent. Some applications, like 
encapsulation of sensitive materials or membrane protein insertion, require solvent-free preparations. 
Depending on the system, each method can yield varying self-assembled superstructures (micelles, 
vesicles, tubes). Homogenization and decrease of the size distribution of vesicle in dispersion can be 
achieved through vortexing, freeze–thaw cycles, extrusion and sonication, or a combination of these 
methods. These steps usually also lead to the decrease of the mean vesicle diameter as well as 
lamellarity of vesicles.10 
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5.3.1.1 Solvent displacement 
In the solvent displacement method, the amphiphile is first dissolved in an appropriate organic solvent 
and then added dropwise to an aqueous solution under vigorous stirring. This leads to the dispersion of 
vesicles of a rather broad size distribution. It is a very fast and convenient method to produce vesicles, 
with the drawback of having low amount of organic solvent remaining in the vesicles and the 
surrounding liquid. Solvent residues may interfere in biological applications and may cause 
fluidization of membranes leading to decreased vesicle stabilities.10 Utilizing the solvent displacement 
technique for generating aggregates in dilute aqueous solutions of PMOXA-PDMS-PMOXA resulted 
in the formation of two populations of aggregates with broad size distribution seen in DLS 
measurement. The estimated size PDI of the aggregates was 0.4 (Figure 27).  
 
Figure 27. DLS data obtained at 90° for mixed aggregates (vesicles and micelles) prepared with the solvent 
displacement method (10 mg/ml of A12B55A12 in PBS buffer, pH 7.4). 
5.3.1.2 Detergent removal 
In the detergent removal method the amphiphilic block copolymer is solubilized in a detergent 
solution. Upon removal of detergent the superstructures are formed.10 Detergent removal can be 
achieved with the aid of different techniques: dialysis49, adsorption on hydrophobic porous beads49  or 
chromatography50. Each of the approaches offers different ways of controlling the removal rate. The 
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rate at which the detergent is removed influences the sizes and morphologies of the resulting 
aggregates: slow detergent removal generally leads to formation of large aggregates. Figures 28 and 29 
show different sizes and morphologies of the aggregates resulting from different detergent removal 
rates. 
 
Figure 28. TEM micrographs of giant vesicles, stained with 2% uranyl acetate, upon slow detergent removal (2 
weeks, 4  ̊C). Scale bar 5000 nm (left) and 2000 nm (right).   
 
Figure 29. TEM micrographs of micelles/vesicles, stained with 2% uranyl acetate, resulting from fast detergent 
removal (3 days, ambient temperature). Scale bar 100nm. 
 
149 
 
5.3.1.3 Film hydration 
 
In the film hydration method, the amphiphilic block copolymer is first dissolved in organic solvent. 
Slow, controlled removal of the solvent leads to the formation of a thin polymer film on solid support. 
After further drying, the thin film is exposed to the aqueous solution resulting in swelling of the 
polymer film. Water molecules  permeate through the defects of the film allowing its hydration.10 The 
lamellar structures present in the polymer film and dilute vesicles were well characterized in literature, 
but the intermediate phases are not well understood.14 Film hydration was the preferential technique, to 
generate vesicular aggregates of well defined sizes. For instance, A12B55A12 vesicles prepared with this 
method are characterized by low size polydispersity (PDI < 0.15) of uniform vesicles, as shown in 
Figure 30. Additionally, this technique was utilized in experiments involving bio-molecules (enzymes, 
membrane proteins), incompatible with the solvent displacement approach.  
 
Figure 30. DLS data obtained at 90° for uniform vesicles prepared with film hydration method (6 mg/ml of 
A12B55A12 in PBS buffer, pH 7.4). 
5.3.2 Self-assembly characterization toolbox 
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Self-assembly properties of PMOXA-PDMS-PMOXA block copolymers were investigated, with the 
set of analytical methods commonly used in physicochemical characterization of colloidal 
superstructures. Techniques employed for investigation of the size and morphology of aggregates 
included: transmission electron microscopy (TEM), cryogenic- transmission electron microscopy 
(cryo-TEM), dynamic and static light scattering (DLS, SLS), fluorescence correlation spectroscopy 
(FCS) and atomic force microscopy (AFM). laser scanning microscopy (LSM) was used for 
visualization of particles and processes involving fluorescent products formation. The interfacial 
behavior of block copolymers membranes was studied using the Langmuir balance (LB) and Brewster 
angle microscopy (BAM).  
5.3.2.1 FCS 
Fluorescence correlation spectroscopy (FCS) measurements were accomplished on a ZEISS LSM 510 
META/Confocor2 microscope equipped with different laser lines.  
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5.3.2.2 Chemicals 
- Acetone-D6, Fluka, puriss., 
- Acid phosphatase, Sigma-Aldrich, lyophilized powder, 3-10 units/mg solid 
- 1,3-Bis(hydroxybutyl)tetramethyldisiloxane, 95% ABCR GmbH, 
- Biotin-D, Sigma-Aldrich, 
- Chloroform, Sigma-Aldrich, 98.8%,  
- Dicyclohexylcarbodiimide (DCC), Fluka, puriss.,  
- Dibutyltin dilaurate, Sigma-Aldrich, 95% 
- 4-dimethylaminopyridine (DMAP), Aldirch, 99%,   
- Diethyl ether, technical Schweizerhall, distilled, 
- Dimethoxydimethylsilane, Sigma-Aldrich, 95%, 
- ELF 97®, Invitrogen,  
- Ethanol, 96% EP, Schweizerhall, 
- Ethyl acetate, Sigma-Aldrich, anhydrous, 99.8%., 
- Hexane, Fluka, puriss.,  
- Hydrochloric acid, Sigma-Aldrich, ACS reagent, 37%, 
- 2-isocyanatoethylmethacrylate, Sigma-Aldrich, 98%, 
- Sodium bicarbonate, Sigma-Aldrich, puriss., 
- Sodium hydroxide, Sigma-Aldrich, reagent ACS, 
- Triethylamine, Sigma-Aldrich, puriss., 
- Triflic anhydride, Sigma-Aldrich, purum., 
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The difficulty in crystallizing channel proteins in three dimensions limits the use of X-ray 
crystallography in solving their structures. In contrast, the amphiphilic character of integral 
membrane proteins promotes their integration into artificial lipid bilayers. Protein–protein 
interactions may lead to ordering of the proteins within the lipid bilayer into two-dimensional 
crystals that are amenable to structural studies by electron crystallography and atomic force 
microscopy. While insertion of membrane proteins in lipid membranes is readily achieved1, 
the mechanisms for crystal formation during or after membrane reconstitution are not well 
understood. The nature of the detergent and lipid, as well as pH and counter-ions are known 
to influence the crystal type and quality 1(ref). Protein–protein interactions may also promote 
crystal stacking and aggregation of the sheet-like crystals, posing problems in data collection 
1. 
Electron crystallography is a structure determination technique that produced excellent 
results for prokaryotic and eukaryotic membrane proteins (ref). It has the attractive feature of 
studying the protein within an environment (the lipid bilayer) close to its natural 
surroundings. In the case where a channel of interest is present only in small amounts, is 
greatly dispersed in the membrane, and cannot be easily manipulated into crystalline arrays, 
2D crystallization of purified channel proteins offers an alternative. Three major processes are 
involved in 2D crystallization of membrane channels: reconstitution of the bilayer with the 
protein; arrangement or rearrangement of the protein into a lattice order, the actual 
crystallization event; and crystal folding and clustering. These processes may occur 
sequentially or concurrently, depending on many poorly understood parameters.1 
1. Two-dimensional (2D) crystallization of membrane proteins in ABA block
copolymer matrix-preliminary work 
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To produce high-quality 2D crystals, the protein of interest must usually be purified from 
other proteins and contaminants. This involves solubilization of the original membrane with 
detergent and commonly requires several subsequent separation steps. Finally, the pure 
protein is obtained in a detergent solution, often with residual lipids. The nature of the 
detergent in both protein purification and subsequent crystallization trials is a critical 
determinant of success. Most frequently, detergents with a high critical micelle concentration 
(CMC), such as octyl-b-glucoside (OG) or n-dodecyl-β-d-maltoside (DDM) have been used, 
because of the ease with which they can be removed by dialysis 1. The bilayer reconstitution 
with membrane proteins is achieved by decreasing the detergent concentration in the presence 
of lipids.1 
There is clear relationship between detergent concentration and the sizes of the formed 
structures. The ‘‘three-stage’’ Lichtenberg’s model (ref) involves: stage I characterized by a 
detergent concentration that is low enough not to disrupt the lipid bilayer, stage II where the 
lipid bilayer and mixed micellar structures coexist, and stage III covers the high detergent 
concentration where only small micellar structures occur. These specific regions are the 
‘‘saturation’’ and ‘‘solubilization’’ points that define completion of the solubilization of large 
structures upon addition of detergent. The micelle-bilayer transition region (Stage II) was 
found key to reconstitution and - by implication, to 2D crystallization. In the next steps 
detergent concentration is decreased, lipid and protein interact due to the exposure of their 
hydrophobic surfaces. With an excess of lipid over protein, the protein is mainly incorporated 
into lipid bilayers, similarly to its native state. In an excess of protein over lipid, the protein 
mostly forms amorphous aggregates, where it is most probably denatured. Another important 
parameter is therefore the lipid:protein ratio (LPR), which should be low enough to promote 
crystal contacts between protein molecules, but not so low that the protein is lost to 
aggregation. Reconstitution is closely linked to the properties of the detergents used during 
both purification and the reconstitution itself (the detergents used for purification can be 
exchanged for a different detergent used for reconstitution). The manner in which the 
detergent concentration is decreased is an important factor. .1, 2 
Utilization of established protocols allowed studies of various membrane proteins in the 
form of two-dimensional crystals (2DX). The scope of our research focused on 2D 
crystallization of: OmpF channels, Maltoporine, Aquaporin-Z and FoF1 ATPase. Two-
dimensional crystals of these proteins were obtained earlier via protein solubilization in 
detergent/lipid mixtures followed by detergent removal – results are shown here for 
comparison: OmpF figure11, Maltoporine Figure 2 ,1 Aquaporin-Z Figure 3, 3 and F0F1 
ATPase Figure 5 and 64 and Figure 7. 
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Figure 1. Large folded vesicle-type DMPC  (1,2-dimyristoyl- sn -glycero-3-phosphocholine) 
membranes reconstituted with OmpF at LPR = 1.0 (scale bar: 1μm).1 
 
 
Figure 2. Membrane from E. coli lipids reconstituted with Maltoporin at LPR  0.1 (vesicles 
with double bilayers in flat areas) (scale bar: 200 nm).1 
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Figure 3. Electron micrograph of negatively stained lipid bilayer reconstituted with AqpZ 
tetramers. Flattened vesicles with densely packed square-shaped particles corresponding to 
AqpZ tetramers self-assembled into mosaic tetragonal lattices at the lipid-to-protein ratio of 2. 
Scale bar represents 100 nm.3 
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Figure 4. Electron micrograph of negatively stained lipid bilayers reconstituted with AqpZ 
tetramers. Large piled-up AqpZ 2D crystal sheets. Scale bar represents 1 µm.3 
 
Fig. 5. Electron micrograph of negatively stained bovine FoF1-ATP synthase proteoliposomes. 
Proteoliposomes from egg yolk phosphatidylcholine PC at the LPR of 1 and protein pre-
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incubated with 0.16 mM DCCD, 0.6 mM ADP, 1 mM AMP-PNP at pH 8. Detergent (DDM) 
was removed by addition of Bio-Beads. Large paracrystalline arrays were visible after 4–5 
days incubation (inset, lower left). Scale bar 250 nm.4 
 
Figure 6. Electron micrograph of negatively stained membrane from a lipid mixture of egg 
yolk PC:DOPC (3:1), reconstituted with F1F0-ATPase, at the LPR of 0.5 (w/w) and pH 7.3 
(no DCCD added). Detergent (DDM) was removed by addition of Bio-Beads. Large 
paracrystalline arrays (>1 µm) were visible after 4–5 days incubation (inset, lower left). Scale 
bar 250 nm.4 
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Fig. 7. Electron micrograph of stained lipid (?) membrane reconstituted with bovine F1F0-
ATP synthase at low LPR. Electron micrograph: egg yolk PC membrane reconstituted with 
ATP synthase at the LPR of 0.4 (w/w). Detergent (DDM) was removed by addition of Bio 
Beads. Gallery: The areas in the electron micrograph marked by broken squares were 
magnified. Strings of F1F0-ATPase complexes in an up-down orientation are discerned. F1 and 
F0 domains are indicated by arrowheads and arrows, respectively. Bottom: Proposed model 
for the orientation of the ATP synthase in the imaged strings. Scale bar: 200 nm. Frame sizes 
of insets: 65 nm.4 
Analysis of two-dimensional protein crystals in lipid bilayers provides structural 
information on the membrane proteins. The lipid bilayer, reconstituted with the protein, 
resembles the protein’s natural environment - cell membrane. In our studies, we screened the 
possibility of two-dimensional crystallization of membrane proteins in ABA block copolymer 
matrix. Successful 2D crystallization of membrane proteins in block copolymer membraned 
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proves not only membrane reconstitution, but may also result in possibilities of protein 
structure determination in such a synthetic environment. In the case of the Aquaporin-Z, 
additional information is obtained for the design of densely packed, flat polymer-protein 
arrays for application in water treatment. Protocols used for 2D crystallization of the series of 
membrane proteins in ABA block copolymers followed the methodology developed for lipid-
based systems, taking into account the molecular weight differences between the stabilizing 
matrixes (lipid / block copolymer). The two methods applied involved: the detergent removal 
method and template method utilizing Ni-NTA functionalized diblock polymer as a template 
at the water/air interface. 
 
 
1.1 A12B55A12 block copolymer-assisted 2D crystallization of membrane 
proteins – detergent removal method 
Detergent removal from lipid-protein-detergent micellar solutions is the most successful 
strategy for proteoliposome reconstitution with integral membrane proteins or into two-
dimensional crystall.2 The protocol commonly used for lipid-based 2D crystallization of 
membrane proteins, utilizing detergent removal with the use of hydrophobic Biobeads SM-2,2 
was adapted to block copolymer-assisted crystallization studies of: Aquaporin-Z, Outer 
membrane protein F and F0F1 ATPase. Figure 8 shows the outline of the detergent removal 
method used. 
 
Figure 8. Outline of detergent removal experiments.  
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The general protocol used for all the investigated membrane proteins involved 
solubilization of the block copolymer, together with the protein in 10% DDM (w/v) solution 
in appropriate buffer. Upon overnight incubation at 4°C, the detergent was removed by 
subsequent addition of appropriate amount of hydrophobic beads2 (Biobeads, Bioraid SM-2).  
Conditions for 2D crystallization were screened by varying polymer to protein ratio 
(PoPR) and detergent removal rate. For Aquaporin-Z, the most suitable conditions resulting in 
large protein-rich sheets were found at PoPR=0.2, with slow detergent removal by subsequent 
addition of biobeads, for 14 days, at 4°C. Figure 9 shows a large Aquaporin-Z rich sheet of 
A12B55A12 membrane. Figure 10 shows the presence of the same type of structures at PoPR=1 
incubated at the same conditions but the structures populate the TEM grids in a much smaller 
number. Figure 11 shows results of experiments performed at ambient temperature were the 
detergent removal was complete within 3 days, resulting in formation of small crystalline 
domains for PoPR of 0.2 and 0.1. 
 
Figure 9. Electron micrographs of stained Aquaporin-Z - copolymer arrays obtained at 0.2 
PoPR upon slow detergent removal (2 weeks, 4°C). 
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Figure 10. Electron micrographs of stained Aquaporin-Z - copolymer arrays obtained at 1 
PoPR upon slow detergent removal (2 weeks, 4°C). 
 
Figure 11. Electron micrographs of: stained Aquaporin-Z - copolymer array obtained at PoPR 
0.2, upon fast detergent removal (left). Small crystalline structures formed and free protein 
tetramers are visible. Scale bar: 200 nm; Large copolymer vesicles reconstituted with 
Aquaporin-Z tetramers obtained at PoPR 0.1 (right), upon fast detergent removal. Scale bar: 
200 nm. 
 
The same conditions were further applied for 2D crystallization of OmpF and FoF1 
ATPase. In the case of OmpF, both PoPR=0.2 and PoPR=2 showed formation of crystal 
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structures, upon fast removal of detergent. Figure 12 shows the crystalline structures obtained 
for OmpF channel at PoPR=2.  
 
 
Figure 12. Electron micrographs of OmpF - copolymer crystals obtained at PoPR=2, with fast 
detergent removal. Scale bars: 200 nm. 
 
FoF1 ATPase is the most fragile and the most complicated of the membrane proteins 
used in our 2D crystallization studies. In the case of this protein, detergent removal resulted in 
the formation of ordered structures. Figure 13 shows electron micrographs of the copolymer – 
ATPase ordered structures. Analysis of the obtained electron micrographs, based on the 
literature research, did not allow clear conclusions on membrane reconstitution or ATPase 
crystallization in ABA block copolymer system. It is difficult to assess whether the protein 
remained intact during detergent removal procedure, and to associate the ordered structures 
formed to either the protein or the copolymer. 
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Figure 13. Electron micrographs of ATPase - copolymer aggregates, obtained at PoPR=2 
(left), PoPR=0.2 (right), with slow detergent removal. Scale bars: 200 nm. 
Detergent removal method, usually used for structure determination of membrane 
proteins in lipid-assisted 2D crystallization, was shown to be applicable for the membrane 
protein-block copolymer system. Densely packed protein arrays in block copolymer matrix 
were obtained in the case of almost all studied membrane proteins. In order to confirm 
crystallinity of the samples, further measurements of electron diffraction in transmission 
electron microscopy and/or cryogenic- transmission electron microscopy are required. 
Performing liquid state atomic force microscopy on the generated protein arrays would also 
allow structural protein studies. These measurements need to be performed.  
1.2 A12B55A12 block copolymer-assisted 2D crystallization of membrane 
proteins – template method 
Membrane proteins bearing polyhistidine tag: AQP-Z and FoF1 ATPase were used in 
polymer monolayer templated crystallization. Figure 14 shows the outline of the experiments. 
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Figure 14. Outline of polymer monolayer template technique. 
All experiments were performed in the Teflon troughs initially designed for lipid-templated 
2D crystallization of membrane proteins.5 The schematic design of the trough is shown in 
figure 15.  
 
 
Figure 15. Teflon wells for lipid layer 2D crystallization experiments. Teflon plates consist of 
eight wells of about 60 μl. Each well is connected to a side hole which allows injections of 
either micellar protein solutions or Bio-Beads. Stainless steel beads of 1 mm diameter (black 
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circles) allow gentle stirring without perturbing the surface lipid layer. Side and top views of 
Teflon wells are drawn to scale.5 
 
The concentration of the polybutadien-polyethylene oxide PB-PEO diblock 
copolymer forming the monolayer at the air-water interface was chosen on the basis of 
Langmuir monolayer experiments (not discussed in this thesis)6. The monolayer concentration 
of nickel complexes exposed to the water phase was regulated by mixing the nickel-NTA-
functionalized diblock copolymer with native, hydroxyl-terminated one, at the ratio of 20/80 
mol/mol. The ratio was adapted from procedures used in the lipid monolayer crystallization 
techniques.5, 7 The membrane protein of interest was solubilized together with ABA polymer 
in 10% (w/v) DDM detergent solution. Concentrations and ratios targeted a protein 
concentration of 100 µg/L in the subphase. Resulting solutions were stirred overnight at 4°C. 
The trough wells were filled with the appropriate, filtered buffer. Monolayer of nickel-NTA-
functionalized PB-PEO was formed at the water-air interface, by spreading of chloroform 
solution (0.6 µL). Upon evaporation of chloroform (ca. 1 h), the ternary mixture (ABA block 
copolymer and protein of interest) was added to the side port of the well. After stabilization of 
the mixture (ca. 1 h), appropriate amounts of Biobeads SM-2 were added every two hours. 
The resulting template-assembled protein arrays were transferred onto the plasma untreated, 
carbon-coated TEM grids. Grids were held by tweezers and dfilms were horizontally 
transferred from the air-water interface. After transfer, the resulting template-assisted 
assemblies were stained with 1% uranyl acetate, rinsed, dried and imaged with transmission 
electron microscopy. PoPR values and detergent removal rates were varied.  
Conclusions drawn from the investigation of the detergent removal rate influence on 
the polymer template-assisted 2D crystallization of the membrane proteins using A12B55A12 
are that the fast detergent removal in ambient temperature is favored, and leads to formation 
of large areas of protein arrays. Figure 16 shows a large area of the TEM grid covered with a 
protein array. 
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Figure 16. Electron micrograph of the stained PB-PEO template-assembled Aquaporin-Z 
array covering a large area of the grid. 
The optimal PoPR values for polymer template-assisted crystallization of Aquaporin-
Z were found in the range of 1-1.2 and resulted in protein-rich arrays. Figure 17 shows the 
comparison of the resulting template-assembled A12B55A12 protein array, with the one utilizing 
lipid matrix as template. 
 
 
 
Figure 17. Comparison of the template-assembled A12B55A12 - Aquaporin-Z array (left), with 
the one utilizing lipid matrix as template 5 (right) - TEM. 
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Figure 18 shows the set of template-assembled A12B55A12 - Aquaporin-Z arrays with PoPR=1. 
 
 
 
Figure 18. Template-assembled A12B55A12 - Aquaporin-Z arrays with PoPR=1 (scale bars: 200 
nm) 
Figure 19 shows single and multi-stack A12B55A12 - Aquaporine-Z  arrays at PoPR=1.2. It is 
difficult to conclude whether the multi-stacking of the polymer-protein arrays occurs during 
the transfer to TEM grids, or is a property of the generated assemblies. 
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Figure 19. Template-assembled single and multi-stack A12B55A12-Aquaporine-Z array with 
PoPR=1.2 - TEM (scale bar: 1000 nm). 
Confirmation of crystallinity of those arrays and analysis of protein structure requires 
further analysis utilizing electron diffraction in transmission electron microscopy and/or 
cryogenic-transmission electron microscopy. Performing liquid state atomic force microscopy 
on the generated protein arrays would also allow additional structural protein studies. The 
choice of the hydrophobic substrate (highly ordered pyrolic graphite, for instance) for AFM 
experiments is preferable and would allow undisturbed transfer of the protein arrays to the 
substrate due to hydrophobicity match with the  surface of the PB-PEO template at the water 
air interface. These measurements are not discussed in this thesis. 
In case of FoF1 ATPase template monolayer crystallization attempt, the control 
experiments showed template reconstitution of the membrane proteins into the structures built 
by lipid molecules present in the stock solution of the protein. Due to the high lipid 
concentration in the stock solution of the protein, further experiments were put on hold until 
the source of the lipid free protein is established.  
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Biomimetics has proved very useful in the design and fabrication of new functional, 
structured materials on the micro- and nanometer scale (reference). Biomimetic refers to 
human-made processes, devices, or systems that mimic or imitate certain aspects of biological 
systems; this has proven possible using biological inspiration from efficient natural designs. 
Biomimetics is not limited to just copying nature: scientists can directly utilize biological 
units themselves, taking advantage of the development of modern biology, in order to 
construct hybrid nanostructured materials. Thus, some of the manufacturing difficulties of 
biomimetics can be avoided. Active proteins, such as kinesin, myosin, and ATP synthase (or 
ATPase) are called ‘‘molecular motors’’ and play an essential role in the cell activity and 
regulate specific functions through their stimuli-responsive mechanical motions. The 
confluence of scientific developments in modern biology and nanoscience now offers the 
potential to design functional hybrid nanomaterials. A major challenge for the construction of 
functional hybrid nanomaterials is how to integrate natural molecular machines such as motor 
proteins into the engineered, active biomimetic systems.8 
Molecular motors such as myosin, kinesin, dynein and ATPase abound in living cells. Myosin 
motors drive muscle contraction and kinesin or dynein motors transport vesicles from one end 
of the cell to the other. All of these linear motors are supplied by biological energy through 
hydrolysis of the universal ‘‘fuel’’ molecule, adenosine 50-triphosphate (ATP). The F0F1-
ATP synthase (or F0F1 ATPase) is responsible for the catalytic synthesis of ATP molecules in 
biological organisms. They are widely present in the membranes of mitochondria, 
chloroplasts and prokaryotic cells, where they convert transmembrane electrochemical proton 
gradients into ATP. The F0F1-ATPase is a well-known rotary motor and probably the best-
understood biological molecular motor. It comprises two separate domains: F0, the 
hydrophobic membrane-bound portion that is responsible for proton translocation and F1, 
which is responsible for ATP hydrolysis or synthesis. The extramembranous F1 catalytic 
subcomplex is attached to the membrane-intrinsic F0 subcomplex by a central stalk and a 
peripheral stalk. Synthesis of ATP in F1 is driven by rotation of the central stalk, driven by 
protons passing through the membrane domain F0. The enzyme can also catalyze the reverse 
reaction, with ATP hydrolysis in F1 driving proton pumping in F0. The rotor is formed by the 
central stalk and a ring of C subunits in F0 which contain an essential carboxylic group. 
Rotation is generated by the binding and release of protons to the carboxylic group in the C-
2. ABA polymer vesicle reconstitution with FoF1
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ring as it enters the interface with the membrane subunit A of F0. The peripheral stalk acts as 
a stator that prevents the a3b3-subcomplex in F1 from following the rotation of the central 
stalk. Direct proof of the rotation of the central stalk within F1-ATPase hydrolysis was 
obtained by monitoring a fluorescently labeled actin filament or a micrometer particle to the g 
subunit. This experiment provided important insights into the mechanism of this molecular 
motor. Another important work (ref) showed an ATP-powered motor with nanofabricated 
propellers linked to the genetically engineered protein F1-ATPase. The rotational motion of 
F1-ATPase was coupled with hydrolysis of ATP. The work showed that F1-ATPase possesses 
energy transduction properties, that is, can convert chemical energy to mechanical energy. As 
a rotary molecular motor and ATP producer, the ATPase has attracted great interest and 
demonstrated numerous potential applications, from the generation of bioenergy to the design 
of novel nanodevices.8 
In order to enable fusion of nanotechnology with biology and study the possibility of 
incorporation of active biological molecular motor protein into synthetic PMOXA-PDMS-
PMOXA membranes, insertion of (E. coli derived) EF0F1 ATP synthase, into polymeric ABA 
block copolymer vesicles was performed. Reconstitution procedures involved detergent 
removal method and membrane destabilization method. Initial experiments involving 
detergent removal method are not discussed here. All conclusions drawn from those studies 
are summarized with results from membrane destabilization procedures.  
Polymer vesicles were prepared from two polymer batches, A12B55A12 and A21B54A21; with 
two preparation methods (film hydration and solvent displacement method). In film hydration 
method, 50 mg of each polymer was solubilized in chloroform in a round bottom flask. 
Evaporation of the solvent on rotary evaporator led to formation of thin films. Films were 
hydrated by 10 ml of HEPES buffer by rotation on rotary evaporator for 3 h and left stirred 
over night. Turbid solutions were filtered 5 times via 0.45 µm membranes on the barrel 
extruder (pressure 10 bar) and 15 times via 0.22 µm membranes, resulting in homogeneous 
turbid solutions. In solvent displacement method, 100 mg of polymers were dissolved in 0.5 
ml of absolute ethanol and added dropwise to 10 ml of stirred HEPES buffer. The solutions 
were stirred overnight and extruded as described above. Resulting solutions were slightly 
turbid, indicating the higher amount of micellar aggregates in solution in comparison to the 
ones obtained with film rehydration. 
Electron microscopy micrographs of polymer vesicles were recorded with PhilipsCM100 
microscope at 80 kV. Figure 20 shows micrographs of stained vesicles prepared with 
A12B55A12 block copolymer in film hydration method and figure 21 - of stained vesicles 
prepared with A21B54A21 commercial polymer (PolymerSource, Canada). 
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FoF1 reconstitution 
Polymer vesicles were destabilized by incubation with sodium cholate for 3 h (0.5% w/v 
cholate final concentration). All further treatment was done on crushed ice. To destabilized 
vesicles, the stock solution of EF0F1 was added to reach the polymer to protein ratio of 50:1, 
and incubated with gentle shaking for 30 minutes. Resulting solutions were purified 
(detergent removal) on NAP5 columns equilibrated with cold HEPES buffer. Turbid fractions 
were collected and used immediately for activity assays. 
Activity assays 
The assay follows the procedure developed for liposome reconstitution with F0F1 (azolectin) 
involving 9-amino-6-chloro-2-methoxyacridine (ACMA) kinetic fluorescence quenching, 
upon addition of ATP, and fluorescence recovery upon addition of (NH4)2SO4. In the assay, 
100 µl of eluted sample was diluted with 900 µl of HEPES buffer and 0.2 µl of ACMA stock 
solution (30 µM final concentration). The fluorescence of samples with the dye was measured 
at the excitation of 410 nm and emission of 490 nm (slit width 3 nm). The quenching was 
performed by addition of 10 µl of 0.1 M ATP solution and the kinetic decrease of 
fluorescence intensity was recorded for proteopolymerosomes. The immediate fluorescence 
restoration was observed upon addition of 5 µl of saturated (NH4)2SO4 solution. All of the 
proteopolymerosomes samples follow the same behavior (see Figure 20), with minor 
deviations of intensity, related to the preparation method. The proteopolymerosomes show 
kinetic quenching of the fluorescence intensity of the ACMA pH-sensitive dye, indicating 
proton pumping activity of the protein. Control measurements with polymer vesicles alone 
show no kinetic activity quenching (Figure 21). 
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Fig 20. Fluorescence quenching in proteopolymersomes. 
 
Fig 21. No kinetic fluorescence quenching for polymer control samples. 
The initial conclusions of successful synthetic membrane reconstitution with the motor 
protein were doubtful, as the protein control sample of the stock solution investigated with the 
same assay showed higher activity, than in the case of proteopolymersomes (Figure 22). 
Activity observed in control stock protein solution shows that the protein is stored in 
proteoliposomal form. This result indicates that lipid molecules (0.8 % w/v) present in stock 
protein solution, when incubated with destabilized vesicles form either mixed aggregates with 
block copolymer molecules, or pure proteoliposomes upon detergent removal. The removal of 
the lipid molecules from the stock solution, on the other hand, may trigger protein 
denaturation.  
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Fig 22. Fluorescence quenching in enzyme control sample. 
The results of the experiments do not allow clear conclusions on whether the activity in 
sample solutions comes from proteopolymerosomes, mixed lipid-polymer aggregates or 
purely lipidic vesicles. 
The encountered problem could be potentially overcome by fluorescent dye labeling of the 
protein, polymer and/or lipid, and performing FCS measurements. This could lead to 
relatively easy conclusions on incorporation of the lipid molecules in the polymeric 
membrane together with the inserted enzyme. Thus, the most promising way to approach and 
overcome the “lipid problem” is to prepare the enzyme stock solutions without lipid addition 
during the extraction step, and in parallel to perform protein extraction with ABA block 
copolymer as an alternative amphiphile, to have the opportunity of working with a more 
defined system. 
Conclusions drawn from the activity assays were additionally confirmed by means of 
attempts of crystallization of F0F1 ATPase with monolayer technique. The stock solution of 
the protein showed reconstitution into lipid aggregates and the influence of the polymer 
cannot be assessed . See chapter 1 of appendix.  
Materials and methods 
Buffer composition 
HEPES buffer 
20 mM HEPES/KOH (pH 8.0), 100 mM KCl, 5 mM MgCl2, 0.1 mM EDTA 
  23
Extraction buffer 
50 mM Tris/HCl (pH 7.5), 100 mM KCl, 250 mM sucrose, 40 mM aminocaproic acid, 15 
mM p-aminobenzamidine, 5 mM MgCl2, 0.1 mM EDTA, 0.8 % (w/v) asolectin, 0.5 % 
sodium deoxycholate, 0.5 % (w/v) sodium cholate, 1.5 % (w/v) octylglucoside, 2.5 % (w/v) 
glycerol, 30 mM imidazole 
 
 
 
 
Direct visualization of PMOXA-PDMA-PMOXA vesicles in TEM is difficult, due to the high 
vacuum in the microscope chamber (high vacuum). Therefore most of the samples were 
stained with uranyl acetate. Appropriate dilution and successful staining results in either 
staining of the vesicular wall, or visualization of the aggregates by exclusion of the stain, 
from the area where the aggregate was present. Exclusion of the staining agent makes the 
aggregates appear bright in the dark area of the stain. 
Vesicles solutions were usually diluted 100-fold with appropriate aqueous solution (pure 
water or buffer). Typically 5 µL of the sample solution was deposited on a carbon-coated 300 
mesh copper grid. After 1 minute incubation the remaining liquid was blotted, washed 2 times 
with pure water, and stained with 2% uranyl acetate by 10 seconds incubation followed by 
blotting. Samples were imaged with a Philips CM100 268D operated at 80 kV.  
Figure 23 shows the only successful direct visualization of A13B110A13 and Figure 24 of 
A15B110A15 vesicles.  
3. TEM of the block copolymer library
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Figure 23. TEM micrographs of direct visualization of A13B110A13 vesicles prepared with film 
hydration method. 
 
 
 
Figure 24. TEM micrographs of direct visualization of A15B110A15 vesicles prepared with film 
hydration method. 
As direct visualization of the vesicles was problematic due to destructive effect of vacuum on 
the vesicular structures, staining became a routine part of the visualization of aggregates in 
TEM. Figure 25 shows series of TEM micrographs of stained vesicles prepared with solvent 
replacement method for: A9B106A9, A65B165A65, A13B110A13 and A15B110A15 . 
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A). A9B106A9 
 
B). A65B165A65 
 
C). A13B110A13 
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D). A15B110A15 
 
Figure 25. Series of TEM micrographs of stained vesicles prepared with solvent replacement 
method for: A9B106A9 - (A), A65B165A65 – (B), A13B110A13 – (C) and A15B110A15 – (D). 
Vesicles prepared in film hydration method were imaged with TEM. Figure 26 shows TEM 
micrographs of stained vesicles of A12B55A12 prepared in film hydration method. Figure 27 
shows TEM micrographs of the commercial A21B54A21 polymer prepared in film hydration 
method.  
  
 
Fig 26 . TEM micrographs of A12B55A12 block copolymer vesicles prepared with film 
hydration method. 
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Fig 27 . TEM micrographs of A21B54A21 block copolymer vesicles prepared with film 
hydration method. 
The detergent removal method introduced and discussed in the chapter  2.2.1.2 of the main 
part of the thesis results in formation of aggregates of different sizes dependent on the 
detergent removal rate. Figure 29 shows small vesicles/micelles prepared by BioBeads SM-2 
fast detergent removal (10% sodium cholate removed in 8 h).  
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Figure 29. TEM micrograph of stained small vesicles/micelles prepared from A65B165A65 by 
fast detergent removal. 
TEM analysis of investigated vesicles solutions showed formation of vesicles (direct 
visualization) and formation of spherical aggregates (stained samples). In cases of TEM 
imaging of stained samples the morphology of the aggregates is not being resolved (micellar 
vs. vesicular structures). Nevertheless careful TEM analysis taking into account staining 
artifacts, combined with additional characterization techniques (DLS/SLS) provided 
significant information on self-assembly properties of investigated block copolymers.  
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